Clinical trial NCT02054520
Conditions: Stage IV Melanoma Metastatic Melanoma
Keywords: Stage IV metastatic melanoma
Sponsor: NewLink Genetics Corporation
Start date: 2014-06-01; Completion date: 2021-01-05
Enrollment: 47 participants; Allocation: RANDOMIZED; Intervention model: PARALLEL

Brief summary:
The purpose of this study is to examine the effectiveness of immune checkpoint inhibitors (drugs called ipilimumab, nivolumab, or pembrolizumab), either given alone, or in combination with the experimental immunotherapy drug, dorgenmeltucel-L, for melanoma. We hypothesize that this form of combinatorial immunotherapy will result in tumor stabilization or shrinkage, significant prolongation of progression-free, disease-free or overall survival compared to the use of immune checkpoint inhibitors alone.

Detailed description:
According to statistics of the American Cancer Society, an estimated 73,800 individuals will be diagnosed with melanoma and 9,900 will die of the disease in 2015 in the Unites States despite current therapy. This protocol attempts to exploit an approach to melanoma immunotherapy using a naturally occurring barrier to xenotransplantation in humans to increase the effectiveness of immunizing patients against their melanoma. The expression of the murine (1,3)galactosyltransferase \[alpha(1,3)GT\] gene results in the cell surface expression of (1,3)galactosyl-epitopes (alpha-gal) on membrane glycoproteins and glycolipids. These epitopes are the major target of the hyperacute rejection response that occurs when organs are transplanted from non-primate donor species into man. Human hosts often have pre-existing anti-alpha-gal antibodies that bind alpha-gal epitopes and lead to rapid activation of complement and cell lysis. The pre-existing anti-alpha-gal antibodies found in most individuals are thought to be due to exposure to alpha-gal epitopes that are naturally expressed on normal gut flora leading to chronic immunological stimulation.

These antibodies may comprise up to 1% of serum IgG. In this phase 2b study, patients with advanced stage melanoma will receive immune checkpoint inhibition consisting of ipilimumab, nivolumab, or pembrolizumab per the treating physician's standard of care. In addition to the immune checkpoint therapy, half of the patients will also receive dorgenmeltucel-L. Dorgenmeltucel-L is composed of irradiated allogeneic melanoma cell lines (HAM-1, HAM-2 and HAM-3). These cell lines have been transduced with a recombinant Moloney murine leukemia virus (MoMLV)-based retroviral vector expressing the murine (1,3)GT gene. Endpoints of the study include safety assessments, efficacy, and immunological responses.

Arms: arm 1: Arm 1A will receive ipilimumab at 3 mg/kg given every 3 weeks for 4 weeks and 300 Million HyperAcute®-Melanoma (HAM) Immunotherapy cells per each immunization, given every week for 4 weeks, every 2 weeks for 5 months, every month for 6 months, and every 3 months for one year. arm 2: Arm 2A will receive ipilimumab alone at 3 mg/kg every 3 weeks for a total of four doses. arm 3: Arm 1B will receive nivolumab alone at 3 mg/kg given every 2 weeks and 300 Million HyperAcute®-Melanoma (HAM) Immunotherapy cells per each immunization, given every week for 4 weeks, every 2 weeks for 5 months, every month for 6 months, and every 3 months for one year. arm 4: Arm 2B will receive nivolumab alone at 3 mg/kg given every 2 weeks arm 5: Arm 1C will receive pembrolizumab at 2 mg/kg given every 3 weeks and 300 Million HyperAcute®-Melanoma (HAM) Immunotherapy cells per each immunization, given every week for 4 weeks, every 2 weeks for 5 months, every month for 6 months, and every 3 months for one year. arm 6: Arm 2C will receive pembrolizumab at 2 mg/kg given every 3 weeks
Interventions: intervention 1: HyperAcute®-Melanoma (HAM) Immunotherapy intervention 2: Ipilimumab intervention 3: Pembrolizumab intervention 4: Nivolumab
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None intervention 4: None

Protocol documents:
Prot_SAP_000.pdf: 
1/*

9HUVLRQ'DWHG



&RQILGHQWLDO








&OLQLFDO7ULDO3URWRFRO
1/*

$3KDVHE6WXG\RI,PPXQH&KHFNSRLQW,QKLELWLRQ:LWKRU:LWKRXW
'RUJHQPHOWXFHO/+\SHU$FXWH0HODQRPD,PPXQRWKHUDS\IRU6WDJH,9
0HODQRPD3DWLHQWV


9HUVLRQ'DWHG
5HSODFHV9HUVLRQ


,1'
2%$
&OLQLFDOWULDOVJRY1&7



6WXG\6SRQVRU
1HZ/LQN*HQHWLFV&RUSRUDWLRQ
,RZD6WDWH8QLYHUVLW\5HVHDUFK3DUN
6RXWK/RRS'ULYH6XLWH
$PHV,RZD86$


,QYHVWLJDWLRQDO$JHQW
'RUJHQPHOWXFHO/+\SHU$FXWH0HODQRPD,PPXQRWKHUDS\+$0



67$7(0(172)&21),'(17,$/,7<
7KHFRQILGHQWLDOLQIRUPDWLRQLQWKHIROORZLQJGRFXPHQWLVSURYLGHGWR\RXDVDQLQYHVWLJDWRUSRWHQWLDO
LQYHVWLJDWRURUFRQVXOWDQWIRUUHYLHZE\\RX\RXUVWDIIDQGDSSOLFDEOHLQVWLWXWLRQDOUHYLHZERDUGV,W
LVXQGHUVWRRGWKDWWKHLQIRUPDWLRQZLOOQRWEHXVHGGLYXOJHGRUSXEOLVKHGZLWKRXWWKHZULWWHQFRQVHQW
RI1HZ/LQN*HQHWLFV&RUSRUDWLRQH[FHSWWRWKHH[WHQWQHFHVVDU\WRREWDLQLQIRUPHGFRQVHQWIURPWKRVH
SHUVRQVWRZKRPVWXG\PHGLFDWLRQPD\EHDGPLQLVWHUHG



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

&RQWDFW,QIRUPDWLRQ

6SRQVRU
1HZ/LQN*HQHWLFV&RUSRUDWLRQ
,RZD6WDWH8QLYHUVLW\5HVHDUFK3DUN
6RXWK/RRS'ULYH6XLWH
$PHV,RZD


93&OLQLFDO	0HGLFDO
$IIDLUV0HGLFDO
0RQLWRU
(XJHQH.HQQHG\0')$&6
93&OLQLFDODQG0HGLFDO$IIDLUV
1HZ/LQN*HQHWLFV&RUSRUDWLRQ
6RXWK/RRS'ULYH6XLWH
$PHV,RZD
2IILFHH[W
)D[
(PDLOJNHQQHG\#OLQNSFRP


&OLQLFDO7ULDO
2SHUDWLRQV
/XFLQGD7HQQDQW5106
6HQLRU'LUHFWRU&OLQLFDO2SHUDWLRQV
1HZ/LQN*HQHWLFV&RUSRUDWLRQ
6RXWK/RRS'ULYH6XLWH
$PHV,RZD
2IILFH
)D[
(PDLOOWHQQDQW#OLQNSFRP


'UXJ6KLSPHQW
6XSSO\&KDLQ
1HZ/LQN*HQHWLFV&RUSRUDWLRQ
6RXWK/RRS'ULYH6XLWH
$PHV,RZD
2IILFHH[W
(PDLOVF#OLQNSFRP
2UGHULQJ:HEVLWHZZZOLQNSFRPGUXJRUGHULQJ

&OLQLFDO5HVHDUFK
6DPSOHV

-HQQLIHU6WHYHQV
&HOOXODU,PPXQRORJ\5HVHDUFK
1HZ/LQN*HQHWLFV&RUSRUDWLRQ
6RXWK/RRS'ULYH6XLWH
$PHV,RZD
2IILFHH[W
)D[
(PDLO&OLQLFDO6DPSOHV#OLQNSFRP

3ULQFLSDO,QYHVWLJDWRUVDQG3DUWLFLSDWLQJ6LWHV
0XOWLSOHLQVWLWXWLRQVWKURXJKRXWWKH8QLWHG6WDWHVZLOOEHFRQGXFWLQJWKLVVWXG\)RUDIXOOOLVWRI
SDUWLFLSDWLQJ LQVWLWXWLRQV SOHDVH UHIHU WR WKH &OLQLFDOWULDOVJRY ZHEVLWH OLVWLQJ IRU WKLV VWXG\
1&7



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

1217(&+1,&$/$%675$&7

8QIRUWXQDWHO\GHVSLWHWKHEHVWFOLQLFDOHIIRUWVDQGEUHDNWKURXJKVLQELRWHFKQRORJ\PRVWSDWLHQWV
GLDJQRVHGZLWKDGYDQFHG6WDJHPHODQRPDFRQWLQXHWRGLHIURPWKHLUGLVHDVH5HDVRQVIRUWKLV
LQFOXGHSDWLHQWVDUHRIWHQGLDJQRVHGDWDWLPHZKHQWKHLUPHODQRPDKDVDOUHDG\VSUHDGWRRWKHU
VLWHVVXFKDVWKHFKHVWFDYLW\ERQHOLYHUDQGEUDLQOLPLWLQJWKHRSWLRQVIRUVXUJLFDOH[FLVLRQDQG
WKHFDQFHUFHOOVDUHUHVLVWDQWRUEHFRPHUHVLVWDQWWRFKHPRWKHUDS\GUXJVXVHGWRWUHDWWKHSDWLHQW
5HVLVWDQFHWRRQHW\SHRIFKHPRWKHUDS\DJHQWRIWHQUDSLGO\OHDGVWRUHVLVWDQFHDJDLQVWPDQ\RWKHU
FKHPRWKHUDS\GUXJV

+DUQHVVLQJWKHKXPDQLPPXQHV\VWHPWRWDUJHWFDQFHUFRXOGUHVXOWLQWKHGHYHORSPHQWRIHIIHFWLYH
WUHDWPHQWRSWLRQVDJDLQVWFDQFHUDQGSRWHQWLDOO\HQKDQFHWKHHIIHFWRIF\WRWR[LFFKHPRWKHUDS\
&DQFHUFHOOVSURGXFHDQXPEHURIDEQRUPDOSURWHLQVRUDEQRUPDODPRXQWVRIFHUWDLQSURWHLQVIRXQG
LQQRUPDOFHOOV,QVRPHFDQFHUVWKHDEQRUPDOSURWHLQH[SUHVVLRQPD\OHDGWRDQLPPXQHUHVSRQVH
DJDLQVWWKHFDQFHUFHOOVPXFKLQWKHVDPHZD\WKHLPPXQHV\VWHPUHVSRQGVWRDQLQIHFWLRQ,Q
SURJUHVVLYHFDQFHUKRZHYHUWKHLPPXQHV\VWHPIDLOVWRLGHQWLI\RUUHVSRQGWRWKHVHDEQRUPDOLWLHV
DQGWKHFDQFHUFHOOVDUHQRWDWWDFNHGRUGHVWUR\HGIRUUHDVRQVQRW\HWIXOO\XQGHUVWRRG


)URPDSUDFWLFDOVWDQGSRLQWDVXFFHVVIXOWXPRULPPXQRWKHUDS\ZLOOOLNHO\UHTXLUHDFRPELQDWLRQ
WUHDWPHQWZLWKDGGLWLRQDOWKHUDSHXWLFLQWHUYHQWLRQVWKDWERWKDFWLYDWHDQLPPXQHUHVSRQVHDQG
UHPRYHUHGXQGDQWPHFKDQLVPVRIWROHUDQFHPDLQWHQDQFH7KLVFOLQLFDOWULDOXWLOL]HVDFRPELQDWLRQ
RIWKHWZRPHWKRGVRIFDQFHULPPXQRWKHUDS\WKHILUVWGRUJHQPHOWXFHO/LVLQWHQGHGWRHGXFDWH
WKH KXPDQ LPPXQH V\VWHP WR UHFRJQL]H WKH DEQRUPDO FRPSRQHQWV IRXQG LQ PHODQRPD FHOOV
UHVXOWLQJLQDQLPPXQHUHVSRQVHLQWHQGHGWRGHVWUR\RUEORFNWKHJURZWKRIWKHFDQFHUDQGWKH
VHFRQGDFKHFNSRLQWLQKLELWRUZLOORYHUFRPHWXPRULQGXFHGLPPXQHVXSSUHVVLRQ

7KHLQYHVWLJDWLRQDOLPPXQRWKHUDS\GRUJHQPHOWXFHO/KHOSVWKHLPPXQHV\VWHPRIPHODQRPD
SDWLHQWV³LGHQWLI\´DQGWDUJHWWKHFDQFHURXVWLVVXH7KLVLPPXQRWKHUDS\LVHQJLQHHUHGWRPLPLFD
NH\GLIIHUHQFHEHWZHHQKXPDQFHOOVDQGWKHFHOOVRIRWKHUPDPPDOV:KHQDKXPDQLPPXQH
V\VWHPLGHQWLILHVFHOOVRUWLVVXHODEHOHGDV³IRUHLJQ´LQWKLVZD\LW³UHMHFWV´WKHVHFHOOVRUWLVVXH
7KLV³UHMHFWLRQ´RFFXUVZKHQWKHSDWLHQW¶VLPPXQHV\VWHPUHVSRQGVWRGLIIHUHQFHVEHWZHHQWKH
FHOOVRIWKHWUDQVSODQWHGRUJDQDQGWKHLURZQLPPXQHV\VWHPE\DWWDFNLQJWKHIRUHLJQWLVVXHLQWKH
VDPH ZD\ DV LW ZRXOG DWWDFN LQIHFWHG WLVVXH 7KLV IRUP RI UHMHFWLRQ LV YHU\ UDSLG DQG KLJKO\
GHVWUXFWLYHDQGWKHLPPXQLW\LWJHQHUDWHVLVORQJODVWLQJ7KLVLVFDOOHGK\SHUDFXWHUHMHFWLRQDQG
WKHLPPXQRWKHUDS\XVHGLQWKLVSURWRFROWULHVWRKDUQHVVWKLVUHVSRQVHWRWHDFKDSDWLHQW¶VLPPXQH
V\VWHPWRILJKWWKHLUPHODQRPDMXVWDVWKHERG\ZRXOGOHDUQWRUHMHFWDWUDQVSODQWHGRUJDQIURPDQ
DQLPDO

7RDFKLHYHWKLVK\SHUDFXWHUHVSRQVHDPRXVHJHQHLVSODFHGLQWRFXOWXUHGKXPDQPHODQRPDFHOOV
7KHVHFHOOVZLOOH[SUHVVDPROHFXOHWKDWZLOOVWLPXODWHDVWURQJLPPXQHUHVSRQVHLQKXPDQV7KHVH
FDQFHU FHOOV DUH LUUDGLDWHG WR SUHYHQW DQ\ JURZWK DQG WKHQ LQMHFWHG DORQJ ZLWK WKH DGGLWLRQDO
WKHUDSLHVLQWRSDWLHQWVZLWKPHODQRPD7KHSUHVHQFHRIWKHPROHFXOHZLOOVWLPXODWHWKHSDWLHQW¶V
LPPXQHV\VWHPWRNLOOWKHLQMHFWHGLPPXQRWKHUDS\FHOOV$VSDUWRIWKHSURFHVVRIGHVWUR\LQJWKH
LPPXQRWKHUDS\ FHOOV WKH SDWLHQW¶V LPPXQH V\VWHP LV VWLPXODWHGWR LGHQWLI\ PDQ\ GLIIHUHQFHV
EHWZHHQWKHVHFDQFHUFHOOVDQGQRUPDOKXPDQFHOOV7KLVH[WUDVWLPXODWLRQLVWKRXJKWWRHQFRXUDJH
LPPXQH UHVSRQVHV DJDLQVW WKH PHODQRPD LQ WKH SDWLHQW EDVHG RQ VKDUHG DEQRUPDOLWLHV RI WKH
PHODQRPDLPPXQRWKHUDS\FHOOVDQGWKHSDWLHQW¶VPHODQRPDFHOOV



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

7KHVWDQGDUGRIFDUHDJHQWVXVHGLQWKLVVWXG\WKHFKHFNSRLQWLQKLELWRUVRILSLOLPXPDEQLYROXPDE
RUSHPEUROL]XPDEWDUJHWPHFKDQLVPVE\ZKLFKWXPRUVHYDGHDSDWLHQW
VLPPXQHV\VWHP7XPRUV
DFTXLUH QXPHURXV SRWHQWLDOO\ LPPXQH UHVSRQVH SURYRNLQJ PXWDWLRQV DV WKH\ GHYHORS  7KH
LPPXQHV\VWHPSOD\VDQLPSRUWDQWVXUYHLOODQFHUROHLQGHWHFWLQJDQGHOLPLQDWLQJWKHVHPDOLJQDQW
FHOOVDVWKH\DULVH7KLVPHDQVWKDWLQRUGHUWRJURZWXPRUVPXVWHYDGHWKHKRVWLPPXQHUHVSRQVH
,QHVVHQFHWKHKRVWLPPXQHV\VWHPPXVWEHUHQGHUHGIXQFWLRQDOO\WROHUDQWWRWXPRUDVVRFLDWHG
DQWLJHQV$SKHQRPHQRQDVFRPSOH[DVV\VWHPLFWROHUDQFHUHTXLUHVWKDWWKHWXPRUHQOLVWVWKH
QDWXUDODUUD\RIKRVWUHJXODWRU\SDWKZD\VWKDWDOUHDG\H[LVWLQWKHLPPXQHV\VWHP

,QWKLVSURWRFROSDWLHQWVZLWKDGYDQFHGPHODQRPDZLOOEHJLYHQDFKHFNSRLQWLQKLELWRUHLWKHU
LSLOLPXPDEQLYROXPDERUSHPEUROL]XPDEZLWKRUZLWKRXWWKHGRUJHQPHOWXFHO/LPPXQRWKHUDS\
WRDVVHVVWKHVDIHW\DQGSURJUHVVLRQIUHHVXUYLYDO3)6DQGRYHUDOOVXUYLYDO26UDWHVLQWKLV
SDWLHQWSRSXODWLRQ




1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

PROTOCOL SYNOPSIS: 

7LWOH
$ 3KDVHE 6WXG\ RI ,PPXQH &KHFNSRLQW ,QKLELWLRQ :LWK RU
:LWKRXW
'RUJHQPHOWXFHO/
+\SHU$FXWH
0HODQRPD
,PPXQRWKHUDS\IRU3DWLHQWVZLWK6WDJH,90HODQRPD

3ULPDU\2EMHFWLYHV
Safety 7R GHWHUPLQH WKH VDIHW\ RI DGPLQLVWUDWLRQ RI LPPXQH
FKHFNSRLQW
LQKLELWLRQ
ZLWK
RU
ZLWKRXW
GRUJHQPHOWXFHO/
+\SHU$FXWH0HODQRPD+$0LPPXQRWKHUDS\IRUSDWLHQWVZLWK
6WDJH,9PHODQRPD

Efficacy  7R DVVHVV WKH SURJUHVVLRQIUHH VXUYLYDO 3)6 RI
PHWDVWDWLF PHODQRPD SDWLHQWV WUHDWHG ZLWK LPPXQH FKHFNSRLQW
LQKLELWLRQZLWKRUZLWKRXWGRUJHQPHOWXFHO/LPPXQRWKHUDS\

6HFRQGDU\2EMHFWLYH
Efficacy7RDVVHVVWKHRYHUDOOUHVSRQVHUDWHGXUDWLRQRIUHVSRQVH
GXUDWLRQRIVWDEOHGLVHDVHDQGRYHUDOOVXUYLYDO26RISDWLHQWVZLWK
6WDJH,9PHODQRPDWUHDWHGZLWKLPPXQHFKHFNSRLQWLQKLELWLRQZLWK
RUZLWKRXWGRUJHQPHOWXFHO/LPPXQRWKHUDS\

Biologic activity  7R PHDVXUH SRVVLEOH DQWLWXPRU LPPXQH
UHVSRQVHVLQPHODQRPDPHWDVWDVHVLQSDWLHQWV7RIXUWKHUGHWHUPLQH
ZKHWKHUWKHKXPRUDODQGFHOOXODUPHGLDWHGDUPVRIWKHKRVWLPPXQH
V\VWHPDUHDFWLYDWHGVHFRQGDU\WRGRUJHQPHOWXFHO/FRPELQHGZLWK
LPPXQHFKHFNSRLQWLQKLELWLRQ/DVWO\WRSHUIRUPFRUUHODWLYHVWXGLHV
RISDWLHQWEORRGVDPSOHVDQGWXPRUZKHQDYDLODEOHWRGHWHUPLQH
WKHPHFKDQLVPRIDQ\REVHUYHGDQWLWXPRUHIIHFW

3RSXODWLRQ
3DWLHQWVZLWK6WDJH,9PHWDVWDWLFPHODQRPD
$UP3DWLHQWVZLOOUHFHLYHLPPXQHFKHFNSRLQWLQKLELWLRQSOXV
GRUJHQPHOWXFHO/
,PPXQH FKHFNSRLQW LQKLELWLRQ FRQVLVWV RI WKH WUHDWLQJ
SK\VLFLDQ¶VVWDQGDUGRIFDUHFKRLFHRILSLOLPXPDEQLYROXPDE
RUSHPEUROL]XPDE
$UP3DWLHQWVZLOOUHFHLYHLPPXQHFKHFNSRLQWLQKLELWLRQDORQH
,PPXQHFKHFNSRLQWLQKLELWLRQFRQVLVWVRIWUHDWLQJSK\VLFLDQ¶V
VWDQGDUG RI FDUH FKRLFH RI LSLOLPXPDE QLYROXPDE RU
SHPEUROL]XPDE


6DPSOH6L]H
2QHKXQGUHGWRWDOSDWLHQWVZLOOEHUDQGRPL]HGZLWKHTXDODOORFDWLRQ
WR$UPSDWLHQWVDQG$UPSDWLHQWV

3DWLHQWVZLOOEHVWUDWLILHGE\LPPXQHFKHFNSRLQWWKHUDS\DQGGLVHDVH
VWDWXVDQGFDWHJRUL]HGDVIROORZV
 ,PPXQHFKHFNSRLQWLQKLELWLRQ
 3DWLHQWVZLWKXQUHVHFWDEOHDGYDQFHGGLVHDVH
 3DWLHQWV ZLWK UHVHFWDEOH DGYDQFHG GLVHDVH ZKR UHFHLYH WKH
LPPXQRWKHUDS\LQDGYDQFHRIUHVHFWLRQ


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

 3DWLHQWVZLWKUHVHFWHGLVRODWHGDGYDQFHGGLVHDVHZKRDUHWUHDWHG
LQDQRDSSDUHQWGLVHDVH1$'VWDWH

,QYHVWLJDWLRQDO'UXJV
'RUJHQPHOWXFHO/
+\SHU$FXWH
0HODQRPD
LPPXQRWKHUDS\
FRQVLVWLQJRIHTXDOFHOOGRVHVRIHDFKRIWKUHHDOORJHQHLFPHODQRPD
FDQFHU
FHOO
OLQHV
HQJLQHHUHG
WR
H[SUHVV
WKH
PXULQH
DJDODFWRV\OWUDQVIHUDVHJHQH

'RVDJH7UHDWPHQW
$UPZLOOUHFHLYHHLWKHU
$UP$LSLOLPXPDEDWPJNJJLYHQHYHU\ZHHNV[GRVHVRU
$UP%QLYROXPDEDWPJJLYHQHYHU\ZHHNVRU
$UP&SHPEUROL]XPDEDWPJNJJLYHQHYHU\ZHHNV$1'
0LOOLRQ+$0FHOOVSHUHDFKLPPXQL]DWLRQJLYHQHYHU\ZHHN
[ HYHU\ ZHHNV IRUPRQWKV HYHU\ PRQWK IRU PRQWKVDQG
HYHU\PRQWKV[

$UPZLOOUHFHLYHHLWKHU
$UP$LSLOLPXPDEDWPJNJJLYHQHYHU\ZHHNV[RU
$UP%QLYROXPDEDWPJJLYHQHYHU\ZHHNVRU
$UP&SHPEUROL]XPDEDWPJNJJLYHQHYHU\ZHHNV


&OLQLFDO(QGSRLQWV
6DIHW\
3URJUHVVLRQIUHHVXUYLYDO3)6
2YHUDOOUHVSRQVHUDWH
'XUDWLRQRIREMHFWLYHUHVSRQVH
'XUDWLRQRIVWDEOHGLVHDVH
2YHUDOOVXUYLYDO26
,PPXQH&RUUHODWLYHV






1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

3URWRFRO6FKHPDVIRU$UP$DQG$UP$
,SLOLPXPDESOXVGRUJHQPHOWXFHO/$UP$
,SLOLPXPDE$ORQH±$UP$


0RQWK
:HHN
'D\
7UHDWPHQW
:HHN
'D\
7UHDWPHQW


+$0


,3,


+$0


5(67


+$0


5(67



+$0,3,


,3,


5(67


5(67


+$0


5(67


,3,


,3,



+$0


5(67


5(67


5(67


+$0,3,


,3,


5(67


5(67



+$0


5(67


,3,


+$0
(YDOXDWHIRU5HVSRQVH


5(67



+$0


5(67


+$0


5(67



+$0


5(67


+$0


5(67


+$0
(YDOXDWHIRU5HVSRQVH

+$0

+$0

+$0
(YDOXDWHIRU5HVSRQVH

+$0

+$0

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH
$UP$+$0,3,/,080$%
$UP$,3,/,080$%$/21(
(YDOXDWHIRU5HVSRQVH
IPIAloneGroup:Aftertreatment,
observefordiseaseprogression.
Ifdiseaseprogresses,subjectsgo
offstudybutwillcontinuetobe
followedforsurvivalstatus.


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

3URWRFRO6FKHPDVIRU$UP%DQG$UP%
1LYROXPDESOXVGRUJHQPHOWXFHO/$UP%
1LYROXPDE$ORQH±$UP%


0RQWK
:HHN
'D\
7UHDWPHQW
:HHN
'D\
7UHDWPHQW


+$0


1,92


+$0


5(67


+$0


1,92



+$01,92


5(67


5(67


1,92


+$01,92


5(67


5(67


1,92



+$01,92


5(67


5(67


1,92


+$01,92


5(67


5(67


1,92



+$01,92


5(67


5(67


+$01,92
(YDOXDWHIRU5HVSRQVH


5(67



+$01,92


5(67


+$01,92


5(67



+$01,92


5(67


+$01,92


5(67


+$01,92
(YDOXDWHIRU5HVSRQVH

+$0

+$0

+$0
(YDOXDWHIRU5HVSRQVH

+$0

+$0

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH
$UP%1,92/80$%$/21(
(YDOXDWHIRU5HVSRQVH
NivolumabAloneGroup:Continue
treatmentQ2weeksuntildisease
progressionorsignificanttoxicity.
Evaluatediseaseevery3months.
Ifdiseaseprogresses,subjectsgo
offstudybutwillcontinuetobe
followedforsurvivalstatus.
&RQWLQXH1LYROXPDE4ZHHNV
$UP%+$01,92/80$%


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


3URWRFRO6FKHPDVIRU$UP&DQG$UP&
3HPEUROL]XPDESOXVGRUJHQPHOWXFHO/$UP&
3HPEUROL]XPDE$ORQH±$UP&



0RQWK
:HHN
'D\
7UHDWPHQW
:HHN
'D\
7UHDWPHQW


+$0


3HPEUR


+$0


5(67


+$0


5(67



+$03HPEUR


3HPEUR


5(67


5(67


+$0


5(67


3HPEUR


3HPEUR



+$0


5(67


5(67


5(67


+$03HPEUR


3HPEUR


5(67


5(67



+$0


5(67


3HPEUR


+$0
(YDOXDWHIRU5HVSRQVH


5(67



+$03HPEUR


5(67


+$0


3HPEUR



+$0


5(67


+$03HPEUR


5(67


+$0
(YDOXDWHIRU5HVSRQVH

+$0

+$0

+$0
(YDOXDWHIRU5HVSRQVH

+$0

+$0

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH

+$0
(YDOXDWHIRU5HVSRQVH
$UP&3(0%52/,=80$%$/21(
(YDOXDWHIRU5HVSRQVH
PembrolizumabAloneGroup:Continue
treatmentuntildiseaseprogressionor
significanttoxicity.Evaluatedisease
every3months.Ifdiseaseprogresses,
subjectsgooffstudybutwillcontinueto
befollowedforsurvivalstatus.
&RQWLQXH3HPEUROL]XPDE4ZHHNV
$UP&+$03(0%52/,=80$%


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO



7DEOHRI&RQWHQWV


,1752'8&7,21


2EMHFWLYHV


3ULPDU\2EMHFWLYH


6HFRQGDU\2EMHFWLYHV


%$&.*5281'


D*DODFWRV\OWUDQVIHUDVHJHQHWKHUDS\DQGWKHK\SHUDFXWHUHMHFWLRQUHVSRQVH


3UH&OLQLFDO([SHULHQFHRI'RUJHQPHOWXFHO/


&OLQLFDO([SHULHQFHRI'RUJHQPHOWXFHO/+\SHU$FXWH0HODQRPD


,SLOLPXPDEDQWL&7/$DQWLERG\


3'&KHFNSRLQW,QKLELWRUV1LYROXPDEDQG3HPEUROL]XPDE


5DWLRQDOHIRU&RPELQLQJ&KHFNSRLQW,QKLELWRUVZLWK'RUJHQPHOWXFHO/


3$7,(176(/(&7,21


(OLJLELOLW\FULWHULD


(OLJLELOLW\DQG2Q6WXG\7HVWV


75($70(173/$1


5HJLVWUDWLRQDQG5DQGRPL]DWLRQ


6WXG\,PSOHPHQWDWLRQ


6XSSRUWLYH&DUH


'XUDWLRQRI7KHUDS\


2II6WXG\7KHUDS\&ULWHULD


3RVW7UHDWPHQW(YDOXDWLRQ0RQLWRULQJ


'26,1*,1)250$7,21


'RUJHQPHOWXFHO/,PPXQRWKHUDS\


,SLOLPXPDE<HUYR\±,QIRUPDWLRQIURPSDFNDJHLQVHUW


1LYROXPDE2SGLYR



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


3HPEUROL]XPDE.H\WUXGD


'26,1*'(/$<6'26(02',),&$7,216


'RVLQJ'HOD\V


'RUJHQPHOWXFHO/+\SHU$FXWH0HODQRPD'RVH0RGLILFDWLRQV


,SLOLPXPDE'RVH0RGLILFDWLRQV


1LYROXPDE'RVLQJ0RGLILFDWLRQV


3HPEUROL]XPDE'RVLQJ0RGLILFDWLRQV


7UHDWPHQWRI&KHFNSRLQW,QKLELWRU5HODWHG,QIXVLRQ5HDFWLRQ


&255(/$7,9(63(&,$/678',(6


3DUDPHWHUVPHDVXUHGDWEDVHOLQHWRHYDOXDWHVXEMHFW¶VJHQHUDOLPPXQRORJLFDOVWDWXV


,PPXQRORJLFDOPRQLWRULQJGXULQJWUHDWPHQWDQGIROORZXS


678'<&$/(1'$56


0($685(0(172)())(&7


$QWLWXPRU(IIHFW±6ROLG7XPRUV


5(*8/$725<$1'5(3257,1*5(48,5(0(176


6XEMHFW'DWD


&7&$(


1RWLILFDWLRQV


'HILQLWLRQVIRU5HSRUWLQJ3XUSRVHV


5HSRUWLQJ)RUPDQG&RQWHQW


5HSRUWLQJ5HTXLUHPHQWVIRU6HULRXV$GYHUVH(YHQWV&)53DUW


+80$168%-(&763527(&7,216


5DWLRQDOHIRU6XEMHFW6HOHFWLRQ


3DUWLFLSDWLRQRI&KLOGUHQ


(YDOXDWLRQRI%HQHILWVDQG5LVNV


&RQVHQW3URFHVVHVDQG'RFXPHQWV



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


5HFUXLWPHQW6WUDWHJ\


3DWLHQW&RQILGHQWLDOLW\


67$7,67,&$/&216,'(5$7,216


6DPSOH6L]H


%OLQGLQJDQG5DQGRPL]DWLRQ


6WDWLVWLFDO0HWKRGRORJ\


$'0,1,675$7,9($1'5(*8/$725<&216,'(5$7,216


5HJXODWRU\&RPSOLDQFH*RRG&OLQLFDO3UDFWLFHV


5HJXODWRU\'RFXPHQWDWLRQ


,QVWLWXWLRQDO5HYLHZ%RDUG,5%


,QIRUPHG&RQVHQW


$GPLQLVWUDWLYH5HTXLUHPHQWV


$33(1',&(6


$33(1',;$$-&&6WDJLQJRI0HODQRPD


$33(1',;%(&2*3HUIRUPDQFH6WDWXV&ULWHULD


$33(1',;&3UHSDUDWLRQRI'RUJHQPHOWXFHO/+\SHU$FXWH0HODQRPD


$33(1',;'0DQDJHPHQWRI$GYHUVH(YHQWVRI,QWHUHVW$OJRULWKPV


$33(1',;($XWRLPPXQH6\PSWRP(YDOXDWLRQ&KHFNOLVW


$33(1',;)6DPSOH,QIRUPHG&RQVHQW'RFXPHQW7HPSODWH




1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

35(&,6

$FFRUGLQJWRVWDWLVWLFVRIWKH$PHULFDQ&DQFHU6RFLHW\DQHVWLPDWHGLQGLYLGXDOVZLOOEH
GLDJQRVHGZLWKPHODQRPDDQGZLOOGLHRIWKHGLVHDVHLQLQWKH8QLWHV6WDWHVGHVSLWH
FXUUHQWWKHUDS\7KLVSURWRFRODWWHPSWVWRH[SORLWDQDSSURDFKWRPHODQRPDLPPXQRWKHUDS\XVLQJ
DQDWXUDOO\RFFXUULQJEDUULHUWR[HQRWUDQVSODQWDWLRQLQKXPDQVWRLQFUHDVHWKHHIIHFWLYHQHVVRI
LPPXQL]LQJ
SDWLHQWV
DJDLQVW
WKHLU
PHODQRPD
7KH
H[SUHVVLRQ
RI
WKH
PXULQH
DJDODFWRV\OWUDQVIHUDVH >D*7@ JHQH UHVXOWV LQ WKH FHOO VXUIDFH H[SUHVVLRQ RI
DJDODFWRV\OHSLWRSHVDJDORQPHPEUDQHJO\FRSURWHLQVDQGJO\FROLSLGV7KHVHHSLWRSHVDUH
WKHPDMRUWDUJHWRIWKHK\SHUDFXWHUHMHFWLRQUHVSRQVHWKDWRFFXUVZKHQRUJDQVDUHWUDQVSODQWHGIURP
QRQSULPDWHGRQRUVSHFLHVLQWRPDQ+XPDQKRVWVRIWHQKDYHSUHH[LVWLQJDQWLDJDODQWLERGLHV
WKDWELQGDJDOHSLWRSHVDQGOHDGWRUDSLGDFWLYDWLRQRIFRPSOHPHQWDQGFHOOO\VLV7KHSUHH[LVWLQJ
DQWLDJDODQWLERGLHVIRXQGLQPRVWLQGLYLGXDOVDUHWKRXJKWWREHGXHWRH[SRVXUHWRDJDOHSLWRSHV
WKDWDUHQDWXUDOO\H[SUHVVHGRQQRUPDOJXWIORUDOHDGLQJWRFKURQLFLPPXQRORJLFDOVWLPXODWLRQ
7KHVHDQWLERGLHVPD\FRPSULVHXSWRRIVHUXP,J*

,QWKLVSKDVHEVWXG\SDWLHQWVZLWKDGYDQFHG6WDJHPHODQRPDZLOOUHFHLYHLPPXQHFKHFNSRLQW
LQKLELWLRQFRQVLVWLQJRILSLOLPXPDEQLYROXPDERUSHPEUROL]XPDESHUWKHWUHDWLQJSK\VLFLDQ¶V
VWDQGDUGRIFDUH,QDGGLWLRQWRWKHLPPXQHFKHFNSRLQWWKHUDS\KDOIRIWKHSDWLHQWVZLOODOVR
UHFHLYHGRUJHQPHOWXFHO/'RUJHQPHOWXFHO/LVFRPSRVHGRILUUDGLDWHGDOORJHQHLFPHODQRPDFHOO
OLQHV+$0+$0DQG+$07KHVHFHOOOLQHVKDYHEHHQWUDQVGXFHGZLWKDUHFRPELQDQW
0RORQH\ PXULQH OHXNHPLD YLUXV 0R0/9EDVHG UHWURYLUDO YHFWRU H[SUHVVLQJ WKH PXULQH
D*7JHQH(QGSRLQWVRIWKHVWXG\LQFOXGHVDIHW\DVVHVVPHQWVHIILFDF\DQGLPPXQRORJLFDO
UHVSRQVHV




1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

 ,1752'8&7,21
1.1
Objectives 
 3ULPDU\2EMHFWLYH
7RDVVHVVVDIHW\RIDQDQWLWXPRUWUHDWPHQWXVLQJLPPXQHFKHFNSRLQWLQKLELWLRQFRQVLVWLQJRI
LSLOLPXPDEQLYROXPDERUSHPEUROL]XPDEDORQHFRPSDUHGWRLPPXQHFKHFNSRLQWLQKLELWLRQSOXV
GRUJHQPHOWXFHO/ LPPXQRWKHUDS\ LQ 6WDJH,9 PHODQRPD SDWLHQWV DQG WR DVVHVV HIILFDF\ DV
LQGLFDWHGE\SURJUHVVLRQIUHHVXUYLYDORIWKRVHSDWLHQWVWUHDWHGZLWKLPPXQHFKHFNSRLQWLQKLELWLRQ
ZLWKRUZLWKRXWGRUJHQPHOWXFHO/LPPXQRWKHUDS\
 6HFRQGDU\2EMHFWLYHV
7RDVVHVVWKHRYHUDOOUHVSRQVHUDWHGXUDWLRQRIUHVSRQVHGXUDWLRQRIVWDEOHGLVHDVHDQGRYHUDOO
VXUYLYDO26RISDWLHQWVZLWK6WDJH,9PHODQRPDWUHDWHGZLWKLPPXQHFKHFNSRLQWLQKLELWLRQZLWK
RUZLWKRXWGRUJHQPHOWXFHO/LPPXQRWKHUDS\

7R DVVHVV WKH LPPXQRORJLFDO UHVSRQVH RI SDWLHQWV ZLWK PHWDVWDWLF PHODQRPD XQGHUJRLQJ
DQWLWXPRU WUHDWPHQW XVLQJ LPPXQH FKHFNSRLQW LQKLELWLRQ ZLWK RU ZLWKRXW GRUJHQPHOWXFHO/
LPPXQRWKHUDS\LQ6WDJH,9PHODQRPDSDWLHQWV

 %$&.*5281'

2.1
D(1,3)Galactosyltransferase gene therapy and the hyperacute rejection response. 

Hyperacute rejection of non-human xenografts 

6WURQJ SUHH[LVWLQJ LPPXQRORJLFDO EDUULHUV WR [HQRWUDQVSODQWDWLRQ RI VROLG RUJDQV IURP ORZHU
PDPPDOVLQWRKXPDQVFDQGHVWUR\DWUDQVSODQWHGRUJDQZLWKLQPLQXWHVWRKRXUVDSKHQRPHQRQ
WHUPHG K\SHUDFXWH UHMHFWLRQ>@ ,W KDV EHHQ GHPRQVWUDWHG WKDW WKH PDMRU FDXVH RI K\SHUDFXWH
UHMHFWLRQLQGXFHGZLWKSRUFLQH[HQRJUDIWVWUDQVSODQWHGLQWREDERRQVLVVHFRQGDU\WRH[SUHVVLRQRI
WKHHQ]\PHDJDODFWRV\OWUDQVIHUDVH>D*7@DQGWKHUHVXOWLQJSUHVHQWDWLRQRIDJDOUHVLGXHV
RQWKHWUDQVSODQWHGSLJRUJDQV>@D*7LVH[SUHVVHGLQDOOPDPPDOLDQVSHFLHVLQFOXGLQJWKH
PRXVH Mus musculus EXW LW LV QRW SUHVHQW LQ ROG ZRUOG SULPDWHV DSHV RU KXPDQV>@ 7KH
D*7JHQHLVQRWDFWLYHLQKXPDQVGXHWRWKHSUHVHQFHRIWZREDVHSDLUIUDPHVKLIWPXWDWLRQV
UHVXOWLQJ D QRQIXQFWLRQDO SVHXGRJHQH>@ $OSKD*7 QRUPDOO\ FDWDO\]HV WKH WUDQVIHU RI
JDODFWRVHIURPXULGLQHGLSKRVSKDWHJDODFWRVH8'3*DOWRWKH1DFHW\OODFWRVDPLQHDFFHSWRUVRQ
FDUERK\GUDWH VLGH FKDLQV LQ D VSHFLILF DOLQNDJH RQ D ODUJH QXPEHU RI JO\FRSURWHLQV RU
JO\FROLSLGV*DOEo*OF1$F5

*DOEo*OF1$F58'3*DOo*DODo*DODo*OF1$F5

$QWLDJDODQWLERGLHVSUHVHQWLQKXPDQVHUDFDQUHFRJQL]HWKLVHSLWRSH>@,QIDFWSUHH[LVWLQJ
KXPDQDQWLERG\DJDLQVWDJDOUHSUHVHQWVDOPRVWRIWRWDOKXPDQDQWLERG\7KHVHDJDOHSLWRSHV
DUHWKHWDUJHWVIRUFRPSOHPHQWPHGLDWHGK\SHUDFXWHUHMHFWLRQ>@2XUVWUDWHJ\ZLOODWWHPSWWRXVH


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

PXULQH D*7 DV D WKHUDSHXWLF WUDQVJHQH LQ FRPELQDWLRQ ZLWK DQ DOORJHQHLF FHOOXODU
LPPXQRWKHUDS\WRLQGXFHK\SHUDFXWHUHMHFWLRQRIKXPDQPHODQRPD

Other potentially important effects on the immune system

3UHYLRXVVWXGLHVKDYHHVWDEOLVKHGWKDWPXOWLSOHPHPEUDQHJO\FRSURWHLQVRQSLJFHOOVSUHVHQWDJDO
UHVLGXHVDQGDUHWDUJHWVIRUKXPDQDQWLDJDODQWLERG\ELQGLQJ>@,QDGGLWLRQPDQ\JO\FRSURWHLQV
SRVVHVVPXOWLSOHFDUERK\GUDWHVLGHFKDLQVDQGFDQH[SUHVVPXOWLSOHGLIIHUHQWDJDOHSLWRSHV6LQFH
ERWK RSVRQL]DWLRQ DQG FRPSOHPHQW IL[DWLRQ DUH GHSHQGHQW RQ HSLWRSH GHQVLW\ D*7
LPPXQRJHQHWKHUDS\RIIHUVSRWHQWLDODGYDQWDJHVRYHURWKHUFDQGLGDWHWUDQVJHQHV7KHD*7
JHQHH[SUHVVLRQFRXOGSHUPLWDODUJHQXPEHURIPHPEUDQHJO\FRSURWHLQVWREHLQGXFHGWRH[SUHVV
WKHVHHSLWRSHVVLPXOWDQHRXVO\2SVRQL]DWLRQRIWXPRUFHOOVFDQRFFXUE\SUHH[LVWLQJRULQGXFHG
DQWLDJDODQWLERGLHVDQGVKRXOGVLJQLILFDQWO\HQKDQFHWXPRUDQWLJHQSUHVHQWDWLRQWRPDFURSKDJHV
E\DJDODQWLERG\FRPSOH[ELQGLQJWRWKHLU)FUHFHSWRUV6WXGLHVGHPRQVWUDWHGWKDWWKHXSWDNHRI
KXPDQWXPRUFHOOVLQWRPDFURSKDJHVDUHVLJQLILFDQWO\HQKDQFHGE\FHOOPHPEUDQHPRGLILFDWLRQV
ZLWK HQ]\PHV XVLQJ D UHFRPELQDQW WUXQFDWHG IRUP RI DQ D*7>@ 7KHVH UHVXOWV XVLQJ
HQ]\PDWLFPRGLILFDWLRQVRIKXPDQFHOOPHPEUDQHVVKRXOGEHWUDQVIHUDEOHWRRXUJHQHWUDQVIHU
DSSURDFK3UHYLRXVDWWHPSWVRILPPXQRWKHUDS\KDYHHPSOR\HGVLQJOHF\WRNLQHPROHFXOHVHJ
,/ ,/ *0&6) RU VLQJOH UHMHFWLRQ DQWLJHQV HJ +/$ % PHODQRPD VSHFLILF WXPRU
DQWLJHQVZKLOHWKHD*7DSSURDFKRIIHUVWKHSRVVLELOLW\RIDEURDG[HQRJHQL]DWLRQRIQRUPDO
DQWLJHQVIRXQGRQWXPRUV

In humans, implanted murine retroviral vector producer cells (VPC’s) are another type of 
Dgal-positive xenograft

93&¶V KDYH EHHQ XVHG IRU in vivo JHQH GHOLYHU\ DV D SRWHQWLDO LPSURYHPHQW RYHU GLUHFW
DGPLQLVWUDWLRQ RI YHFWRU DORQH WR LQFUHDVH WUDQVGXFWLRQ HIILFLHQF\ LQ ERWK DQLPDO PRGHOV DQG
KXPDQFOLQLFDOWULDOV>@,WKDVEHHQGHPRQVWUDWHGWKDWPXULQHUHWURYLUDO93&¶VDQGWKHYLUDO
YHFWRUVWKH\SURGXFHERWKH[SUHVVDJDOUHVLGXHVDQGWKHUHIRUHDUHHIILFLHQWO\O\VHGE\DQWLERG\
DQG FRPSOHPHQW ZLWKLQ PLQXWHV DIWHU EHLQJ H[SRVHG WR KXPDQ VHUXP  7KLV LV GXH WR WKH
H[SUHVVLRQ RI DJDOUHVLGXHV RQ WKH FHOOV DQG WKH YLUDO HQYHORSH GHULYHG IURP WKH 93&
PHPEUDQH>@/LQNDQGFRZRUNHUVGHPRQVWUDWHGWKDWKHSDULQHQR[DSDULQRUV&5VROXEOHIRUP
RI&RPSOHPHQWUHFHSWRUFDQVSHFLILFDOO\EORFNO\VLVRIPXULQHFHOOVE\KXPDQVHUXP>@7KHVH
ZRUNHUVK\SRWKHVL]HGWKDWWKLVGLVDGYDQWDJHIRUPXULQH93&¶VFRXOGEHDQDGYDQWDJHRXVQRYHO
PHWKRGWRGHVWUR\WXPRUFHOOV7KHK\SRWKHVLVLVWKDWH[SUHVVLRQRIWKHD*7JHQHXVLQJD
UHWURYLUDOYHFWRULQDOORJHQHLFPHODQRPDFDQFHUFHOOVZLOOOHDGWRDJDOHSLWRSHH[SUHVVLRQDQG
DQWLDJDODQWLERGLHVWKDWDUHNQRZQWREHSUHVHQWDQGLQKLJKWLWHULQWKHPDMRULW\RISDWLHQWVVKRXOG
WKHQELQGWKLVHSLWRSHDQGDFWLYDWHWKHFODVVLFDODQGDOWHUQDWLYHSDWKZD\RIFRPSOHPHQWWRLQGXFH
WXPRUFHOOO\VLVSRVVLEO\HQKDQFLQJWXPRULPPXQRJHQLFLW\

5HIHUHQFHVIRUWKLVVHFWLRQ
 3UXLWW6..LUN$'%ROOLQJHU550DUVK-+HQU\&&ROOLQV%+/HYLQ-
/0DXOW-5+HLQOH-6,EUDKLP65XGROSK$5%DOGZLQ,:LOOLDP0DQG
6DQILOLSSR)7KHHIIHFWRIVROXEOHFRPSOHPHQWUHFHSWRUW\SHRQK\SHUDFXWHUHMHFWLRQ
RISRUFLQH[HQRJUDIWVTransplantation
 /DL/.ROEHU6LPRQGV'3DUN.:&KHRQJ+7*UHHQVWHLQ-/,P*6
6DPXHO0%RQN$5LHNH$'D\%10XUSK\&1&DUWHU'%+DHOH\5-


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

3UDWKHU563URGXFWLRQRIDJDODFWRV\OWUDQVIHUDVHNQRFNRXWSLJVE\QXFOHDUWUDQVIHU
FORQLQJScience
 *DOLOL86KRKHW6%.REULQ(6WXOWV&/DQG0DFKHU%$0DQDSHVDQG2OG
:RUOGPRQNH\VGLIIHUIURPRWKHUPDPPDOVLQWKHH[SUHVVLRQRIDOSKDJDODFWRV\O
HSLWRSHVRQQXFOHDWHGFHOOVJ Biol Chem
 /DUVHQ5'5LYHUD0DUUHUR&$(UQVW/.&XPPLQJV5'DQG/RZH-%
)UDPHVKLIWDQGQRQVHQVHPXWDWLRQVLQDKXPDQJHQRPLFVHTXHQFHKRPRORJRXVWRD
PXULQH8'3*DOEHWD'*DO'*OF1$FDOSKDJDODFWRV\OWUDQVIHUDVHF'1$
J Biol Chem
 6DQGULQ069DXJKDQ+$'DENRZVNL3/DQG0F.HQ]LH,)$QWLSLJ,J0
DQWLERGLHVLQKXPDQVHUXPUHDFWSUHGRPLQDQWO\ZLWK*DODOSKD*DOHSLWRSHV
Proc Natl Acad Sci U S A
 3ODWW-/9HUFHOORWWL*0'DOPDVVR$30DWDV$-%ROPDQ501DMDULDQ-
6DQG%DFK)+7UDQVSODQWDWLRQRIGLVFRUGDQW[HQRJUDIWVDUHYLHZRISURJUHVV
Immunol. Today
 *DOLOL8DQG/DWHPSOH'&1DWXUDODQWLJDODQWLERG\DVDXQLYHUVDODXJPHQWHURI
DXWRORJRXVWXPRUYDFFLQHLPPXQRJHQLFLW\Immunol. Today
 &ROOLQV0.7DNHXFKL<&RVVHW)/7DLORU&DQG:HLVV5$'HYHORSPHQWRI
UHFRPELQDQWUHWURYLUXVHVVXLWDEOHIRULQYLYRJHQHGHOLYHU\Cold Spring Harbor 
Meeting: Gene Therapy6HSW
 6RPLD1DQG9HUPD,0*HQHWKHUDS\WULDOVDQG7ULEXODWLRQV1DWXUH5HY*HQHWLFV

&XOYHU.:5DP=:DOEULGJH6,VKLL+2OGILHOG(+DQG%ODHVH50,Q
YLYRJHQHWUDQVIHUZLWKUHWURYLUDOYHFWRUSURGXFHUFHOOVIRUWUHDWPHQWRIH[SHULPHQWDO
EUDLQWXPRUVScience.
/LQN&-/HY\-36HUHJLQD7$WFKLQVRQ5DQG0RRUPDQ'3URWHFWLRQRI
FRPSOHPHQWPHGLDWHGO\VLVRIPXULQHYHFWRUSURGXFHUFHOOVE\V&5DQGORZPROHFXODU
ZHLJKWKHSDULQVLQCancer Gene Therapy0D]DUDNLV+DQG6ZDUW6-HGV
SS,%&/LEUDU\6HULHV/RQGRQ8.
/LQN&-6HUHJLQD7$WFKLQVRQ5+$0O$0XOGRRQ5/HY\-3(OLFLWLQJ
K\SHUDFXWH[HQRJUDIWUHVSRQVHWRWUHDWKXPDQFDQFHUDJDODFWRV\OWUDQVIHUDVHJHQH
WKHUDS\Anticancer Res
2.2
Pre-Clinical Experience of Dorgenmeltucel-L

$OORIWKHFRPSRQHQWVRIGRUJHQPHOWXFHO/LPPXQRWKHUDS\KDYHEHHQHYDOXDWHGLQDYDULHW\RI
SUHFOLQLFDO VWXGLHV LQ PLFH DV ZHOO DV LQ SKDVH DQG KXPDQ FOLQLFDO VWXGLHV 7KH VDIHW\ RI
GRUJHQPHOWXFHO/KDVEHHQGHPRQVWUDWHGin vivoLQPLFH6XEVWDQWLDOSUHFOLQLFDOGDWDRQWKHVDIHW\
DQGHIILFDF\RIUHODWHGLPPXQRWKHUDSLHVKDYHEHHQSXEOLVKHG6SHFLILFSUHFOLQLFDOLQIRUPDWLRQLV
DYDLODEOHLQWKH,QYHVWLJDWRU¶V%URFKXUH

2.3
Clinical Experience of Dorgenmeltucel-L (HyperAcute Melanoma) 

,Q WKH SKDVH GRUJHQPHOWXFHO/ 7ULDO 1/* VXEMHFWV UHFHLYHG WKH PHODQRPD
LPPXQRWKHUDS\ 6L[ SDWLHQWV PHQ DQG ZRPHQ PHDQ DJH \HDUV UDQJH  ZHUH
YDFFLQDWHG ZLWK RQH SULPLQJ GRVH RI PLOOLRQ FHOOV DQG XS WR HOHYHQ ERRVWHU GRVHV RI


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

PLOOLRQ FHOOV 2EVHUYHG HYHQWV XQUHODWHG RU XQOLNHO\ WR EH UHODWHG WR WKH LPPXQRWKHUDS\
LQFOXGHG *UDGH IDWLJXH SUXULWXV QDXVHD YRPLWLQJ FRQVWLSDWLRQ G\VSKDJLD GHUPDO FKDQJH
IDFLDO HGHPD K\SHUJO\FHPLD SDLQ DQG QRFWXULD *UDGH HYHQWV SRVVLEO\ UHODWHG WR WKH
LPPXQRWKHUDS\ LQFOXGHG IDWLJXH QDXVHDDQGG\VJHXVLD*UDGHHYHQWVXQUHODWHGRUXQOLNHO\
UHODWHGWRWKHLPPXQRWKHUDS\LQFOXGHSUXULWXVFHOOXOLWLVOHIWKHPLDQRSVLDDQGKHDGDFKH2QH
*UDGHFHOOXOLWLVZDVREVHUYHGDIWHUDEURZQUHFOXVHVSLGHUELWHLQRQHRIWKHVXEMHFWV(YHQWV
SUREDEO\RUGHILQLWHO\UHODWHGWRWKHLPPXQRWKHUDS\LQFOXGH*UDGHDQGLQMHFWLRQVLWHUHDFWLRQV
WR LQFOXGH UHGQHVV VZHOOLQJ DQG LWFKLQJ )LYH RI WKH VL[ SDWLHQWV ZHQW RII VWXG\ GXH WR
SURJUHVVLRQRIGLVHDVHDQGGXHWRFRQFXUUHQWLOOQHVV2QHVXEMHFWUHPDLQVRQORQJWHUPIROORZXS
ZLWKVWDEOHGLVHDVH!\HDUV

5LNHU et al KDYH VLQFH FRPSOHWHG D SKDVH FOLQLFDO WULDO RI GRUJHQPHOWXFHO/ 1/*
1HZ/LQN *HQHWLFV FRPELQHG ZLWK SHJ\ODWHG LQWHUIHURQ 6\ODWURQ70 0HUFN 7ULDO GHVLJQ
FRQVLVWHG RI D ZHHN UHJLPHQ ZLWK WKH LQLWLDO ZHHNO\ WUHDWPHQWV FRQVLVWLQJ RI
GRUJHQPHOWXFHO/DORQHLQWUDGHUPDOO\IROORZHGE\DGGLWLRQDOWUHDWPHQWVRIGRUJHQPHOWXFHO/
SOXV6\ODWURQ70VXEFXWDQHRXVO\JNJ7ULDOHQGSRLQWVLQFOXGHFOLQLFDOUHVSRQVHRYHUDOOVDIHW\
DQGFRUUHODWLYHILQGLQJVIRUREVHUYHGDQWLWXPRUHIIHFW7KH\UHSRUWDWRWDORISDWLHQWVDFFUXHG
ZLWKDPHGLDQDJHPDOHZLWKSDWLHQWVFRPSOHWLQJWKHWULDOVWRSSHGGXHWRSURJUHVVLYH
GLVHDVH3'

%\5(&,67FULWHULDRI6WDJH,9SDWLHQWVWKHUHZHUHFRPSOHWHUHVSRQGHUV&5ZLWKVWDEOH
GLVHDVH6'DQGZLWKQRHYLGHQFHRIGLVHDVH1('DIWHUUHVHFWLRQ)RU6WDJH,,,SDWLHQWV
UHPDLQV1('SDWLHQWZLWKVORZO\SURJUHVVLYHGLVHDVHZLWKDVLQJOHVLWHUHVHFWHGDQGFXUUHQWO\
1('7KHPHGLDQRYHUDOOVXUYLYDOLVPRQWKVZLWKRIWKHSDWLHQWVVXUYLYLQJIRU!\HDU
DQGVWLOODOLYH$OOHYDOXDEOHSDWLHQWVVHURFRQYHUWHGGHYHORSLQJDXWRLPPXQH
DQWLERGLHV9LWLOLJRGHYHORSHGLQSDWLHQWVFRUUHODWLQJZLWK&5DQG1('

7KH\FRQFOXGHWKDWFRPELQDWRULDOLPPXQRWKHUDS\ZLWKGRUJHQPHOWXFHO/SOXV6\ODWURQ70VKRZV
FOLQLFDO HIILFDF\ ZLWK WXPRU UHJUHVVLRQ DQG FRQFRPLWDQW LPPXQH DFWLYDWLRQ 2SWLPL]DWLRQ RI
GRVLQJ VFKHGXOHV DQG WKHUDSHXWLF HIILFDF\ VKRXOG EH IXUWKHU H[SORUHG LQ RUGHU WR HQKDQFH WKH
EHQHILWRIWKLVSURPLVLQJLPPXQRWKHUDSHXWLFDSSURDFK5LNHUHWDO7KH2FKVQHU-RXUQDO

2.4
Ipilimumab (anti-CTLA-4 antibody)

,SLOLPXPDELVDPRQRFORQDODQWLERG\WKDWEORFNVWKHLPPXQRVXSSUHVVLYHUHFHSWRU&7/$RQ7
FHOOVWKXVHQKDQFLQJGLVLQKLELWLQJLPPXQHUHVSRQVHVDJDLQVWWKHWXPRU%HFDXVHRIWKHUROH
&7/$ SOD\V LQ XQGHUPLQLQJ DQWLWXPRU 7 FHOO UHVSRQVHV WKH XVH RI &7/$ EORFNDGH LQ
FRPELQDWLRQZLWKDUDQJHRIFDQFHULPPXQRWKHUDSLHVKDVEHHQLQYHVWLJDWHGLQSUHFOLQLFDOPRGHOV
DQGIRXQGWRHQKDQFHDQWLWXPRU7FHOOUHVSRQVLYHQHVV,SLOLPXPDEKDVUHFHQWO\EHHQDSSURYHGE\
WKH)'$IRUXQUHVHFWDEOHDQGPHWDVWDWLFPHODQRPDDQGKDVGHPRQVWUDWHGSUHOLPLQDU\DQWLWXPRU
HIIHFWDVDVLQJOHDJHQWLQRWKHUVROLGWXPRUVLQFOXGLQJPHWDVWDWLF16&/&DQGSURVWDWHFDUFLQRPD

7UHDWPHQWZLWKLSLOLPXPDELQFUHDVHVPHGLDQRYHUDOOVXUYLYDOLQERWKSUHYLRXVO\XQWUHDWHGDQG
SUHYLRXVO\WUHDWHGSDWLHQWVZLWKPHWDVWDWLF6WDJH,,,RU,9PHODQRPD+RGLHWDO5REHUWHW
DO,QFUHDVHLQPHGLDQVXUYLYDOZDVDSSUR[LPDWHO\WRPRQWKVEXW!RISDWLHQWV
HYHQWXDOO\SURJUHVVHG,SLOLPXPDE<HUYR\LVFXUUHQWO\DSSURYHGIRUPHWDVWDWLFRUXQUHVHFWDEOH
PHODQRPDDWDGRVHRIPJNJHYHU\ZHHNV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO



2.5
PD-1 Checkpoint Inhibitors (Nivolumab and Pembrolizumab) 

7ZRDQWL±SURJUDPPHGGHDWK3'DQWLERGLHVQLYROXPDEDQGSHPEUROL]XPDEZHUHDSSURYHG
LQE\WKH)RRGDQG'UXJ$GPLQLVWUDWLRQIRUWKHWUHDWPHQWRIPHWDVWDWLFPHODQRPDDIWHU
SURJUHVVLRQGXULQJLSLOLPXPDEWUHDWPHQWDQGLQSDWLHQWVZLWK%5$)PXWDWHGPHODQRPDDIWHU
SURJUHVVLRQ GXULQJ WUHDWPHQW ZLWK D %5$) LQKLELWRU 7KHVH DQWLERGLHV ZHUH DVVRFLDWHG ZLWK
REMHFWLYHUHVSRQVHVLQWRRISDWLHQWV7ZRSKDVHWULDOVKDYHVKRZQVXSHULRUHIILFDF\RI
QLYROXPDE DV FRPSDUHG ZLWK FKHPRWKHUDS\ LQ SUHYLRXVO\ XQWUHDWHG SDWLHQWV ZLWK ZLOGW\SH
%5$)WXPRUVRULQSDWLHQWVZLWKHLWKHUPXWDQWRUZLOGW\SH%5$)WXPRUVDIWHUSURJUHVVLRQGXULQJ
LSLOLPXPDEWKHUDS\DQGLQSDWLHQWVZLWKWXPRUVSRVLWLYHIRU%5$)PXWDWLRQDIWHUSURJUHVVLRQ
GXULQJWUHDWPHQWZLWKD%5$)LQKLELWRU5REHUW&1(-0DQG:HEHU-6/DQFHW
5HFHQWO\ SHPEUROL]XPDE ZDV DVVRFLDWHG ZLWK ORQJHU SURJUHVVLRQIUHH VXUYLYDO DQG RYHUDOO
VXUYLYDO DQG KLJKHU UHVSRQVH UDWHV WKDQ WKRVH DVVRFLDWHG ZLWK LSLOLPXPDE LQ D SKDVH WULDO
LQYROYLQJSDWLHQWVZLWKDGYDQFHGPHODQRPD5REHUW&1(-0

,Q0D\UHVXOWVIURPWKH&KHFN0DWHWULDOZHUHSUHVHQWHG7KLVVWXG\LQYROYLQJSDWLHQWV
ZLWK SUHYLRXVO\ XQWUHDWHG DGYDQFHG PHODQRPD WUHDWPHQW ZLWK QLYROXPDE DORQH RU ZLWK WKH
FRPELQDWLRQ RI QLYROXPDE DQG LSLOLPXPDE UHVXOWHG LQ VLJQLILFDQWO\ ORQJHU SURJUHVVLRQIUHH
VXUYLYDO DQG KLJKHU REMHFWLYH UHVSRQVH UDWHV WKDQ GLG WUHDWPHQW ZLWK LSLOLPXPDE DORQH 7KH
LQFLGHQFHRIDGYHUVHHYHQWVLQWKLVVWXG\ZDVLQJHQHUDOORZHVWLQWKHQLYROXPDEJURXSDQGKLJKHVW
LQWKHFRPELQDWLRQJURXS

3HPEUROL]XPDEZDVILUVWHYDOXDWHGLQWKHODUJHSKDVH.(<127(VWXG\5REHUW&/DQFHW
,QDSRROHGDQDO\VLVRISDWLHQWVZLWKDGYDQFHGPHODQRPDHQUROOHGLQ.(<127(
DQGDIWHUDPHGLDQIROORZXSGXUDWLRQRIPRQWKVWKHUHVSRQVHUDWHZDVWKHUHVSRQVHZDV
PDLQWDLQHGLQRIWKRVHSDWLHQWVDQGPHGLDQRYHUDOOVXUYLYDOZDVPRQWKV5LEDV$

,Q .(<127( 3' LQKLELWLRQ LV FRPSDUHG ZLWK &7/$ EORFNDGH LQ D FRQWUROOHG
UDQGRPL]HG WULDO LQYROYLQJ SDWLHQWV ZLWK DGYDQFHG PHODQRPD 7KH HVWLPDWHG PRQWK
SURJUHVVLRQIUHHVXUYLYDOUDWHVZHUHIRUSDWLHQWVUHFHLYLQJSHPEUROL]XPDEHYHU\ZHHNV
 IRU WKRVH UHFHLYLQJ SHPEUROL]XPDE HYHU\ ZHHNV DQG  IRU WKRVH UHFHLYLQJ
LSLOLPXPDE 0HGLDQ HVWLPDWHV RI SURJUHVVLRQIUHH VXUYLYDO ZHUH PRQWKV  FRQILGHQFH
LQWHUYDO>&,@WRPRQWKV&,WRDQGPRQWKV&,WR
UHVSHFWLYHO\2QH\HDUHVWLPDWHVRIVXUYLYDOZHUHIRUSDWLHQWVUHFHLYLQJSHPEUROL]XPDE
HYHU\ZHHNVKD]DUGUDWLRIRUGHDWKDVFRPSDUHGZLWKWKHLSLOLPXPDEJURXS&,
WR3IRUWKRVHUHFHLYLQJSHPEUROL]XPDEHYHU\ZHHNVKD]DUGUDWLR
IRUGHDWKDVFRPSDUHGZLWKWKHLSLOLPXPDEJURXS&,WR3 DQG
IRUWKRVHUHFHLYLQJLSLOLPXPDE5REHUWV&1(-0

%DVHG RQ WKHVH GDWD PDQ\ FOLQLFLDQ DUH FKDQJLQJ SUDFWLFH SDWWHUQV WR XVH 3' LQKLELWRUV
QLYROXPDEDQGSHPEUROL]XPDEDVILUVWOLQHWUHDWPHQWLQSUHIHUHQFHWRLSLOLPXPDE




1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


2.6
Rationale for Combining Checkpoint Inhibitors with Dorgenmeltucel-L 

3UHFOLQLFDOGDWDKDYHGHPRQVWUDWHGV\QHUJ\EHWZHHQYDFFLQHDSSURDFKHVWRFDQFHUWUHDWPHQWDQG
FKHFNSRLQWLQKLELWRUV,QDPXULQHPRGHORIPHODQRPDWKHFRPELQDWLRQRIDZKROHFHOOYDFFLQH
DQGLSLOLPXPDEVKRZHGV\QHUJLVWLFUHVXOWV+ROPJDDUG1(-07KHJRDORIWKLVVWXG\LVWR
DSSO\ WKLV DSSURDFK WR SDWLHQWV ZLWK PHWDVWDWLF PHODQRPD FRPELQLQJ D +\SHU$FXWH
LPPXQRWKHUDS\ ZKROH FHOO YDFFLQH ZLWK WKH LPPXQH FKHFNSRLQWV LSLOLPXPDE QLYROXPDE RU
SHPEUROL]XPDE

 3$7,(176(/(&7,21
3.1
Eligibility criteria 

0XVW EH FRQILUPHG ZLWKLQ GD\V SULRU WR VWXG\ HQUROOPHQWUHJLVWUDWLRQ H[FHSW IRU E+&*
FRQILUPZLWKLQZHHNZKHQDSSURSULDWH6XEMHFWVZKRDUHSRVLWLYHIRUWKH%5$)PXWDWLRQ
ZKRKDYHQRWUHFHLYHG%5$)LQKLELWRUV\HWPD\EHHQUROOHGWRWKLVVWXG\EDVHGRQWKHGLVFUHWLRQ
RIWKHWUHDWLQJSK\VLFLDQDQGPD\UHFHLYH%5$)LQKLELWRUVIROORZLQJWKLVVWXG\

,QFOXVLRQFULWHULD

x +LVWRORJLFDOF\WRORJLFDOGLDJQRVLVRIPHODQRPD
x $-&&6WDJH,9DQ\7DQ\10PHWDVWDWLFSURJUHVVLYHUHIUDFWRU\PHODQRPD
x 3DWLHQWVPD\KDYHDGYDQFHGXQUHVHFWDEOH6WDJH,9GLVHDVHUHVHFWDEOH6WDJH,9GLVHDVH
RUUHFHQWO\UHVHFWHG6WDJH,9GLVHDVHZHHNVSULRUZLWKQRDSSDUHQWGLVHDVH1$'
x (DVWHUQ&RRSHUDWLYH2QFRORJ\*URXS(&2*3HUIRUPDQFH6WDWXVVHH$SSHQGL[%
x 6HUXPDOEXPLQ!JPG/
x $GHTXDWHRUJDQIXQFWLRQLQFOXGLQJ
o 0DUURZ+HPRJORELQ!JPG/DEVROXWHJUDQXORF\WHFRXQW$*&!PP
SODWHOHWV!PPDEVROXWHO\PSKRF\WHFRXQW!PP
o +HSDWLF6HUXPWRWDOELOLUXELQ[XSSHUOLPLWRIQRUPDO8/1$/76*37DQG
$676*27[8/1
o 5HQDO6HUXPFUHDWLQLQHV&U[8/1
x 3ULRUWKHUDS\IRUPHODQRPDWKDWPD\LQFOXGHVXUJHU\UDGLDWLRQWKHUDS\LPPXQRWKHUDS\
LQFOXGLQJLQWHUOHXNLQVDQGLQWHUIHURQDQGRUGLIIHUHQWUHJLPHQWVRIV\VWHPLF
FKHPRWKHUDS\WDUJHWHGWKHUDS\RURWKHUH[SHULPHQWDOV\VWHPLFWKHUDSLHV3ULRU
WUHDWPHQWZLWKLPPXQHFKHFNSRLQWLQKLELWRUVLVQRWDOORZHGVHH([FOXVLRQFULWHULD
x 3DWLHQWVPXVWEH!ZHHNVVLQFHPDMRUVXUJHU\UDGLRWKHUDS\FKHPRWKHUDS\ZHHNVLI
WKH\ZHUHWUHDWHGZLWKQLWURVXUHDVRUELRWKHUDS\WDUJHWHGWKHUDSLHV
x 3DWLHQWVPXVWKDYHWKHDELOLW\WRXQGHUVWDQGWKHVWXG\LWVULVNVVLGHHIIHFWVSRWHQWLDO
EHQHILWVDQGEHDEOHWRJLYHZULWWHQLQIRUPHGFRQVHQWWRSDUWLFLSDWH3DWLHQWVPD\QRWEH
FRQVHQWHGE\DGXUDEOHSRZHURIDWWRUQH\'3$
x 0DOHDQGIHPDOHVXEMHFWVRIFKLOGSURGXFLQJSRWHQWLDOPXVWDJUHHWRXVHcontraception or 
avoidance of pregnancy measuresZKLOHHQUROOHGRQVWXG\DQGUHFHLYLQJWKHH[SHULPHQWDO
GUXJDQGIRURQHPRQWKDIWHUWKHODVWLPPXQL]DWLRQ


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


([FOXVLRQFULWHULD
x $JH\HDUVROG
x Active&16PHWDVWDVHVRUFDUFLQRPDWRXVPHQLQJLWLV3DWLHQWVZLWK&16OHVLRQVWKDWKDYH
EHHQWUHDWHGDQGZKRKDYHQRHYLGHQFHRISURJUHVVLRQLQWKHEUDLQRQ&705,IRU
PRQWKDUHHOLJLEOH
x 3UHJQDQWRUQXUVLQJZRPHQGXHWRWKHXQNQRZQHIIHFWVRILPPXQL]DWLRQRQWKH
GHYHORSLQJIHWXVRUQHZERUQLQIDQW
x 2WKHUPDOLJQDQF\ZLWKLQILYH\HDUVH[FHSWWKDWWKHIROORZLQJPD\EHHOLJLEOH
o SDWLHQWVFXUDWLYHO\WUHDWHGIRUORFDOL]HGVTXDPRXVRUEDVDOFHOOFDUFLQRPDRIWKHVNLQ
RUIRUFDUFLQRPDin situRIWKHXWHULQHFHUYL[&,1RUEUHDVW
o SDWLHQWVZLWKDKLVWRU\RIPDOLJQDQWWXPRUZKRKDYHEHHQGLVHDVHIUHHIRUDWOHDVWILYH
\HDUVDQGDUHQRWFXUUHQWO\EHLQJWUHDWHG
x +LVWRU\RIDQDOORJHQHLFVROLGRUJDQWUDQVSODQWRUERQHPDUURZWUDQVSODQWRUFXUUHQW
DFWLYHLPPXQRVXSSUHVVLYHWKHUDS\VXFKDVF\FORVSRULQHWDFUROLPXVHWF
x 6XEMHFWVWDNLQJV\VWHPLFSDUHQWDOO\RURUDOO\FRUWLFRVWHURLGWKHUDS\IRUDQ\UHDVRQ
LQFOXGLQJUHSODFHPHQWWKHUDS\IRUK\SRDGUHQDOLVPDUHQRWHOLJLEOH7RSLFDOVWHURLGVDUH
DFFHSWDEOHDVDUHLQWUDQDVDOVWHURLGV
x
$FWLYHLQIHFWLRQRUDQWLELRWLFVZLWKLQKRXUVSULRUWRVWXG\HQUROOPHQWLQFOXGLQJ
XQH[SODLQHGIHYHUWHPS!q&LIGHHPHGFOLQLFDOO\VLJQLILFDQWE\WKHWUHDWLQJ
SK\VLFLDQ
x (YLGHQFHRIactiveDXWRLPPXQHGLVHDVHHJV\VWHPLFOXSXVHU\WKHPDWRVLVUKHXPDWRLG
DUWKULWLVZLWKWKHH[FHSWLRQRIYLWLOLJR3DWLHQWVZLWKDUHPRWHKLVWRU\RIDVWKPDRUPLOG
DVWKPDDUHHOLJLEOH
x 2WKHUVHULRXVPHGLFDOFRQGLWLRQVWKDWPD\EHH[SHFWHGWROLPLWOLIHH[SHFWDQF\WROHVV
WKDQ\HDUVHJOLYHUFLUUKRVLV
x $Q\FRQGLWLRQSV\FKLDWULFRURWKHUZLVHWKDWZRXOGSUHFOXGHLQIRUPHGFRQVHQW
FRQVLVWHQWIROORZXSRUFRPSOLDQFHZLWKDQ\DVSHFWRIWKHVWXG\HJXQWUHDWHG
VFKL]RSKUHQLDRURWKHUVLJQLILFDQWFRJQLWLYHLPSDLUPHQWHWF
x 3DWLHQWVKDYLQJSUHYLRXVO\XQGHUJRQHVSOHQHFWRP\
x 3DWLHQWVZLWKNQRZQKHSDWLWLVRUXQVWDEOHOLYHUGLVHDVHDQGRUSRVLWLYHVHURORJLHVIRU
+HSDWLWLV%RU&DQG+,9
x 3DWLHQWVZLWKVLFNOHFHOODQHPLDRUWKDODVVHPLDPDMRU
x 6XEMHFWVZKRUHFHLYHGSULRUWUHDWPHQWZLWKLPPXQHFKHFNSRLQWLQKLELWLRQFRQVLVWLQJRI
LSLOLPXPDEWUHPHOLPXPDEQLYROXPDESHPEUROL]XPDERURWKHUDQWLERG\WR&7/$RU
3'
3.2
Eligibility and On-Study Tests

%DVHOLQHDQGRQVWXG\WHVWVZLOOLQFOXGHVHH6HFWLRQ6WXG\&DOHQGDU

x %DVHOLQHKLVWRU\DQGFRPSOHWHSK\VLFDOH[DPLQDWLRQ
x 6HUXPFKHPLVWULHVLQFOXGLQJHOHFWURO\WHV%81FUHDWLQLQHFDOFLXPJOXFRVHDQG
DOEXPLQOLYHUIXQFWLRQWHVWVLQFOXGLQJWRWDOELOLUXELQ$/76*37$676*27/'+
DQGDONDOLQHSKRVSKDWDVHTXDQWLWDWLYHLPPXQRJOREXOLQV,J*,J0DQG,J(&%&ZLWK
SODWHOHWVDQGGLIIHUHQWLDO


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

x 7K\URLGVWLPXODWLQJKRUPRQH76+DQGIUHH7
x 3UHJQDQF\WHVWLQJZLWKVHUXPE+&*LQZRPHQRIFKLOGEHDULQJSRWHQWLDO
x %ORRGDSSUR[LPDWHO\P/IRUPHDVXUHPHQWRIDQWLĮJDODQGDQWLWXPRUDQWLERGLHVWR
EHGUDZQRQ'D\EHIRUHWUHDWPHQWDGPLQLVWUDWLRQDQGDVRXWOLQHGLQ6HFWLRQ
x )RUSDWLHQWVUHFHLYLQJWKHGRUJHQPHOWXFHO/LPPXQRWKHUDS\ZKROHEORRG
DSSUR[LPDWHO\P/IRUUHSOLFDWLRQFRPSHWHQWUHWURYLUXV5&5WHVWLQJRQ'D\SULRU
WRWKHILUVWLPPXQL]DWLRQDQGZLOOEHVHQWWR1HZ/LQN*HQHWLFV
x &RQWUDVWHQKDQFHG&7VFDQRIWKHFKHVWDQGDEGRPHQor ZKROHERG\3(7&7IXVLRQ
VFDQ&7VFDQRU05,VFDQRIWKHEUDLQLINQRZQRUVXVSHFWHGEUDLQPHWDVWDVHV,I
LQGLFDWHG&7VFDQRIWKHQHFNor XOWUDVRXQG3(7VFDQDQGRUUDGLRQXFOHLGHERQHVFDQ
PD\DOVREHREWDLQHG3(7VFDQVDQGUDGLRQXFOLGHERQHVFDQVPD\QRWEHXVHGIRU
GHWHUPLQDWLRQRIUHVSRQVH
x 0HDVXUDEOHGLVHDVHRUVROLGOHVLRQVOLYHUPDVVHVO\PSKQRGHVDQGVNLQQRGXOHVZLOOEH
PHDVXUHGDQGUHFRUGHGSUHWKHUDS\XVLQJ5(&,67LU5&FULWHULD
x :KROHEORRGDSSUR[LPDWHO\P/LQSXUSOHWRSWXEHVIRU3%/VIRULQWUDFHOOXODU
F\WRNLQHVDQG(/,6327WREHGUDZQRQ'D\EHIRUHWUHDWPHQWDGPLQLVWUDWLRQDQGDV
RXWOLQHGLQ6HFWLRQ7KHVHVDPSOHVZLOOEHVHQWWR1HZ/LQN*HQHWLFVIRUWHVWLQJ

%DVHOLQHHYDOXDWLRQVDUHWREHFRQGXFWHGZLWKLQGD\VSULRUWRVWDUWRISURWRFROWKHUDS\XQOHVV
RWKHUZLVHVSHFLILHG,QWKHHYHQWWKDWWKHSDWLHQW
VFRQGLWLRQKDVVLJQLILFDQWO\GHWHULRUDWHGHJ
VLJQLILFDQWLQFUHDVHLQV\PSWRPVRUZRUVHQLQJRI(&2*36ODERUDWRU\HYDOXDWLRQVVKRXOGEH
UHSHDWHGZLWKLQGD\VSULRUWRLQLWLDWLRQRIWKHUDS\
 75($70(173/$1
4.1
Registration and Randomization

$OOSDWLHQWVPXVWEHUHJLVWHUHGRQVWXG\EHIRUHEHJLQQLQJWKHUDS\7UHDWLQJSK\VLFLDQPXVWGHFODUH
ZKLFKLPPXQHFKHFNSRLQWWKHUDS\ZLOOEHXVHGSULRUWRHQUROOLQJDSDWLHQW

$OOVXEMHFWVPXVWKDYHDVLJQHG,QIRUPHG&RQVHQW'RFXPHQWDQGDFRPSOHWHG(OLJLELOLW\
&KHFNOLVW )RUP EHIRUH UHJLVWUDWLRQ RQ WKH VWXG\ 7R UHJLVWHU D VXEMHFW IRU WKLV SURWRFRO DQ
DXWKRUL]HG SK\VLFLDQ RU WKHLU GHVLJQHH PXVW )$; RU (0$,/ WKH VXEMHFW LQIRUPDWLRQ WR WKH
1HZ/LQN *HQHWLFV 5HJLVWUDWLRQ 2IILFH RU WKH VLWH¶V GHVLJQDWHG &5$ EHWZHHQ WKH KRXUV RI
$0DQG30&HQWUDO6WDQGDUG7LPH0RQGD\WKURXJK)ULGD\)$;
(0$,/3DWLHQW5HJLVWUDWLRQV#OLQNSFRP1RHYHQLQJZHHNHQGRUKROLGD\UHJLVWUDWLRQVZLOOEH
SHUPLWWHG  $Q RQOLQH UDQGRPL]DWLRQ SURFHVV ZLOO EH XVHG WR SURYLGH VLWHV ZLWK WUHDWPHQW
DVVLJQPHQWVIRUWKLVVWXG\$UDQGRPL]DWLRQSODQZLOOEHSURYLGHGWRWKHVLWHVGHWDLOLQJWKHSURFHVV
2QFHHOLJLELOLW\DQGGLVHDVHVWDWXVVWUDWXPLVFRQILUPHGE\1HZ/LQNDQGWKHVXEMHFWUDQGRPL]HG
1HZ/LQNZLOO)$;RU(0$,/DFRQILUPDWLRQRIUHJLVWUDWLRQWRWKHVLWH7KHWUHDWPHQWDVVLJQPHQW
ZLOOEHSURYLGHGWRWKHVLWHE\(0$,/7KHFOLQLFDOVLWH¶VVWRUDJHIDFLOLW\SKDUPDF\ZLOOQRWUHOHDVH
WKHLPPXQRWKHUDS\XQWLOWKHGD\RIWKHVFKHGXOHGLPPXQL]DWLRQ

$ILOHRIFRSLHVRIDOOUHSRUWVODERUDWRU\VWXGLHVDQGRWKHUSHUWLQHQWLQIRUPDWLRQGRFXPHQWLQJWKH
VXEMHFW¶V HOLJLELOLW\ IRU VWXG\ ZLOO EH PDLQWDLQHG LQ WKH &OLQLFDO 5HVHDUFK 2IILFH RI 1HZ/LQN
*HQHWLFV&RUSRUDWLRQ


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

4.2
Study Implementation

7KLV VWXG\ ZLOO EH FRQGXFWHG LQ DFFRUGDQFH ZLWK WKH SURFHGXUHV DQG SROLFHV HVWDEOLVKHG E\
&%(5)'$2IILFHRI%LRWHFKQRORJ\$VVHVVPHQW2%$WKH,QVWLWXWLRQDO%LRVDIHW\&RPPLWWHH
,%&DQGWKH,5%7KHVWXG\DQGFRQVHQWIRUPZLOOEHGLVFXVVHGIXOO\ZLWKHDFKSDWLHQWDQG
LQIRUPHGZULWWHQFRQVHQWREWDLQHG

7UHDWPHQWPXVWEHJLQZLWKLQZHHNVRIUHJLVWUDWLRQ

6WXG\$JHQW$GPLQLVWUDWLRQVHH$SSHQGL[&

7KHGRUJHQPHOWXFHO/LPPXQRWKHUDS\FHOOVZLOOEHLQMHFWHGLQWUDGHUPDOO\LGXVLQJWXEHUFXOLQ
RURWKHUVPDOOV\ULQJHZLWKDJDXJHQHHGOH,QMHFWLRQVZLOOEHDGPLQLVWHUHGDVGLYLGHGGRVHV
DQGDGPLQLVWHUHGRQDQDOWHUQDWLQJEDVLVZLWKHDFKLPPXQRWKHUDS\F\FOHJLYHQLQWKHXSSHUDQGRU
ORZHU H[WUHPLWLHV ,PPXQL]DWLRQV ZLOO EH DYRLGHG ZLWKLQ DQ H[WUHPLW\ WKDW KDV SUHYLRXVO\
XQGHUJRQHDFRPSOHWHO\PSKQRGHGLVVHFWLRQ

3DWLHQWVZLOOEHPRQLWRUHGEHIRUHDQGDIWHUHDFKLQMHFWLRQE\WKHQXUVLQJVWDII

x 0RQLWRULQJLVWRLQFOXGHWHPSHUDWXUH7SXOVH3EORRGSUHVVXUH%3DQGUHVSLUDWRU\
UDWH5PHDVXUHGZLWKLQPLQXWHVEHIRUHDGPLQLVWUDWLRQRIWKHLPPXQRWKHUDS\DQG
WKHQZLWKLQPLQXWHVDIWHUWKHLPPXQL]DWLRQ,QDGGLWLRQSDWLHQWVZLOOEHPRQLWRUHGIRU
VLJQVRIDFXWHDOOHUJLFUHDFWLRQVLQFOXGLQJORFDORUGLVVHPLQDWHGVNLQUDVKDQGRWKHUDGYHUVH
UHDFWLRQV
x 6KRXOGDQDGYHUVHHYHQWRFFXUDIWHUGLVFKDUJHSDWLHQWVZLOOEHLQVWUXFWHGWRLPPHGLDWHO\
FRQWDFW WKH 3ULQFLSDO ,QYHVWLJDWRU $VVRFLDWH ,QYHVWLJDWRU RU UHVHDUFK QXUVH IRU IXUWKHU
HYDOXDWLRQDQGRUWUHDWPHQW
x 3DWLHQWVGHYHORSLQJ*UDGHRUJUHDWHUDFXWHDGYHUVHUHDFWLRQVZLOOEHPRQLWRUHGIRUDQ
DGGLWLRQDOKRXUVRUXQWLOWKH$(KDVUHVROYHGWROHVVWKDQ*UDGH0HGLFDOO\LQGLFDWHG
WUHDWPHQWRIWKH$(ZLOOEHDGPLQLVWHUHG,IDQDFXWH$(RI*UDGHRUJUHDWHUSHUVLVWVIRU
PRUHWKDQKRXUVGHVSLWHREVHUYDWLRQDQGRUWUHDWPHQWDGHFLVLRQRQZKHWKHUWRFRQWLQXH
REVHUYDWLRQLQVWLWXWHRUPRGLI\WUHDWPHQWRIWKH$(RUDGPLWWKHSDWLHQWWRWKHLQSDWLHQW
XQLWIRUIXUWKHUREVHUYDWLRQDQGRUWUHDWPHQWZLOOEHPDGHE\WKH3ULQFLSDO,QYHVWLJDWRUVRU
GHVLJQHHV

$ GHWDLOHG GHVFULSWLRQ RI WKH LPPXQRWKHUDS\ VWRUDJH KDQGOLQJ DQG UHFRQVWLWXWLRQ IRU
LPPXQL]DWLRQPD\EHIRXQGLQ6HFWLRQ
4.3
Supportive Care

3DWLHQWV DUH WR EH PRQLWRUHG GXULQJ HDFK LPPXQL]DWLRQ DV GHVFULEHG DERYH LQ 6HFWLRQ
8QH[SHFWHGDGYHUVHHYHQWVZLOOEHWUHDWHGDVPHGLFDOO\LQGLFDWHGE\WKHLQYROYHGSK\VLFLDQV
&RPSOLFDWLRQVRIWKHSDWLHQW¶VXQGHUO\LQJPHODQRPDRUFRPRUELGPHGLFDOFRQGLWLRQVXQUHODWHG
WRWKHVWXG\WUHDWPHQWZLOOEHWUHDWHGSURPSWO\E\WKHVWXG\SK\VLFLDQVZLWKUHIHUUDOEDFNWRWKH
SDWLHQW¶VSULPDU\PHGLFDOFDUHSURYLGHUDVDSSURSULDWH


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

4.4
Duration of Therapy

3DWLHQWVZKRVHWXPRUSURJUHVVHVRQWKHUDS\ZLOOEHRIIVWXG\+RZHYHUPLOGSURJUHVVLRQ
LQFUHDVH LQ WXPRU VL]H DW WKH EHJLQQLQJ RI WKH WUHDWPHQW LV DOORZHG JLYHQ WKH XVXDO GHOD\HG
UHVSRQVHSVHXGRSURJUHVVLRQVHHQZLWKLPPXQRWKHUDS\:ROFKRNHWDO

3DWLHQWVZKRH[SHULHQFHD6$(ZKLFKWULJJHUVVWRSSLQJUXOHVIRULPPXQHFKHFNSRLQWLQKLELWRUV
LSLOLPXPDEQLYROXPDERUSHPEUROL]XPDEDVGHVFULEHGLQWKHLUUHVSHFWLYHSDFNDJHLQVHUWVZLOOEH
SHUPDQHQWO\ GLVFRQWLQXHG IURP WKH LPPXQH FKHFNSRLQW LQKLELWRU 7KH\ FDQ EH FRQWLQXHG RQ
GRUJHQPHOWXFHO/LILQ$UPRQFHUHFRYHUHGIURPLPPXQHFKHFNSRLQWLQKLELWRUWR[LFLW\

3DWLHQWVDUHDOVRRIIVWXG\ZKR
x H[SHULHQFHLQWHUFXUUHQWLOOQHVVWKDWSUHYHQWVIXUWKHUDGPLQLVWUDWLRQRIWUHDWPHQW
x GHFLGHWRZLWKGUDZIURPWKHVWXG\
x H[SHULHQFHJHQHUDO RU VSHFLILF FKDQJHV LQ WKH SDWLHQW
V FRQGLWLRQWKDWUHQGHU WKHP
XQDFFHSWDEOHIRUIXUWKHUWUHDWPHQWLQWKHMXGJPHQWRIWKHLQYHVWLJDWRU
4.5
Off-Study Therapy Criteria
3DWLHQWV ZLOO EH UHPRYHG IURP VWXG\ WKHUDS\ ZKHQ DQ\ RI WKH FULWHULD OLVWHG LQ 6HFWLRQ
DSSOLHV7KH UHDVRQ IRU VWXG\ UHPRYDO DQG WKH GDWH WKH SDWLHQW ZDVUHPRYHGPXVWEH
GRFXPHQWHGRQWKH&DVH5HSRUW)RUP

4.6
Post-Treatment Evaluation/Monitoring

)RUSDWLHQWVZKRUHFHLYHWKHLPPXQRWKHUDS\DQGFRPSOHWHRUJRRIIWUHDWPHQWHDUO\IROORZXS
YLVLWVZLOOEHPDGHXQWLO\HDUVRUGHDWKZKLFKHYHUFRPHVILUVW

/RQJWHUP&OLQLFDO0RQLWRULQJRI6XEMHFWV3DUWLFLSDWLQJLQWKLV*HQH7UDQVIHU7ULDO
6XEMHFWVVXUYLYLQJIRUPRUHWKDQ\HDUVZLOOEHIROORZHGRQD\HDUO\EDVLVIRUDWOHDVWDGGLWLRQDO
\HDUV \HDUV WRWDO DV UHFRPPHQGHG E\ WKH )'$ %LRORJLF 5HVSRQVH 0RGLILHU¶V $GYLVRU\
&RPPLWWHH%50$&IRUODWHVHTXHODHRIJHQHWUDQVIHU

,QIRUPDWLRQWREHFROOHFWHGDQGPDGHDYDLODEOHWRWKH)'$LQWKH,1'DQQXDOUHSRUWDQGUHSRUWV
WRRWKHUUHJXODWRU\DJHQFLHVDVPDQGDWHGZLOOLQFOXGH
x &OLQLFDOLQIRUPDWLRQRQde novoFDQFHUVQHXURORJLFDODXWRLPPXQHDQGKHPDWRORJLFDO
GLVRUGHUV
x 8QH[SHFWHGPHGLFDOSUREOHPVKRVSLWDOL]DWLRQVDQGPHGLFDWLRQV
x ([SHFWHGRUXQH[SHFWHGSDWLHQWGHDWKDQGFDXVHRIGHDWK
 '26,1*,1)250$7,21

7KHVWXG\LVGHVLJQHGWRHYDOXDWHWKHDGGLWLRQRIGRUJHQPHOWXFHO/WRVWDQGDUGRIFDUHFKHFNSRLQW
LPPXQRWKHUDS\7KHIROORZLQJLQIRUPDWLRQDERXWLSLOLPXPDEQLYROXPDEDQGSHPEUROL]XPDELV
SURYLGHGDVEDFNJURXQGDQGGUDZQIURPWKHSDFNDJHLQVHUWVRIWKHUHVSHFWLYHLPPXQRWKHUDSLHV
7KHLQIRUPDWLRQVKRXOGQRWEHFRQVLGHUHGFRPSOHWHQRUFRPSUHKHQVLYH7KHDGPLQLVWUDWLRQRI


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

WKHVHDJHQWVLSLOLPXPDEQLYROXPDEDQGSHPEUROL]XPDEVKRXOGEHGRQHDWWKHGLUHFWLRQRIWKH
WUHDWLQJSK\VLFLDQDFFRUGLQJWRWKHSK\VLFLDQ¶VXVXDOVWDQGDUGRIFDUHSUDFWLFHV
5.1
Dorgenmeltucel-L Immunotherapy 

'RUJHQPHOWXFHO/LPPXQRWKHUDS\FRQVLVWVRIHTXDOTXDQWLWLHVRIWKUHHFHOOXODUFRPSRQHQWV7KH
FHOOXODUFRPSRQHQWV+$0+$0DQG+$0RIGRUJHQPHOWXFHO/LPPXQRWKHUDS\KDYH
EHHQGHULYHGIURPDOORJHQHLFPHODQRPDFDQFHUFHOOOLQHV+$0LVGHULYHGIURPWKHKXPDQ
PHODQRPDFHOOOLQH*+$0LVGHULYHGIURPWKHPHODQRPDFHOOOLQH6.0(/DQG+$0
LVGHULYHGIURPWKHKXPDQPHODQRPDFHOOOLQH&2/20DVWHUFHOOEDQNVRIWKHVHFHOOXODU
FRPSRQHQWVKDYHEHHQHQJLQHHUHGWRH[SUHVVWKHPXULQHĮ*7JHQH'XULQJPDQXIDFWXULQJ
WKHFHOOVDUHDPSOLILHGDQGKDUYHVWHGXQGHUVWHULOHFXOWXUHFRQGLWLRQVWKHQLUUDGLDWHG7KHSURGXFW
LVWKHQVWRUHGLQWKHYDSRUSKDVHRIOLTXLGQLWURJHQXQWLOUHOHDVHGIRUVKLSPHQW$OOSURGXFWLRQORWV
DUH VXEMHFWHG WR WHVWLQJ WR DVVXUH FRPSOLDQFH ZLWK DOO SURGXFW VSHFLILFDWLRQV EHIRUH WKH\ DUH
UHOHDVHGIRUFOLQLFDOXVH

7KHLPPXQRWKHUDS\FHOOV+$0+$0+$0DUHVXSSOLHGLQGLYLGXDOO\SDFNDJHGLQVWHULOH
P/JDVNHWVHDOHGFU\RYLDOV(DFKYLDOFRQWDLQVDFHOOVXVSHQVLRQLQDQHXWUDOVDOLQHVROXWLRQ
ZLWKKXPDQDOEXPLQ863DQGJO\FHULQH863$IWHUWKDZLQJWKHFRQWHQWRIWKHYLDOVLVDWXUELG
\HOORZZKLWH OLTXLG ,QMHFWLRQV PXVW EH DGPLQLVWHUHG ZLWKLQ PLQXWHV RI WKDZLQJ WKH
LPPXQRWKHUDS\

)RU DGPLQLVWUDWLRQ HDFK RI WKH WKUHH LPPXQRWKHUDS\ FHOOXODU FRPSRQHQWV LV DGPLQLVWHUHG
VHSDUDWHO\  3DWLHQWV UHFHLYH D WRWDO RI VL[  LQMHFWLRQV SHU LPPXQL]DWLRQ SURFHGXUH 7KH
FRPSRQHQWVSHFLILFDWLRQVDUHOLVWHGLQ7DEOHEHORZ

7DEOH,PPXQRWKHUDS\6SHFLILFDWLRQV

7KH GRVH RI GRUJHQPHOWXFHO/ LPPXQRWKHUDS\ JLYHQ LQ WKLV VWXG\ LV PLOOLRQ +$0 FHOOV
:KHQJLYLQJDGRVHRI0+$0FHOOVWKHFOLQLFDOVLWHZLOOJLYHLQMHFWLRQVLQMHFWLRQVRI
P/RI+$0LQMHFWLRQVRIP/RI+$0LQMHFWLRQVRIP/RI+$0

7KH+$0LPPXQRWKHUDS\FHOOVDUHLQMHFWHGLQWUDGHUPDOO\LGXVLQJDVPDOOWXEHUFXOLQV\ULQJH
ZLWKDJDXJHQHHGOH,QMHFWLRQVDUHVSOLWEHWZHHQWKHIRUHDUPVDQGWKLJKVRQDURWDWLQJEDVLV
DWHDFKLPPXQL]DWLRQ

)RUSUHSDUDWLRQIRULQMHFWLRQVHH$SSHQGL[&




'RUJHQPHOWX
FHO/

)LOO
9ROXPH

&HOOV
SHU9LDO

9LDO6L]H
9ROXPHWR
EH,QMHFWHG
9ROXPH
SHUHDFK
,QMHFWLRQ
7RWDO&HOOV
SHU
7UHDWPHQW

RI
,QMHFWLRQV
+$0
P/
[
[P/
P/
P/
0

+$0
P/
[
[P/
P/
P/
0

+$0
P/
[
[P/
P/
P/
0

727$/


YLDOV
P/

0











1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

6SHFLILF5LVN$GYHUVH(YHQWVWR+\SHU$FXWHLPPXQRWKHUDS\
$QXPEHURISDWLHQWVUHFHLYLQJ+\SHU$FXWHLPPXQRWKHUDS\IRUFDQFHUVRIWKHOXQJSDQFUHDV
DQG VNLQ H[SHULHQFH VNLQ UHDFWLRQV DW WKH VLWH RI LPPXQL]DWLRQ 7KH W\SHV RI LQIODPPDWRU\
UHVSRQVHREVHUYHGYDULHGDPRQJLQGLYLGXDOV7KHIROORZLQJVNLQUHDFWLRQVKDYHEHHQREVHUYHG

$$FXWH5HDFWLRQ

,QPRVWFDVHVSDWLHQWVUHFHLYLQJ+\SHU$FXWHLPPXQRWKHUDS\H[SHULHQFHDUDSLGLQIODPPDWRU\
UHDFWLRQDWWKHVLWHRILQMHFWLRQ7KLVUHDFWLRQLVFKDUDFWHUL]HGE\VZHOOLQJHU\WKHPDKHDWLQWKH
DUHDPLOGGLVFRPIRUWDQGLWFKLQJ

%'HOD\HG7\SH+\SHUVHQVLWLYLW\UHDFWLRQV

6RPHSDWLHQWVDOVRH[SHULHQFHD'7+OLNHUHDFWLRQ,QWKLVFDVHWKHLQIODPPDWRU\UHVSRQVHWDNHV
WZRWRWKUHHGD\VWRGHYHORS

7KHIROORZLQJUHDFWLRQVKDYHEHHQREVHUYHGGXULQJLPPHGLDWHO\DIWHUDQLPPXQL]DWLRQDQGRU
GD\VODWHU

3DLQ

(U\WKHPD5HGQHVV

3UXULWXV,WFKLQJ

6ZHOOLQJ

,QGXUDWLRQ+DUGHQLQJ

,UULWDWLRQ'LVFRPIRUW

:DUPQHVV

7RKHOSDOOHYLDWHDQ\GLVFRPIRUWWKDWWKHSDWLHQWPLJKWH[SHULHQFHGXHWRDQDGYHUVHUHDFWLRQDW
WKHLQMHFWLRQVLWHWKHIROORZLQJWUHDWPHQWRSWLRQVDUHDFFHSWDEOH

x )LUVWWU\LFHRUFROGFRPSUHVVHVWRWKHDUHD
x ,ILWFKLQJGLVFRPIRUWFRQWLQXHVGLSKHQK\GUDPLQHFUHDPRUDSSURSULDWHDOWHUQDWLYH
DQWLKLVWDPLQHFUHDPFDQEHXVHG
x ,ILWFKLQJGLVFRPIRUWLVQRWDOOHYLDWHGZLWKWRSLFDOFUHDPRUDOGLSKHQK\GUDPLQHRU
DSSURSULDWHDOWHUQDWLYHDQWLKLVWDPLQHPD\EHXVHG
x $FHWDPLQRSKHQRULEXSURIHQFDQDOVREHXVHGIRUSDLQGLVFRPIRUW

7KHPRVWIUHTXHQWO\UHSRUWHG+\SHU$FXWHUHODWHGDGYHUVHHYHQWVDOOJUDGHVH[SHULHQFHGLQWKH
0HODQRPD&OLQLFDO7ULDOVDQG2&,DUHLQMHFWLRQVLWHUHDFWLRQVIDWLJXHDQGQDXVHD

)RU PRUH GHWDLOV RQ DGYHUVH HYHQWV REVHUYHG SOHDVH VHH WKH ,QYHVWLJDWRU¶V %URFKXUH IRU
GRUJHQPHOWXFHO/LPPXQRWKHUDS\

3URFXUHPHQW
7KHDOORJHQHLFGRUJHQPHOWXFHO/LPPXQRWKHUDS\LVSUHSDUHGYLDOHGVXSSOLHGDQGVKLSSHGE\
1HZ/LQN*HQHWLFV&RUSRUDWLRQ'RUJHQPHOWXFHO/LVVKLSSHGE\DLUFDUULHUWRWKHFOLQLFDOVLWHRQ
GU\LFH(DFKVKLSPHQWLVDFFRPSDQLHGE\&OLQLFDO,QYHVWLJDWLRQDO0DWHULDO6KLSPHQW5HFHLSW
)RUPDQGD&HUWLILFDWHRI$QDO\VLVIRUSURGXFWVDIHW\WHVWLQJ8SRQUHFHLSWDWWKHFOLQLFDOVLWHWKH
SURGXFWLVXQSDFNHGE\DGHVLJQDWHGSHUVRQVDQGLPPHGLDWHO\WUDQVIHUUHGWRWKHYDSRUSKDVHRI


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

D OLTXLG QLWURJHQ VWRUDJH WDQN 7KH GUXJ ZLOO EH VWRUHG LQ WKH FOLQLFDO VLWH¶V ,QYHVWLJDWLRQDO
3KDUPDF\RUGHVLJQDWHGDUHDLQDPRQLWRUHGOLTXLGQLWURJHQFU\RIUHH]HUXQGHUVWULFW4&FRQGLWLRQV
7KHSURFHGXUHIRUSUHSDUDWLRQLVRXWOLQHGLQ$SSHQGL[&

'UXJ$FFRXQWDELOLW\
)'$UHJXODWLRQVUHTXLUHLQYHVWLJDWRUVWRHVWDEOLVKDUHFRUGRIWKHUHFHLSWXVHDQGGLVSRVLWLRQRI
DOOLQYHVWLJDWLRQDODJHQWV,QYHVWLJDWRUVPD\GHOHJDWHUHVSRQVLELOLW\IRUGUXJRUGHULQJVWRUDJH
DFFRXQWDELOLW\ DQG SUHSDUDWLRQ WR KLVKHU GHVLJQHH 7KH LQYHVWLJDWRU RU WKH UHVSRQVLEOH SDUW\
GHVLJQDWHGE\WKHLQYHVWLJDWRUPXVWPDLQWDLQDFDUHIXOUHFRUGRIWKHLQYHQWRU\DQGGLVSRVLWLRQRI
DOODJHQWVUHFHLYHG

5.2
Ipilimumab (Yervoy®) – Information from package insert

'HVFULSWLRQ
,SLOLPXPDE<HUYR\LVDUHFRPELQDQWKXPDQPRQRFORQDODQWLERG\WKDWELQGVWRWKHF\WRWR[LF
7O\PSKRF\WHDVVRFLDWHGDQWLJHQ&7/$,SLOLPXPDELVDQLJ*NDSSDLPPXQRJOREXOLQ
ZLWK DQ DSSUR[LPDWH PROHFXODU ZHLJKW RI N'D  ,SLOLPXPDE LV SURGXFHG LQ PDPPDOLDQ
&KLQHVHKDPVWHURYDU\FHOOFXOWXUH

0HFKDQLVPRI$FWLRQ
&7/$LVDQHJDWLYHUHJXODWRURI7FHOODFWLYDWLRQ,SLOLPXPDEELQGVWR&7/$DQGEORFNVWKH
LQWHUDFWLRQRI&7/$ZLWKLWVOLJDQGV&'&'%ORFNDGHRI&7/$KDVEHHQVKRZQWR
DXJPHQW7FHOODFWLYDWLRQDQGSUROLIHUDWLRQ7KHPHFKDQLVPRIDFWLRQRILSLOLPXPDE¶VHIIHFWLQ
SDWLHQWV ZLWK PHODQRPD LV LQGLUHFW SRVVLEO\ WKURXJK 7FHOO PHGLFDWHG DQWLWXPRU LPPXQH
UHVSRQVHV

3KDUPDFRNLQHWLFV
7KHSKDUPDFRNLQHWLFVRILSLOLPXPDEZDVVWXGLHGLQSDWLHQWVZLWKXQUHVHFWDEOHRUPHWDVWDWLF
PHODQRPDZKRUHFHLYHGGRVHVRIRUPJNJDGPLQLVWHUHGRQFHHYHU\ZHHNVIRUIRXU
GRVHV3HDNFRQFHQWUDWLRQ&PD[WURXJKFRQFHQWUDWLRQ&PLQDQGDUHDXQGHUWKHFXUYH$8&RI
LSLOLPXPDEZHUHIRXQGWREHGRVHSURSRUWLRQDOZLWKLQWKHGRVHUDQJHH[DPLQHG8SRQUHSHDWHG
GRVLQJ RI <(592< DGPLQLVWHUHG HYHU\ ZHHNV LSLOLPXPDE FOHDUDQFH ZDV IRXQG WR EH
WLPHLQYDULDQWDQGPLQLPDOV\VWHPLFDFFXPXODWLRQZDVREVHUYHGDVHYLGHQWE\DQDFFXPXODWLRQ
LQGH[RIIROGRUOHVV,SLOLPXPDEVWHDG\VWDWHFRQFHQWUDWLRQZDVUHDFKHGE\WKHWKLUGGRVH7KH
IROORZLQJPHDQSHUFHQWFRHIILFLHQWRIYDULDWLRQSDUDPHWHUVZHUHJHQHUDWHGWKURXJKSRSXODWLRQ
SKDUPDFRNLQHWLF DQDO\VLV WHUPLQDO KDOIOLIH RIGD\V  V\VWHPLF FOHDUDQFH &/ RI
P/KDQGYROXPHRIGLVWULEXWLRQDWVWHDG\VWDWH9VVRI/7KHPHDQ
6' LSLOLPXPDE &PLQ DFKLHYHG DW VWHDG\VWDWH ZLWK WKH PJNJ UHJLPHQ ZDV PFJP/


Specific Populations: &URVVVWXG\DQDO\VHVZHUHSHUIRUPHGRQGDWDIURPSDWLHQWVZLWKDYDULHW\
RIFRQGLWLRQVLQFOXGLQJSDWLHQWVZLWKPHODQRPDZKRUHFHLYHGVLQJOHRUPXOWLSOHLQIXVLRQVRI
LSLOLPXPDE DW GRVHV RI  RU PJNJ 7KH HIIHFWV RI YDULRXV FRYDULDWHV RQ LSLOLPXPDE
SKDUPDFRNLQHWLFVZHUHDVVHVVHGLQSRSXODWLRQSKDUPDFRNLQHWLFDQDO\VHV

,SLOLPXPDE &/ LQFUHDVHG ZLWK LQFUHDVLQJ ERG\ ZHLJKW KRZHYHU QR GRVH DGMXVWPHQW RI
LSLOLPXPDE LV UHTXLUHGIRU ERG\ZHLJKW DIWHU DGPLQLVWUDWLRQ RQDPJNJEDVLV7KHIROORZLQJ


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

IDFWRUVKDGQRFOLQLFDOO\PHDQLQJIXOHIIHFWRQWKH&/RILSLOLPXPDEDJHUDQJHWR\HDUV
JHQGHU FRQFRPLWDQW XVH RI EXGHVRQLGH SHUIRUPDQFH VWDWXV +/$$ VWDWXV SRVLWLYH
DQWLLSLOLPXPDE DQWLERG\ VWDWXV SULRU XVH RI V\VWHPLF DQWLFDQFHU WKHUDS\ RU EDVHOLQH ODFWDWH
GHK\GURJHQDVH /'+ OHYHOV 7KH HIIHFW RI UDFH ZDV QRW H[DPLQHG DV WKHUH ZHUH LQVXIILFLHQW
QXPEHUVRISDWLHQWVLQQRQ&DXFDVLDQHWKQLFJURXSV

Renal Impairment: &UHDWLQLQHFOHDUDQFHDWEDVHOLQHGLGQRWKDYHDFOLQLFDOO\LPSRUWDQWHIIHFWRQ
LSLOLPXPDESKDUPDFRNLQHWLFVLQSDWLHQWVZLWKFDOFXODWHGFUHDWLQLQHFOHDUDQFHYDOXHVRIP/PLQ
RUJUHDWHU
Hepatic Impairment: %DVHOLQH $67 WRWDO ELOLUXELQ DQG $/7 OHYHOV GLG QRW KDYH D FOLQLFDOO\
LPSRUWDQW HIIHFW RQ LSLOLPXPDE SKDUPDFRNLQHWLFV LQ SDWLHQWV ZLWK YDULRXV GHJUHHV RI KHSDWLF
LPSDLUPHQW

3KDUPDFHXWLFDO'DWD
,SLOLPXPDELVDVWHULOHSUHVHUYDWLYHIUHHFOHDUWRVOLJKWO\RSDOHVFHQWFRORUOHVVWRSDOH\HOORZ
VROXWLRQ IRU LQWUDYHQRXV LQIXVLRQ ZKLFK PD\ FRQWDLQ D VPDOO DPRXQW RI YLVLEOH
WUDQVOXFHQWWRZKLWH DPRUSKRXV LSLOLPXPDE SDUWLFXODWHV  ,W LV VXSSOLHG LQ VLQJOHXVH YLDOV RI
PJP/DQGPJP/(DFKPLOOLOLWHUFRQWDLQVPJRILSLOLPXPDE 

6XSSO\
,SLOLPXPDELVFRPPHUFLDOO\DYDLODEOH

6SHFLILF5LVN$GYHUVH(YHQWVZLWKLSLOLPXPDE
,SLOLPXPDE FDQ UHVXOW LQ VHYHUH DQG IDWDO LPPXQHPHGLDWHG DGYHUVH UHDFWLRQV GXH WR 7FHOO
DFWLYDWLRQDQGSUROLIHUDWLRQ7KHVHLPPXQHPHGLDWHGUHDFWLRQVPD\LQYROYHDQ\RUJDQV\VWHP
KRZHYHUWKHPRVWFRPPRQVHYHUHLPPXQHPHGLDWHGDGYHUVHUHDFWLRQVDUHHQWHURFROLWLVKHSDWLWLV
GHUPDWLWLVLQFOXGLQJWR[LFHSLGHUPDOQHFURO\VLVQHXURSDWK\DQGHQGRFULQRSDWK\7KHPDMRULW\
RIWKHVHLPPXQHPHGLDWHGUHDFWLRQVLQLWLDOO\PDQLIHVWHGGXULQJWUHDWPHQWKRZHYHUDPLQRULW\
RFFXUUHGZHHNVWRPRQWKVDIWHUGLVFRQWLQXDWLRQRILSLOLPXPDE

3HUPDQHQWO\GLVFRQWLQXHLSLOLPXPDEDQGLQLWLDWHV\VWHPLFKLJKGRVHFRUWLFRVWHURLGWKHUDS\IRU
VHYHUH LPPXQHPHGLDWH UHDFWLRQV  $VVHVV SDWLHQWV IRU VLJQV DQG V\PSWRPV RI HQWHURFROLWLV
GHUPDWLWLV QHXURSDWK\ DQG HQGRFULQRSDWK\ DQG HYDOXDWH FOLQLFDO FKHPLVWULHV LQFOXGLQJ OLYHU
IXQFWLRQWHVWVDQGWK\URLGIXQFWLRQWHVWVDWEDVHOLQHDQGEHIRUHHDFKGRVH)RUVSHFLILFGHWDLOVRI
WR[LFLW\ PDQDJHPHQW WKH WUHDWLQJ SK\VLFLDQ LV LQVWUXFWHG WR UHIHU WR WKH SDFNDJH LQVHUW IRU
LSLOLPXPDEDQGWRIROORZWKHLQVWUXFWLRQVDQGDOJRULWKPVWKHUHLQ

6SHFLILF DWWHQWLRQ WR GHYHORSPHQW RI DXWRLPPXQH HYHQWV GXULQJ SHULRGLF VWXG\ YLVLWV FDQ EH
HYDOXDWHG E\ DQ RSWLRQDO FKHFNOLVWSURYLGHGLQ$SSHQGL[ ( 7KLV FKHFNOLVW LQDGGLWLRQWRWKH
VHURORJLFWHVWVREWDLQHGFDQEHXVHGE\WKHVWXG\SK\VLFLDQVWRGHWHUPLQHLIIXUWKHUHYDOXDWLRQIRU
DXWRLPPXQHGLVHDVHLVZDUUDQWHGE\DQDSSURSULDWHVSHFLDOLVWLQWKHRUJDQV\VWHPDIIHFWHG7KLV
FDQEHGRQHWRDYRLGPLVLQWHUSUHWDWLRQRIVSXULRXVDXWRLPPXQHWHVWUHVXOWV

7ULDOVXVLQJLPPXQRPRGXODWRU\DJHQWVVXFKDVLSLOLPXPDE&7/$KDYHVKRZQDFRUUHODWLRQ
EHWZHHQ GLVHDVH UHVSRQVH DQG VR FDOOHG DXWRLPPXQH EUHDNWKURXJK HYHQWV $%(V OLNH
K\SRSK\VLWLV FROLWLV DXWRLPPXQH KHSDWLWLV RU GHUPDWLWLV ,W LV IRU WKLV UHDVRQ WKDW WKH\ DUH
GLVWLQJXLVKHGIURPRWKHUDGYHUVHHYHQWV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

5.3
Nivolumab (Opdivo) 

'HVFULSWLRQ
%LQGLQJRIWKH3'OLJDQGV3'/DQG3'/WRWKH3'UHFHSWRUIRXQGRQ7FHOOVLQKLELWV
7FHOOSUROLIHUDWLRQDQGF\WRNLQHSURGXFWLRQ8SUHJXODWLRQRI3'OLJDQGVRFFXUVLQVRPHWXPRUV
DQG VLJQDOLQJ WKURXJK WKLV SDWKZD\ FDQ FRQWULEXWH WR LQKLELWLRQ RI DFWLYH 7FHOO LPPXQH
VXUYHLOODQFHRIWXPRUV1LYROXPDELVDKXPDQLPPXQRJOREXOLQ*,J*PRQRFORQDODQWLERG\
WKDWELQGVWRWKH3'UHFHSWRUDQGEORFNVLWVLQWHUDFWLRQZLWK3'/DQG3'/UHOHDVLQJ3'
SDWKZD\PHGLDWHGLQKLELWLRQRIWKHLPPXQHUHVSRQVHLQFOXGLQJWKHDQWLWXPRULPPXQHUHVSRQVH
1LYROXPDELVDQ,J*NDSSDLPPXQRJOREXOLQWKDWKDVDFDOFXODWHGPROHFXODUPDVVRIN'D

3KDUPDFRNLQHWLFV
7KH SKDUPDFRNLQHWLFV 3. RI QLYROXPDE ZDV VWXGLHG LQ SDWLHQWV RYHU D GRVH UDQJH RI 
WRPJNJDGPLQLVWHUHGDVDVLQJOHGRVHRUDVPXOWLSOHGRVHVRIQLYROXPDEHYHU\RUZHHNV
%DVHGRQDSRSXODWLRQSKDUPDFRNLQHWLF3.DQDO\VLVXVLQJGDWDIURPSDWLHQWVWKHJHRPHWULF
PHDQFRHIILFLHQWRIYDULDWLRQ>&9@FOHDUDQFH&/LVP/KJHRPHWULFPHDQ
YROXPHRIGLVWULEXWLRQDWVWHDG\VWDWH9VVLV/DQGJHRPHWULFPHDQHOLPLQDWLRQ
KDOIOLIHWLVGD\V6WHDG\VWDWHFRQFHQWUDWLRQVRIQLYROXPDEZHUHUHDFKHGE\
ZHHNV ZKHQ DGPLQLVWHUHG DW PJNJ HYHU\ ZHHNV DQG V\VWHPLF DFFXPXODWLRQ ZDV
DSSUR[LPDWHO\IROG7KHH[SRVXUHWRQLYROXPDELQFUHDVHGGRVHSURSRUWLRQDOO\RYHUWKHGRVH
UDQJHRIWRPJNJDGPLQLVWHUHGHYHU\ZHHNV

Specific Populations %DVHG RQ D SRSXODWLRQ 3. DQDO\VLV XVLQJ GDWD IURP SDWLHQWV WKH
FOHDUDQFHRIQLYROXPDELQFUHDVHGZLWKLQFUHDVLQJERG\ZHLJKWVXSSRUWLQJDZHLJKWEDVHGGRVH
7KHSRSXODWLRQ3.DQDO\VLVVXJJHVWHGWKDWWKHIROORZLQJIDFWRUVKDGQRFOLQLFDOO\LPSRUWDQWHIIHFW
RQ WKH FOHDUDQFH RI QLYROXPDE DJH WR\HDUV JHQGHU UDFH EDVHOLQH /'+ 3'/
H[SUHVVLRQWXPRUW\SHWXPRUVL]HUHQDOLPSDLUPHQWDQGPLOGKHSDWLFLPSDLUPHQW

Renal Impairment7KHHIIHFWRIUHQDOLPSDLUPHQWRQWKHFOHDUDQFHRIQLYROXPDEZDVHYDOXDWHG
E\ D SRSXODWLRQ 3. DQDO\VLV LQ SDWLHQWV ZLWK PLOG H*)5 WRP/PLQP Q 
PRGHUDWHH*)5WRP/PLQPQ RUVHYHUHH*)5WRP/PLQP
Q UHQDOLPSDLUPHQW1RFOLQLFDOO\LPSRUWDQWGLIIHUHQFHVLQWKHFOHDUDQFHRIQLYROXPDEZHUH
IRXQGEHWZHHQSDWLHQWVZLWKUHQDOLPSDLUPHQWDQGSDWLHQWVZLWKQRUPDOUHQDOIXQFWLRQ

Hepatic Impairment 7KH HIIHFW RI KHSDWLF LPSDLUPHQW RQ WKH FOHDUDQFH RI QLYROXPDE ZDV
HYDOXDWHGE\SRSXODWLRQ3.DQDO\VHVLQSDWLHQWVZLWKPLOGKHSDWLFLPSDLUPHQWWRWDOELOLUXELQ>7%@
OHVVWKDQRUHTXDOWRWKHXSSHUOLPLWRIQRUPDO>8/1@DQG$67JUHDWHUWKDQ8/1RU7%OHVVWKDQ
WRWLPHV8/1DQGDQ\$67Q 1RFOLQLFDOO\LPSRUWDQWGLIIHUHQFHVLQWKHFOHDUDQFHRI
QLYROXPDEZHUHIRXQGEHWZHHQSDWLHQWVZLWKPLOGKHSDWLFLPSDLUPHQWDQGSDWLHQWVZLWKQRUPDO
KHSDWLFIXQFWLRQ1LYROXPDEKDVQRWEHHQVWXGLHGLQSDWLHQWVZLWKPRGHUDWH7%JUHDWHUWKDQWR
WLPHV8/1DQGDQ\$67RUVHYHUHLPSDLUPHQW7%JUHDWHUWKDQWLPHV8/1DQGDQ\$67

3KDUPDFHXWLFDO'DWD
1LYROXPDE LV D FOHDU WR RSDOHVFHQW FRORUOHVV WR SDOH\HOORZ VROXWLRQ 'LVFDUG WKH YLDO LI WKH
VROXWLRQ LV FORXG\ LV GLVFRORUHG RU FRQWDLQV H[WUDQHRXV SDUWLFXODWH PDWWHU RWKHU WKDQ D IHZ
WUDQVOXFHQWWRZKLWHSURWHLQDFHRXVSDUWLFOHV'RQRWVKDNHWKHYLDO,WLVVXSSOLHGLQPJP/
PJP/DQGPJP/PJP/VROXWLRQLQVLQJOHXVHYLDOV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


6XSSO\
1LYROXPDELVFRPPHUFLDOO\DYDLODEOH

6SHFLILF5LVN$GYHUVH(YHQWV
1LYROXPDEFDQFDXVHVHYHUHDQGIDWDOLPPXQHPHGLDWHGDGYHUVHHIIHFWV0DQ\RUJDQVV\VWHPV
FDQEHLQYROYHG7KHPRVWFRPPRQVHYHUHDGYHUVHHYHQWVLQFOXGHSQHXPRQLWLVFROLWLVKHSDWLWLV
QHSKULWLVDQGWK\URLGGLVHDVHHLWKHUK\SRWK\URLGLVPRUK\SHUWK\URLGLVP$GGLWLRQDOLPPXQH
PHGLDWHG UHDFWLRQV REVHUYHG LQFOXGH DGUHQDO LQVXIILFLHQF\ SDQFUHDWLWLV QHXURSDWKLHV
K\SRSK\VLWLVDQG*XLOODLQ%DUUHV\QGURPH

0DQDJHPHQWRIWKHVHFRQGLWLRQVLQFOXGHVZLWKKROGLQJRIQLYROXPDEDGPLQLVWUDWLRQRIKLJKGRVH
FRUWLFRVWHURLGVDQGLIDSSURSULDWHLQLWLDWLRQRIKRUPRQHUHSODFHPHQWWKHUDS\
5.4
Pembrolizumab (Keytruda) 

'HVFULSWLRQ
3HPEUROL]XPDELVDKXPDQL]HGPRQRFORQDODQWLERG\WKDWEORFNVWKHLQWHUDFWLRQEHWZHHQ3'DQG
LWV OLJDQGV 3'/ DQG 3'/ 3HPEUROL]XPDE LV DQ ,J* NDSSD LPPXQRJOREXOLQ ZLWK DQ
DSSUR[LPDWHPROHFXODUZHLJKWRIN'D%LQGLQJRIWKH3'OLJDQGV3'/DQG3'/WRWKH
3'UHFHSWRUIRXQGRQ7FHOOVLQKLELWV7FHOOSUROLIHUDWLRQDQGF\WRNLQHSURGXFWLRQ8SUHJXODWLRQ
RI 3' OLJDQGV RFFXUV LQ VRPH WXPRUVDQGVLJQDOLQJWKURXJKWKLVSDWKZD\FDQFRQWULEXWHWR
LQKLELWLRQ RI DFWLYH 7FHOO LPPXQH VXUYHLOODQFH RI WXPRUV 3HPEUROL]XPDE LV D PRQRFORQDO
DQWLERG\ WKDW ELQGV WR WKH 3' UHFHSWRU DQG EORFNV LWV LQWHUDFWLRQ ZLWK 3'/ DQG 3'/
UHOHDVLQJ3'SDWKZD\PHGLDWHGLQKLELWLRQRIWKHLPPXQHUHVSRQVHLQFOXGLQJWKHDQWLWXPRU
LPPXQHUHVSRQVH


3KDUPDFRNLQHWLFV
7KHSKDUPDFRNLQHWLFVRISHPEUROL]XPDEZDVVWXGLHGLQSDWLHQWVZKRUHFHLYHGGRVHVRIWR
PJNJHYHU\ZHHNVRUWRPJNJHYHU\ZHHNV%DVHGRQDSRSXODWLRQSKDUPDFRNLQHWLF
DQDO\VLVWKHPHDQ>FRHIILFLHQWRIYDULDWLRQ&9@FOHDUDQFH&/LV/GD\DQG
WKHPHDQ&9HOLPLQDWLRQKDOIOLIHWLVGD\V6WHDG\VWDWHFRQFHQWUDWLRQVRI
SHPEUROL]XPDEZHUHUHDFKHGE\ZHHNVRIUHSHDWHGGRVLQJZLWKDQHYHU\ZHHNUHJLPHQDQG
WKHV\VWHPLFDFFXPXODWLRQZDVIROG7KHSHDNFRQFHQWUDWLRQ&PD[WURXJKFRQFHQWUDWLRQ
&PLQDQGDUHDXQGHUWKHSODVPDFRQFHQWUDWLRQYHUVXVWLPHFXUYHDWVWHDG\VWDWH$8&VVRI
SHPEUROL]XPDELQFUHDVHGGRVHSURSRUWLRQDOO\LQWKHGRVHUDQJHRIWRPJNJHYHU\ZHHNV
Specific Populations7KHHIIHFWVRIYDULRXVFRYDULDWHVRQWKHSKDUPDFRNLQHWLFVRISHPEUROL]XPDE
ZHUHDVVHVVHGLQSRSXODWLRQSKDUPDFRNLQHWLFDQDO\VHV7KH&/RISHPEUROL]XPDELQFUHDVHGZLWK
LQFUHDVLQJ ERG\ ZHLJKW WKH UHVXOWLQJ H[SRVXUH GLIIHUHQFHV ZHUH DGHTXDWHO\ DGGUHVVHG E\ WKH
DGPLQLVWUDWLRQRIDZHLJKWEDVHGGRVH7KHIROORZLQJIDFWRUVKDGQRFOLQLFDOO\LPSRUWDQWHIIHFWRQ
WKH&/RISHPEUROL]XPDEDJHUDQJHWR\HDUVJHQGHUUHQDOLPSDLUPHQWPLOGKHSDWLF
LPSDLUPHQW DQG WXPRU EXUGHQ 7KH HIIHFW RI UDFH FRXOG QRW EH DVVHVVHG GXH WR OLPLWHG GDWD
DYDLODEOHLQQRQ:KLWHSDWLHQWV
Renal Impairment7KHHIIHFWRIUHQDOLPSDLUPHQWRQWKH&/RISHPEUROL]XPDEZDVHYDOXDWHGE\
SRSXODWLRQ SKDUPDFRNLQHWLF DQDO\VHV LQ SDWLHQWV ZLWK PLOG H*)5 WRP/PLQP


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

Q 
PRGHUDWH
H*)5
WRP/PLQP
Q 
RU
VHYHUH
H*)5
WRP/PLQPQ UHQDOLPSDLUPHQWFRPSDUHGWRSDWLHQWVZLWKQRUPDOH*)5JUHDWHU
WKDQRUHTXDOWRP/PLQPQ UHQDOIXQFWLRQ1RFOLQLFDOO\LPSRUWDQWGLIIHUHQFHVLQ
WKH&/RISHPEUROL]XPDEZHUHIRXQGEHWZHHQSDWLHQWVZLWKUHQDOLPSDLUPHQWDQGSDWLHQWVZLWK
QRUPDOUHQDOIXQFWLRQ.
Hepatic Impairment7KHHIIHFWRIKHSDWLFLPSDLUPHQWRQWKH&/RISHPEUROL]XPDEZDVHYDOXDWHG
E\SRSXODWLRQSKDUPDFRNLQHWLFDQDO\VHVLQSDWLHQWVZLWKPLOGKHSDWLFLPSDLUPHQW7%OHVVWKDQRU
HTXDOWR8/1DQG$67JUHDWHUWKDQ8/1RU7%EHWZHHQDQGWLPHV8/1DQGDQ\$67
Q FRPSDUHGWRSDWLHQWVZLWKQRUPDOKHSDWLFIXQFWLRQ7%DQG$67OHVVWKDQRUHTXDOWR8/1
Q 1RFOLQLFDOO\LPSRUWDQWGLIIHUHQFHVLQWKH&/RISHPEUROL]XPDEZHUHIRXQGEHWZHHQ
SDWLHQWVZLWKPLOGKHSDWLFLPSDLUPHQWDQGQRUPDOKHSDWLFIXQFWLRQ3HPEUROL]XPDEKDVQRWEHHQ
VWXGLHGLQSDWLHQWVZLWKPRGHUDWH7%JUHDWHUWKDQWRWLPHV8/1DQGDQ\$67RUVHYHUH
7%JUHDWHUWKDQWLPHV8/1DQGDQ\$67KHSDWLFLPSDLUPHQW

3KDUPDFHXWLFDO'DWD
3HPEUROL]XPDEIRULQMHFWLRQLVDVWHULOHSUHVHUYDWLYHIUHHZKLWHWRRIIZKLWHO\RSKLOL]HGSRZGHU
LQVLQJOHXVHYLDOV(DFKYLDOLVUHFRQVWLWXWHGDQGGLOXWHGIRULQWUDYHQRXVLQIXVLRQ(DFKP/RI
UHFRQVWLWXWHGVROXWLRQFRQWDLQVPJRISHPEUROL]XPDEDQGLVIRUPXODWHGLQ/KLVWLGLQHPJ
SRO\VRUEDWHPJDQGVXFURVHPJ0D\FRQWDLQK\GURFKORULFDFLGVRGLXPK\GUR[LGH
WRDGMXVWS+WR

6XSSO\
3HPEUROL]XPDELVFRPPHUFLDOO\DYDLODEOH

6SHFLILF5LVNV$GYHUVH(YHQWV
3HPEUROL]XPDEFDQFDXVHVHYHUHLPPXQHPHGLDWHGDGYHUVHHYHQWVDQGFDQLQYROYHPXOWLSOHRUJDQ
V\VWHPV 6HYHUH LPPXQH PHGLDWHG DGYHUVH HYHQWV LQFOXGH SQHXPRQLWLV FROLWLV KHSDWLWLV
K\SRSK\VLWLV QHSKULWLV DQG K\SRWK\URLGLVP DQG K\SHUWK\URLGLVP $GGLWLRQDO VHYHUH LPPXQH
PHGLDWHG DGYHUVH HYHQWV FDQ LQFOXGH GHUPDWLWLV XYHLWLV P\RVLWLV SDQFUHDWLWLV DQG DGUHQDO
LQVXIILFLHQF\

)RUVXVSHFWHGLPPXQHPHGLDWHGDGYHUVHUHDFWLRQVHQVXUHDGHTXDWHHYDOXDWLRQWRFRQILUPHWLRORJ\
RUH[FOXGHRWKHUFDXVHV%DVHGRQWKHVHYHULW\RIWKHDGYHUVHUHDFWLRQZLWKKROGSHPEUROL]XPDE
DQGDGPLQLVWHUFRUWLFRVWHURLGV
 '26,1*'(/$<6'26(02',),&$7,216

7KHGRVLQJGHOD\DQGPRGLILFDWLRQLQIRUPDWLRQFRQWDLQHGLQWKLVVHFWLRQFRQFHUQLQJLSLOLPXPDE
QLYROXPDE DQG SHPEUROL]XPDE LV SURYLGHG IRU EDFNJURXQG SXUSRVHV 'RVLQJ GHOD\V DQG  RU
PRGLILFDWLRQRIWKHVHDJHQWVVKRXOGEHSHUIRUPHGFRQVLVWHQWZLWKVWDQGDUGRIFDUHSUDFWLFHE\WKH
WUHDWLQJSK\VLFLDQZLWKLQWKHJXLGHOLQHVSURYLGHGLQWKHUHVSHFWLYHSDFNDJHLQVHUWV
6.1
Dosing Delays 

$VLJQLILFDQWQXPEHURISDWLHQWVHQWHUHGLQWRFOLQLFDOWULDOVDWWKHFOLQLFDOVLWHVOLYHRXWVLGHRIWKH
DUHDLQFOXGLQJSDWLHQWVUHIHUUHGIURPDFURVVWKH8QLWHG6WDWHV'XHWRSRWHQWLDOVFKHGXOLQJRUWUDYHO


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

GLIILFXOWLHV XQUHODWHG LQWHUFXUUHQW LOOQHVV SDWLHQW VRFLDO RU HPSOR\PHQW LVVXHV ZHHNHQGV
JRYHUQPHQWDQGRWKHUKROLGD\VWUHDWPHQWVPD\QRWEHDEOHWREHDGPLQLVWHUHGRQWKHSODQQHG
SURWRFROVFKHGXOH6WXG\YLVLWVPD\EHSHUIRUPHGGD\VIURPWKHWDUJHWHGVWXG\YLVLWGDWHWR
DOORZIRUKROLGD\VDQGRWKHUVFKHGXOLQJFRQIOLFWV
6.2
Dorgenmeltucel-L (HyperAcute-Melanoma) Dose Modifications 

7KHUH LV QR SURYLVLRQ PDGH LQ WKLV SURWRFRO IRU WKH UHGXFWLRQ RI WKH GRVH RU RWKHU GRVLQJ
PRGLILFDWLRQRIWKHLPPXQRWKHUDS\WUHDWPHQW
6.3
Ipilimumab Dose Modifications 

7KHDGPLQLVWUDWLRQRILSLOLPXPDEXQGHUWKLVSURWRFROLVWREHZLWKLQDFFRUGDQFHZLWKWKHSDFNDJH
LQVHUW IRU LSLOLPXPDE 7KLV LQFOXGHV WR[LFLW\ PDQDJHPHQW DQG GRVLQJ DGMXVWPHQWV RU
GLVFRQWLQXDWLRQRILSLOLPXPDE7KHIROORZLQJLVLQWHQGHGWRKLJKOLJKWDVSHFWVRIPDQDJHPHQW

x ,SLOLPXPDE UHODWHG WR[LFLWLHV PXVW EH UHVROYHG WR EDVHOLQH RU  *UDGH SULRU WR
DGPLQLVWHULQJWKHQH[WGRVH
x 1RGRVHUHGXFWLRQVIRULSLOLPXPDEDUHDOORZHG
x ,SLOLPXPDEFDQEHGHOD\HGLIWKHUHDVRQIRUWKHGHOD\LVWR[LFLW\$(DQGLIUHVROYHGWR
*UDGHRUEHWWHUFDQUHVWDUWDQGFRQWLQXHHYHU\ZHHNVXQWLODOOSODQQHGGRVHVDUH
DGPLQLVWHUHGRUZHHNVIURPILUVWGRVHZKLFKHYHURFFXUVHDUOLHU
x 3OHDVH UHIHU WR WKH $( PDQDJHPHQW DOJRULWKPV SURYLGHG E\ WKH SDFNDJH LQVHUW IRU
LSLOLPXPDE RQ PDQDJHPHQW RI SRWHQWLDOO\ LSLOLPXPDEUHODWHG DGYHUVH HYHQWV DOVR LQ
$SSHQGL['
x /LYHUIXQFWLRQWHVWV$67$/7WRWDOELOLUXELQZLOOEHHYDOXDWHGIRUHYHU\VXEMHFWSULRUWR
DGPLQLVWUDWLRQRILSLOLPXPDE%ORRGVDPSOHVPXVWEHFROOHFWHGDQGDQDO\]HGZLWKLQGD\V
SULRUWRGRVLQJ/LYHUIXQFWLRQWHVWUHVXOWVPXVWEHUHYLHZHGE\WKHSULQFLSDOLQYHVWLJDWRU
RUGHVLJQHHSULRUWRLSLOLPXPDEDGPLQLVWUDWLRQDQGPHHWGRVLQJFULWHULDVSHFLILFDWLRQV
o [8/1IRU$67DQG$/7DQG[8/1IRUWRWDOELOLUXELQ
x ,IDEQRUPDO/)7YDOXHVDUHGHWHFWHGWKHVXEMHFWPXVWEHPDQDJHGXVLQJKHSDWRWR[LFLW\
DOJRULWKPVHH$SSHQGL['

7UHDWPHQWPD\UHVXPHZKHQWKH$(VUHVROYHVWR*UDGHRUEDVHOLQHYDOXH

'XULQJLSLOLPXPDEDGPLQLVWUDWLRQLSLOLPXPDEPXVWEHSHUPDQHQWO\GLVFRQWLQXHGLIWKHVXEMHFW
H[SHULHQFHVDQ\RIWKHIROORZLQJWR[LFLWLHV(YHQWVUHTXLULQJSHUPDQHQWGLVFRQWLQXDWLRQDUH
x *UDGHRUPRWRURUVHQVRU\QHXURSDWK\UHJDUGOHVVRIFDXVDOLW\
x $Q\$(ZKLFKLQWKHMXGJPHQWRIWKHLQYHVWLJDWRUSUHVHQWVDVXEVWDQWLDOFOLQLFDOULVNWR
WKHVXEMHFWZLWKLQYHVWLJDWLRQDOGUXJGRVLQJ
x $Q\*UDGHH\HSDLQRUUHGXFWLRQRIYLVXDODFXLW\WKDWGRHVQRWUHVSRQGWRWRSLFDO
WKHUDS\DQGGRHVQRWLPSURYHWR*UDGHRUEHWWHUVHYHULW\ZLWKWRSLFDOWKHUDS\RUUHTXLUHV
V\VWHPLFWUHDWPHQW
x $Q\RWKHU*UDGHQRQVNLQUHODWHG$(ZLWKWKHH[FHSWLRQRIODERUDWRU\DEQRUPDOLWLHV
DQG*UDGHQDXVHDDQGYRPLWLQJ
x $Q\*UDGHODERUDWRU\DEQRUPDOLWLHV
x 3HUVLVWHQW *UDGH DGYHUVH UHDFWLRQV WKDW SXVK LSLOLPXPDE DGPLQLVWUDWLRQ EH\RQG WKH


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

ZHHN ZLQGRZ IURP ILUVW GRVH RU LQDELOLW\ WR UHGXFH FRUWLFRVWHURLG GRVH WR PJ
SUHGQLVRQHRUHTXLYDOHQWSHUGD\
x 6HYHUHRIOLIHWKUHDWHQLQJDGYHUVHUHDFWLRQVLQFOXGLQJDQ\RIWKHIROORZLQJ
o &ROLWLV ZLWK DEGRPLQDO SDLQ IHYHU LOHXV RU SHULWRQHDO VLJQV LQFUHDVH LQ VWRRO
IUHTXHQF\*UDGH
o $67RU$/7!WLPHVWKH8/1RUWRWDOELOLUXELQ!WLPHVWKH8/1
o 6WHYHQV-RKQVRQV\QGURPHWR[LFHSLGHUPDOQHFURO\VLVRUUDVKFRPSOLFDWHGE\IXOO
WKLFNQHVVGHUPDOXOFHUDWLRQRUQHFURWLFEXOORXVRUKHPRUUKDJLFPDQLIHVWDWLRQV
o 6HYHUHPRWRURUVHQVRU\QHXURSDWK\*XLOODLQ%DUUHV\QGURPHRUP\DVWKHQLDJUDYLV
o 6HYHUH LPPXQHPHGLDWHG UHDFWLRQV LQYROYLQJ DQ\ RUJDQ V\VWHP HJ QHSKULWLV
SQHXPRQLWLVSDQFUHDWLWLVP\RFDUGLWLV
o 6HYHUHLQIXVLRQUHDFWLRQVHH6HFWLRQ

6.4
Nivolumab Dosing Modifications 

7KHUHDUHQRUHFRPPHQGHGGRVHPRGLILFDWLRQVIRUK\SRWK\URLGLVPRUK\SHUWK\URLGLVP,PPXQH
PHGLDWHGDGYHUVHHYHQWVVKRXOGEHWUHDWHGZLWKFRUWLFRVWHURLGVLQDFFRUGDQFHZLWKWKHJXLGHOLQHV
LQWKHSDFNDJHLQVHUW

:LWKKROGQLYROXPDEIRUDQ\RIWKHIROORZLQJ

*UDGHSQHXPRQLWLV

*UDGHRUFROLWLV

$VSDUWDWHDPLQRWUDQVIHUDVH$67RUDODQLQHDPLQRWUDQVIHUDVH$/7JUHDWHUWKDQDQGXS
WRWLPHVXSSHUOLPLWRIQRUPDO8/1RUWRWDOELOLUXELQJUHDWHUWKDQDQGXSWRWLPHV
8/1

&UHDWLQLQHJUHDWHUWKDQDQGXSWRWLPHV8/1RUJUHDWHUWKDQWLPHVEDVHOLQH

$Q\RWKHUVHYHUHRU*UDGHWUHDWPHQWUHODWHGDGYHUVHUHDFWLRQV
5HVXPHQLYROXPDELQSDWLHQWVZKRVHDGYHUVHUHDFWLRQVUHFRYHUWR*UDGHWR

3HUPDQHQWO\GLVFRQWLQXHQLYROXPDEIRUDQ\RIWKHIROORZLQJ

$Q\OLIHWKUHDWHQLQJRU*UDGHDGYHUVHUHDFWLRQ

*UDGHRUSQHXPRQLWLV

*UDGHFROLWLV

$67RU$/7JUHDWHUWKDQWLPHV8/1RUWRWDOELOLUXELQJUHDWHUWKDQWLPHV8/1

&UHDWLQLQHJUHDWHUWKDQWLPHV8/1

$Q\VHYHUHRU*UDGHWUHDWPHQWUHODWHGDGYHUVHUHDFWLRQWKDWUHFXUV

,QDELOLW\WRUHGXFHFRUWLFRVWHURLGGRVHWRPJRUOHVVRISUHGQLVRQHRUHTXLYDOHQWSHUGD\
ZLWKLQZHHNV

3HUVLVWHQW*UDGHRUWUHDWPHQWUHODWHGDGYHUVHUHDFWLRQVWKDWGRQRWUHFRYHUWR*UDGHRU
UHVROYHZLWKLQZHHNVDIWHUODVWGRVHRIQLYROXPDE
6.5
Pembrolizumab Dosing Modifications 

)RULPPXQHPHGLDWHGDGYHUVHUHDFWLRQVDGPLQLVWHUFRUWLFRVWHURLGVEDVHGRQWKHVHYHULW\RIWKH
UHDFWLRQ6HHSDFNDJHLQVHUWIRUJXLGHOLQHV



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

:LWKKROGSHPEUROL]XPDEIRUDQ\RIWKHIROORZLQJ
x *UDGHSQHXPRQLWLV
x *UDGHRUFROLWLV
x 6\PSWRPDWLFK\SRSK\VLWLV
x *UDGHQHSKULWLV
x *UDGHK\SHUWK\URLGLVP
x $VSDUWDWHDPLQRWUDQVIHUDVH$67RUDODQLQHDPLQRWUDQVIHUDVH$/7JUHDWHUWKDQDQGXS
WRWLPHVXSSHUOLPLWRIQRUPDO8/1RUWRWDOELOLUXELQJUHDWHUWKDQDQGXSWRWLPHV
8/1
x $Q\RWKHUVHYHUHRU*UDGHWUHDWPHQWUHODWHGDGYHUVHUHDFWLRQ
5HVXPHSHPEUROL]XPDELQSDWLHQWVZKRVHDGYHUVHUHDFWLRQVUHFRYHUWR*UDGH

3HUPDQHQWO\GLVFRQWLQXHSHPEUROL]XPDEIRUDQ\RIWKHIROORZLQJ
x $Q\OLIHWKUHDWHQLQJDGYHUVHUHDFWLRQ
x *UDGHRUSQHXPRQLWLV
x *UDGHRUQHSKULWLV
x $67RU$/7JUHDWHUWKDQWLPHV8/1RUWRWDOELOLUXELQJUHDWHUWKDQWLPHV8/1
x )RUSDWLHQWVZLWKOLYHUPHWDVWDVLVZKREHJLQWUHDWPHQWZLWK*UDGH$67RU$/7LI$67
RU$/7LQFUHDVHVE\JUHDWHUWKDQRUHTXDOWRUHODWLYHWREDVHOLQHDQGODVWVIRUDWOHDVW
ZHHN
x *UDGHRULQIXVLRQUHODWHGUHDFWLRQV
x ,QDELOLW\WRUHGXFHFRUWLFRVWHURLGGRVHWRPJRUOHVVRISUHGQLVRQHRUHTXLYDOHQWSHUGD\
ZLWKLQZHHNV
x 3HUVLVWHQW*UDGHRUDGYHUVHUHDFWLRQVWKDWGRQRWUHFRYHUWR*UDGHZLWKLQZHHNV
DIWHUODVWGRVHRISHPEUROL]XPDE
x $Q\VHYHUHRU*UDGHWUHDWPHQWUHODWHGDGYHUVHUHDFWLRQWKDWUHFXUV

6.6
Treatment of Checkpoint Inhibitor Related Infusion Reaction 

,QIXVLRQ UHDFWLRQV VKRXOG EH JUDGHG DFFRUGLQJ WR &7&$( YHUVLRQ $OOHUJLF UHDFWLRQ
K\SHUVHQVLWLYLW\FULWHULD

6HYHUHLQIXVLRQUHDFWLRQUHTXLUHVSHUPDQHQWGLVFRQWLQXDWLRQIRUIXUWKHUWUHDWPHQW

$SSURSULDWH PHGLFDO WKHUDS\ LQFOXGLQJ IOXLGV HSLQHSKULQH FRUWLFRVWHURLGV ,9 DQWLKLVWDPLQHV
EURQFKRGLODWRUVDQGR[\JHQVKRXOGEHDYDLODEOHIRUXVHLQWKHWUHDWPHQWRIVXFKUHDFWLRQV

,QHDFKFDVHRIDQLQIXVLRQUHDFWLRQWKHLQYHVWLJDWRUVKRXOGLQVWLWXWHWUHDWPHQWPHDVXUHVDFFRUGLQJ
WRWKHEHVWDYDLODEOHPHGLFDOSUDFWLFH




1/*

9HUVLRQ'DWHG
&RQILGHQWLDO



 &255(/$7,9(63(&,$/678',(6
 Parameters measured at baseline to evaluate subject’s general immunological status 

%DVHOLQHVDPSOHVPXVWEHREWDLQHGRQ'D\EHIRUHVWLPPXQL]DWLRQ7RWDO,J*,J0,J(
7.2
Immunological monitoring during treatment and follow-up 

$QWLD*DO$EGHWHUPLQDWLRQ,J*E\LQGLUHFW(/,6$DQG$QWLWXPRU$EPHDVXUHGE\
(/,6$

6HUXPVDPSOHVIURPSDWLHQWVFROOHFWHGEHIRUHGXULQJDQGDIWHULPPXQL]DWLRQZLOOEHDQDO\]HG
VLPXOWDQHRXVO\WRHYDOXDWHWKHLPPXQRWKHUDS\LQGXFHGKXPRUDOLPPXQHUHVSRQVH

$SSUR[LPDWHO\P/RIEORRGZLOOEHREWDLQHGIURPSDWLHQWVDWWKHWLPHSRLQWVVSHFLILHGLQWKH
VWXG\ FDOHQGDU 6HFWLRQ LQ VHUXP VHSDUDWRU WXEHV [P/ UHGJUD\ VSHFNOHG WRS WXEH
SURYLGHGE\1HZ/LQN*HQHWLFV6DPSOHLVVHQWVDPHGD\DWURRPWHPSHUDWXUHRYHUQLJKWH[SUHVV
WR1HZ/LQN*HQHWLFVIRUDVVD\6DPSOHVVKRXOGQRWEHVKLSSHGRQ)ULGD\VRUWKHGD\EHIRUH86
)HGHUDOKROLGD\V

(/,6327RU,QWUDFHOOXODUF\WRNLQHVDQG'HWHFWLRQRI,&26&'7FHOOV

3XUSRVH7RGHWHUPLQHQDWXUHDQGIUHTXHQF\RI7FHOOUHDFWLYLW\E\LQWUDFHOOXODUF\WRNLQHVWDLQLQJ
LQ SHULSKHUDO EORRG O\PSKRF\WHV 3%/ IURP SDWLHQWV WUHDWHG ZLWK GRUJHQPHOWXFHO/
LPPXQRWKHUDS\

7KH WUHDWPHQW ZLWK LSLOLPXPDE LQGXFHG WKH LQFUHDVH RI DFWLYDWHG 7 FHOO LQ FLUFXODWLRQ 7KHVH
DFWLYDWHG7FHOOVKDYHWKHIROORZLQJSKHQRW\SH,&26&'7FHOOV0RUHRYHULWKDVEHHQ
UHSRUWHG WKDW WKH LQFUHDVHG DQG SHUVLVWHQFH RI DFWLYDWHG 7 FHOOV DIWHU LSLOLPXPDE WUHDWPHQW
FRUUHODWHGZLWKEHWWHURXWFRPH

,QWKLVVWXG\ZHZLOOGHWHUPLQHWKHSUHVHQFHDQGSHUVLVWHQFHRIDFWLYDWHG7FHOOVDIWHUWUHDWPHQW
ZLWKLSLOLPXPDERURWKHULPPXQHFKHFNSRLQWWKHUDSLHVXVLQJ)$&6DQDO\VLVXVLQJIUR]HQFHOOV
VLQFHUHVXOWVXVLQJIUHVKO\LVRODWHG7FHOOVZKHUHVKRZQWREHFRPSDUDEOH

$SSUR[LPDWHO\P/RIZKROHEORRGZLOOEHFROOHFWHGLQ('7$[P/SXUSOHWRSWXEHV
VXSSOLHGE\1HZ/LQN*HQHWLFVDWWKHWLPHSRLQWVVSHFLILHGLQWKHVWXG\FDOHQGDU6HFWLRQ
6DPSOHZLOOEHVKLSSHGVDPHGD\DWURRPWHPSHUDWXUHRYHUQLJKWH[SUHVVHGWR1HZ/LQN*HQHWLFV
6DPSOHVVKRXOGQRWEHVKLSSHGRQ)ULGD\VRUWKHGD\EHIRUH86)HGHUDOKROLGD\V





1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

7RWDOO\PSKRF\WHFRXQWVRUDEVROXWHO\PSKRF\WHFRXQW$/&
,W¶VEHHQUHSRUWHGSUHYLRXVO\WKDWWKHLQFUHDVHRIDEVROXWHO\PSKRF\WHVFRXQWV$/&FRUUHODWHV
ZLWK RYHUDOO UHVSRQVH DQG VXUYLYDO LQ PHODQRPD SDWLHQWV WUHDWHG ZLWK ,SLOLPXPDE  ,W LV
VXJJHVWHGWKDWSDWLHQWVZLWKOHVVWKDQFHOOVX/ZLOOEHOHVVOLNHO\WRUHVSRQGWRWKHUDS\

,Q WKLV WULDO ZH ZLOO GHWHUPLQH &%& DQG /'+ WR FRUUHFW KHPRO\VLV DIWHU WUHDWPHQW ZLWK
LSLOLPXPDERURWKHULPPXQHFKHFNSRLQWWKHUDSLHVDVLWZDVSXEOLVKHGSUHYLRXVO\&%&DQG
/'+ZLOOEHGHWHUPLQHGEHIRUHGXULQJDQGDIWHUWKHUDS\UHIHUWRVWXG\FDOHQGDU7KHVHVWXGLHV
ZLOOEHSHUIRUPHGDWWKHFOLQLFDOVLWHVDQGGDWDZLOOEHVHQWWR1HZ/LQN*HQHWLFV

2SWLRQDO3UHDQGSRVWWUHDWPHQWFROOHFWLRQRIWXPRUVDPSOHVIRUDQDO\VLVRIWXPRU
LQILOWUDWLQJO\PSKRF\WHV
 &ROOHFWLRQRIWXPRUELRSVLHVEHIRUHDQGDIWHULPPXQL]DWLRQIRU,PPXQRKLVWRFKHPLVWU\
VWXGLHV
 &ROOHFWLRQRIUHVHFWDEOHWXPRUVDIWHUWUHDWPHQWWRORRNIRU&'LQILOWUDWHVDQGFRUUHODWH
ZLWKUHVSRQVH

%ULHIO\DVPDOOWXPRUVDPSOHZLOOEHSURFXUHGSULRUWRGHILQLWLYHVXUJLFDOWUHDWPHQWDQGSULRUWR
WKHILUVWVHULHVRILPPXQL]DWLRQVSUHWUHDWPHQWWXPRUVSHFLPHQDQGDSRUWLRQZLOOEHVHQWWR
SDWKRORJ\IRUGHILQLWLYHDQDO\VLVZKLOHDVHFRQGSRUWLRQZLOOEHVQDSIUR]HQLQOLTXLGQLWURJHQ

7KHSDWLHQWZLOOWKHQXQGHUJRWUHDWPHQWSHUSURWRFROZLWKDGGLWLRQDOELRSVLHVDWVHOHFWWLPHSRLQWV
DWWKHGLVFUHWLRQRIWKHWUHDWLQJSK\VLFLDQ,IWKHHQWLUHWXPRULVUHVHFWHGDWDODWHUWLPHSRLQWDIWHU
WKHFRPSOHWLRQRIWKHWULDOVDPSOHVZLOOEHDQDO\]HGDVRXWOLQHGEHORZ

6WDQGDUGKLVWRORJLFDODQDO\VLVRIWKHWLVVXHVHFWLRQVZLWKDVSHFLILFIRFXVRQWKHLQILOWUDWLQJ7FHOO
DQGGHQGULWLFFHOOSRSXODWLRQZLOOEHSHUIRUPHGQRWOLPLWHGWR&'&'&'&'&&'
&' &' &' &' 6WDQGDUG KLVWRORJLF DQDO\VLV RI WXPRU FHOOV LQ DGGLWLRQ WR
LPPXQRKLVWRFKHPLFDODQDO\VLVRIWXPRUFHOOVZLOODOVREHSHUIRUPHGQRWOLPLWHGWR0$57
JS7\URVLQDVH(621<7537530$*(*$*(WXPRUDQWLJHQV

%LRORJLFVSHFLPHQVDUFKLYHIRU5HSOLFDWLRQ&RPSHWHQW5HWURYLUXV

7KHIROORZLQJELRORJLFVSHFLPHQVIURPDOOVXEMHFWVUHFHLYLQJGRUJHQPHOWXFHO/ZLOOEHFROOHFWHG
DQGDUFKLYHGDW1HZ/LQN*HQHWLFVIRUUHSOLFDWLRQFRPSHWHQWUHWURYLUXV

x 3UHWUHDWPHQWEDVHOLQHDOLTXRWVRIFLWUDWHGRU('7$DQWLFRDJXODWHGSODVPDPODQG
YLDEOHSHULSKHUDOEORRGPRQRQXFOHDUFHOOV

$FXWH DQG FRQYDOHVFHQW VHUD REWDLQHGLQDVVRFLDWLRQZLWKDFXWHXQH[SODLQHGLOOQHVVVKRXOG EH
FROOHFWHGDQGDUFKLYHGZKHQDSSURSULDWHDVMXGJHGE\WKHLQYHVWLJDWRURUDQGWKHLQIHFWLRXVGLVHDVH
SK\VLFLDQ

5HIHUHQFHVIRUWKLVVHFWLRQ

 &DUWKRQ%&-':ROFKRN-<XDQ$.DPDW'61J7DQJ-6XQ*.X3
7URQFRVR&-/RJRWKHWLV-3$OOLVRQDQG36KDUPD3UHRSHUDWLYH&7/$


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

EORFNDGHWROHUDELOLW\DQGLPPXQHPRQLWRULQJLQWKHVHWWLQJRIDSUHVXUJLFDOFOLQLFDOWULDO
Clin Cancer Res 
 3DJH'%-<XDQDQG-':ROFKRN7DUJHWLQJF\WRWR[LF7O\PSKRF\WHDQWLJHQ
LQLPPXQRWKHUDSLHVIRUPHODQRPDDQGRWKHUFDQFHUVImmunotherapy 
 .X*<-<XDQ'%3DJH6(6FKURHGHU.63DQDJHDV5'&DUYDMDO3%
&KDSPDQ*.6FKZDUW]-3$OOLVRQDQG-':ROFKRN6LQJOHLQVWLWXWLRQ
H[SHULHQFHZLWKLSLOLPXPDELQDGYDQFHGPHODQRPDSDWLHQWVLQWKHFRPSDVVLRQDWHXVH
VHWWLQJO\PSKRF\WHFRXQWDIWHUGRVHVFRUUHODWHVZLWKVXUYLYDOCancer 
 <XDQ-'%3DJH*<.X</L=0X&$UL\DQ+)*DOODUGR5$5RPDQ$,
+HLQH6/7HU]XOOL(5LWWHU6*QMDWLF*5LWWHU$$-XQJEOXWK-3$OOLVRQ/-
2OGDQG-':ROFKRN&RUUHODWLRQRIFOLQLFDODQGLPPXQRORJLFDOGDWDLQD
PHWDVWDWLFPHODQRPDSDWLHQWZLWKKHWHURJHQHRXVWXPRUUHVSRQVHVWRLSLOLPXPDEWKHUDS\
Cancer Immun 
 :HEHU-62+DPLG6'&KDVDORZ'<:X603DUNHU6*DOEUDLWK6*QMDWLF
DQG'%HUPDQ,SLOLPXPDELQFUHDVHVDFWLYDWHG7FHOOVDQGHQKDQFHVKXPRUDO
LPPXQLW\LQSDWLHQWVZLWKDGYDQFHGPHODQRPDJ Immunother 
 7KRPSVRQ-$2+DPLG'0LQRU$$PLQ,*5RQ55LGROIL+$VVL'%HUPDQ
-6LHJHODQG-6:HEHU,SLOLPXPDELQWUHDWPHQWQDLYHDQGSUHYLRXVO\WUHDWHG
SDWLHQWVZLWKPHWDVWDWLFPHODQRPDUHWURVSHFWLYHDQDO\VLVRIHIILFDF\DQGVDIHW\GDWDIURPD
SKDVH,,WULDOJ Immunother 



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

 678'<&$/(1'$56

6WXG\&DOHQGDUIRU$UP$,SLOLPXPDESOXV'RUJHQPHOWXFHO/,PPXQRWKHUDS\
,SLOLPXPDE PJNJ ,9 JLYHQ 4ZHHNV [ GRUJHQPHOWXFHO/ FRQWLQXHV IRU XS WR 
LPPXQL]DWLRQV6WXG\YLVLWVPD\EHSHUIRUPHGGD\VIURPWKHWDUJHWHGVWXG\YLVLWGDWHWR
DOORZIRUKROLGD\VDQGRWKHUVFKHGXOLQJFRQIOLFWV)ROORZXSYLVLWVPD\EHSHUIRUPHGZHHNV
IURPWKHWDUJHWHGVWXG\YLVLWGDWH



/(*(1')25$//678'<&$/(1'$56
$ 'RUJHQPHOWXFHO/+\SHU$FXWH0HODQRPDPLOOLRQ+$0FHOOVDGPLQLVWHUHGLQWUDGHUPDOO\
% 6HUXPFKHPLVWULHVLQFOXGLQJ%81FUHDWLQLQHFDOFLXPDOEXPLQJOXFRVHHOHFWURO\WHVOLYHUIXQFWLRQWHVWVLQFOXGLQJWRWDO
ELOLUXELQ$/76*37$676*27DONDOLQHSKRVSKDWDVHDQG/'+6KRXOGEHGUDZQDWWKHILUVWIROORZXSYLVLWDQGWKHQ
DVFOLQLFDOO\LQGLFDWHGZKHQVXEMHFWVDUHLQIROORZXS
& 6HUXPRUXULQHSUHJQDQF\WHVW:RPHQRIFKLOGEHDULQJSRWHQWLDO
( )RUDOOVXEMHFWV,PPXQRJOREXOLQV,J*,J0,J(ZLOOEHGUDZQDQGVHQWWRLQVWLWXWLRQ¶VFOLQLFDOODERUDWRU\EHIRUH
WUHDWPHQWGXULQJWUHDWPHQWDQGWKHQDWWKHILUVWIROORZXSYLVLW
) )RUVXEMHFWVUHFHLYLQJ+$0LPPXQRWKHUDS\3HULSKHUDOEORRGFROOHFWLRQP/SXUSOHWRSWXEHSURYLGHGE\1HZ/LQN
*HQHWLFVLVWREHVHQWVDPHGD\RQURRPDLURYHUQLJKWH[SUHVVWR1HZ/LQN*HQHWLFVIRU5&5WHVWLQJIRUUHWURYLUXV'UDZ
SULRUWRILUVWLPPXQL]DWLRQ'D\RQO\
+ )RUDOOVXEMHFWV'UDZDSSUR[LPDWHO\P/ZKROHEORRGFROOHFWHGLQODUJHP/SXUSOHWRSWXEHVSURYLGHGE\
1HZ/LQN*HQHWLFVIRU7FHOODVVD\V6DPSOHLVVHQWVDPHGD\DWURRPWHPSHUDWXUHRYHUQLJKWH[SUHVVWR1HZ/LQN
*HQHWLFV7REHGUDZQLPPHGLDWHO\EHIRUHWUHDWPHQWVRQWKHVFKHGXOHGGD\VDQGDWWKHILUVWIROORZXSYLVLW
,
)RUDOOVXEMHFWV'UDZDQGVHQGVHUXPVHSDUDWRUWXEHVDSSUR[LPDWHO\P/UHGJUD\VSHFNOHGWRSWXEHSURYLGHGE\
1HZ/LQN*HQHWLFVIRUWXPRUDQWLERG\WLWHUV6DPSOHLVVHQWVDPHGD\DWURRPWHPSHUDWXUHRYHUQLJKWH[SUHVVWR1HZ/LQN
*HQHWLFVIRUDVVD\7REHGUDZQLPPHGLDWHO\EHIRUHWUHDWPHQWVRQWKHVFKHGXOHGGD\VDQGDWWKHILUVWIROORZXSYLVLW
- 7XPRUELRSVLHVVKRXOGEHREWDLQHGZKHQSRVVLEOHDWWKHVFKHGXOHGWLPHSRLQWV
67)893OHDVHFRPSOHWHDOOSURFHGXUHVDVRXWOLQHGLQWKHVWXG\FDOHQGDUVXQGHUVW)89
PreͲ
Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Mo Mo Mo Mo Mo Mo Mo Mo Mo Mo
Study
1
2
3
4
5
6
7
8
9
10
11
12
13
14
16
18
20
22
24
7
8
9
10
11
12
15
18
21
24
DAY
1
8
15
22
29
36
43
50
57
64
71
78
85
92 106 120 134 148 162
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
HAMInjections
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
Ipilimumab
X
X
X
X
Informedconsent
X
Demographics
X
Medicalhistory
X
Concurrentmeds
X
Physicalexam
X
X
X
X
X
X
X
X
X
Vitalsigns
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Height
X
Weight
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Performancestatus
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
CBCw/diff,plts
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Serumchemistry
(withLDH)
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
bͲHCG
C
TSHandFreeT4
X
X
X
X
X
IgG,IgM,IgE
E
E
E
E
E
E
RCR
F
BloodforImmune
Assays(Tcells)
H
H
H
H
H
H
H
H
H
BloodforantiͲtumor
Ab
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
OptionalTumor
Biopsy
J
J
J
RadiologicTumor
(RECIST/iRRC)
evaluation
X
X
X
X
X
X
X
X
X
X
AE/SAEEvaluation
ͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲCompleteperSOCͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲ
ͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲEvaluatethroughoutStudyandFollowUpPerProtocolͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲ
EVALUATIONS
1ST
FUV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


6WXG\&DOHQGDUIRU$UP$,SLOLPXPDE$ORQH
,SLOLPXPDEPJNJ,9JLYHQ4ZHHNV[WKHQHYDOXDWHGLVHDVH6WXG\YLVLWVPD\EH
SHUIRUPHGGD\VIURPWKHWDUJHWHGVWXG\YLVLWGDWHWRDOORZIRUKROLGD\VDQGRWKHUVFKHGXOLQJ
FRQIOLFWV)ROORZXSYLVLWVPD\EHSHUIRUPHGZHHNVIURPWKHWDUJHWHGVWXG\YLVLWGDWH

(9$/8$7,216
3UH
6WXG\
:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

67
)89


'
'
'
'
'
'
'
'
'
'
'
'
'
,SLOLPXPDE

;


;


;


;




,QIRUPHGFRQVHQW
;














'HPRJUDSKLFV
;














0HGLFDOKLVWRU\
;














&RQFXUUHQWPHGV
;
;;

3K\VLFDOH[DP
;
;


;


;


;



;
9LWDOVLJQV
;
;


;


;


;


;
;
+HLJKW
;














:HLJKW
;
;


;


;


;



;
3HUIRUPDQFHVWDWXV
;
;


;


;


;


;
;
&%&ZGLIISOWV
;
;


;


;


;


;
;
6HUXPFKHPLVWU\
ZLWK/'+
%
%


%


%


%


%
%
%+&*
&














76+DQG)UHH7
;
;


;


;


;


;

,J*,J0,J(

(











(
(
%ORRGIRU,PPXQH
$VVD\V7FHOOV

+





+






+
%ORRGIRU
DQWLWXPRU$E

,


,


,


,


,
,
2SWLRQDO7XPRU
%LRSVLHV

-





-


-




5DGLRORJLF7XPRU
5(&,67L55&
HYDOXDWLRQ
;












;
;
$GYHUVHHYHQW
HYDOXDWLRQ

;;
;






1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

6WXG\&DOHQGDUIRU$UP%1LYROXPDESOXV'RUJHQPHOWXFHO/
1LYROXPDEPJ4ZHHNVXQWLOGLVHDVHSURJUHVVLRQRUVLJQLILFDQWWR[LFLW\GRUJHQPHOWXFHO/
FRQWLQXHVIRUXSWRLPPXQL]DWLRQV6WXG\YLVLWVPD\EHSHUIRUPHGGD\VIURPWKHWDUJHWHG
VWXG\YLVLWGDWHWRDOORZIRUKROLGD\VDQGRWKHUVFKHGXOLQJFRQIOLFWV)ROORZXSYLVLWVPD\EH
SHUIRUPHGZHHNVIURPWKHWDUJHWHGVWXG\YLVLWGDWH





(DFK6XEVHTXHQW&\FOH
'D\VDQG±1LYROXPDEPJJLYHQ,92EWDLQ9636&%&&KHPLVWULHV
'D\±76+DQG)UHH7:HLJKW




PreͲ Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Mo Mo Mo Mo Mo Mo Mo Mo Mo Mo
Study
1
2
3
4
5
6
7
8
9
10
11
12
13
14
16
18
20
22
24
7
8
9
10
11
12
15
18
21
24
DAY
1
8
15
22
29
36
43
50
57
64
71
78
85
92 106 120 134 148 162
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
HAMInjections
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
Nivolumab
X
X
X
X
X
X
X
X
X
X
X
Informedconsent
X
Demographics
X
Medicalhistory
X
Concurrentmeds
X
Physicalexam
X
X
X
X
X
X
X
X
Vitalsigns
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Height
X
Weight
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Performancestatus
X
X
X
X
X
X
X
X
X
X
X
X
X
X
CBCw/diff,plts
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Serumchemistry
(withLDH)
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
bͲHCG
C
TSHandFreeT4
X
X
X
X
X
X
X
IgG,IgM,IgE
E
E
E
E
E
E
RCR
F
BloodforImmune
Assays(Tcells)
H
H
H
H
H
H
H
H
H
BloodforantiͲtumor
Ab
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
OptionalTumor
Biopsy
J
J
J
RadiologicTumor
(RECIST/iRRC)
evaluation
X
X
X
X
X
X
X
X
X
X
AE/SAEEvaluation
EVALUATIONS
ͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲCompleteperSOCͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲ
ͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲEvaluatethroughoutStudyandFollowUpPerProtocolͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲ
ͲͲͲContinueevery2weekswithNivolumabͲͲͲ
ͲͲͲContinueevery2weekswithNivolumabͲͲͲ
ͲͲͲContinueevery2weekswithNivolumabͲͲͲ
ͲͲͲContinueevery2weekswithNivolumabͲͲͲ
ͲͲͲObtainatleastmonthlywithNivolumabͲͲͲ
XͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲX
1ST
FUV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

6WXG\&DOHQGDUIRU$UP%1LYROXPDE$ORQH
1LYROXPDEPJ4ZHHNVXQWLOGLVHDVHSURJUHVVLRQRUVLJQLILFDQWWR[LFLW\6WXG\YLVLWVPD\EH
SHUIRUPHGGD\VIURPWKHWDUJHWHGVWXG\YLVLWGDWHWRDOORZIRUKROLGD\VDQGRWKHUVFKHGXOLQJ
FRQIOLFWV)ROORZXSYLVLWVPD\EHSHUIRUPHGZHHNVIURPWKHWDUJHWHGVWXG\YLVLWGDWH

(9$/8$7,216
3UH
6WXG\
:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

67
)89


'
'
'
'
'
'
'
'
'
'
'
'
'
1LYROXPDE

;

;

;

;

;

;

;

,QIRUPHGFRQVHQW
;














'HPRJUDSKLFV
;














0HGLFDOKLVWRU\
;














&RQFXUUHQWPHGV
;
;;

3K\VLFDOH[DP
;
;












;
9LWDOVLJQV
;
;

;

;

;

;

;

;
;
+HLJKW
;














:HLJKW
;
;



;



;



;
;
3HUIRUPDQFHVWDWXV
;
;

;

;

;

;

;

;
;
&%&ZGLIISOWV
;
;

;

;

;

;

;

;
;
6HUXPFKHPLVWU\
ZLWK/'+
%
%

%

%

%

%

%

%
&
%+&*
&














76+DQG)UHH7
;
;



;



;



;

,J*,J0,J(

(











(
(
%ORRGIRU,PPXQH
$VVD\V7FHOOV

+





+






+
%ORRGIRU
DQWLWXPRU$E

,

,

,



,



,
,
2SWLRQDO7XPRU
%LRSVLHV

-





-



-



7XPRU
PHDVXUHPHQWV
;












;
;
5DGLRORJLF
5(&,67L55F
HYDOXDWLRQ
;












;
;
$GYHUVHHYHQW
HYDOXDWLRQ

;;
;

(DFK6XEVHTXHQW&\FOH
'D\VDQG±1LYROXPDEPJJLYHQ,92EWDLQ9636&%&&KHPLVWULHV
'D\±76+DQG)UHH7%ORRGIRUDQWLWXPRU$EPRQWKO\[HYHU\PRQWKV[:HLJKW





1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

6WXG\&DOHQGDUIRU$UP&3HPEUROL]XPDESOXV'RUJHQPHOWXFHO/
3HPEUROL]XPDE PJNJ JLYHQ 4ZHHNV XQWLO GLVHDVH SURJUHVVLRQ RU VLJQLILFDQW WR[LFLW\
GRUJHQPHOWXFHO/FRQWLQXHVIRUXSWRLPPXQL]DWLRQV6WXG\YLVLWVPD\EHSHUIRUPHGGD\V
IURPWKHWDUJHWHGVWXG\YLVLWGDWHWRDOORZIRUKROLGD\VDQGRWKHUVFKHGXOLQJFRQIOLFWV)ROORZXS
YLVLWVPD\EHSHUIRUPHGZHHNVIURPWKHWDUJHWHGVWXG\YLVLWGDWH




(DFK6XEVHTXHQW&\FOH
x 3HPEUROL]XPDEPJNJ,9JLYHQHYHU\ZHHNV
x 9636&%&&KHPLVWULHVFRPSOHWHGHYHU\ZHHNVZKLOHUHFHLYLQJ3HPEUROL]XPDE
x 76+DQG)UHH7FRPSOHWHGDWOHDVWPRQWKO\ZKLOHUHFHLYLQJ3HPEUROL]XPDE
x %ORRGIRUDQWLWXPRU$EPRQWKO\[HYHU\PRQWKV[
x
,PDJLQJIRUGLVHDVHHYDOXDWLRQFRPSOHWHGHYHU\PRQWKV



PreͲ
Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Wk Mo Mo Mo Mo Mo Mo Mo Mo Mo Mo
Study
1
2
3
4
5
6
7
8
9
10
11
12
13
14
16
18
20
22
24
7
8
9
10
11
12
15
18
21
24
DAY
1
8
15
22
29
36
43
50
57
64
71
78
85
92 106 120 134 148 162
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
Ͳ
HAMInjections
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
A
Pembrolizamub
X
X
X
X
Informedconsent
X
Demographics
X
Medicalhistory
X
Concurrentmeds
X
Physicalexam
X
X
X
X
X
X
X
X
X
Vitalsigns
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Height
X
Weight
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Performancestatus
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
CBCw/diff,plts
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Serumchemistry
(withLDH)
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
B
bͲHCG
C
TSHandFreeT4
X
X
X
X
X
X
X
IgG,IgM,IgE
E
E
E
E
E
RCR
F
BloodforImmune
Assays(Tcells)
H
H
H
H
H
H
H
H
H
BloodforantiͲtumor
Ab
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
OptionalTumor
Biopsy
J
J
J
RadiologicTumor
(RECIST/iRRC)
evaluation
X
X
X
X
X
X
X
X
X
X
AE/SAEEvaluation
EVALUATIONS
ͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲCompleteperSOCͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲ
ͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲEvaluatethroughoutStudyandFollowUpPerProtocolͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲ
ͲͲͲͲͲͲͲͲͲͲContinuePembrolizamubevery3weeksͲͲͲͲͲͲͲͲͲͲͲ
ͲͲͲͲObtainatleastmonthlyduringPembrolizamub
XͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲͲX
1ST
FUV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

6WXG\&DOHQGDUIRU$UP&3HPEUROL]XPDE$ORQH
3HPEUROL]XPDEPJNJJLYHQ4ZHHNVXQWLOGLVHDVHSURJUHVVLRQRUVLJQLILFDQWWR[LFLW\6WXG\
YLVLWVPD\EHSHUIRUPHGGD\VIURPWKHWDUJHWHGVWXG\YLVLWGDWHWRDOORZIRUKROLGD\VDQG
RWKHUVFKHGXOLQJFRQIOLFWV)ROORZXSYLVLWVPD\EHSHUIRUPHGZHHNVIURPWKHWDUJHWHGVWXG\
YLVLWGDWH
(9$/8$7,216
3UH
6WXG\
:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

:N

67
)89


'
'
'
'
'
'
'
'
'
'
'
'
'
3HPEUROL]XPDE

;


;


;


;


;

,QIRUPHGFRQVHQW
;














'HPRJUDSKLFV
;














0HGLFDOKLVWRU\
;














&RQFXUUHQWPHGV
;
;;

3K\VLFDOH[DP
;
;


;


;


;


;
;
9LWDOVLJQV
;
;


;


;


;


;
;
+HLJKW
;














:HLJKW
;
;


;


;


;


;
;
3HUIRUPDQFHVWDWXV
;
;


;


;


;


;
;
&%&ZGLIISOWV
;
;


;


;


;


;
;
6HUXPFKHPLVWU\
ZLWK/'+
%
%


%


%


%


%
%
%+&*
&














76+DQG)UHH7
;
;


;


;


;


;

,J*,J0,J(

(











(
(
%ORRGIRU,PPXQH
$VVD\V7FHOOV

+





+






+
%ORRGIRU
DQWLWXPRU$E

,


,


,


,


,
,
2SWLRQDO7XPRU
%LRSVLHV

-





-


-




7XPRU
PHDVXUHPHQWV
;












;
;
5DGLRORJLF
5(&,67L55F
HYDOXDWLRQ
;












;
;
$GYHUVHHYHQW
HYDOXDWLRQ

;;
;

(DFK6XEVHTXHQW&\FOH
x 3HPEUROL]XPDEPJNJ,9JLYHQHYHU\ZHHNV
x
9636&%&&KHPLVWULHV76+DQG)UHH7%ORRGIRUDQWLWXPRU$EPRQWKO\[HYHU\
PRQWKV[
x
,PDJLQJIRUGLVHDVHHYDOXDWLRQFRPSOHWHGHYHU\PRQWKV

)ROORZ8S9LVLWVIRU$//6XEMHFWVDIWHUVW)89
x ,PDJLQJWREHFRPSOHWHGHYHU\PRQWKVXQWLOGLVHDVHSURJUHVVLRQDIWHUGLVHDVH
SURJUHVVLRQLPDJLQJLVFRPSOHWHGSHUVWDQGDUGRIFDUH
x 6XUYLYDOVWDWXVFKHFNVWREHFRPSOHWHGDWOHDVWHYHU\PRQWKVXQWLOGHDWKRUORVWWR
IROORZXS
x $OORWKHUDVVHVVPHQWVVKRXOGEHFRPSOHWHGSHUVWDQGDUGRIFDUHSUDFWLFHV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

 0($685(0(172)())(&7
9.1
Antitumor Effect – Solid Tumors

(DFKWLPHDWXPRUDVVHVVPHQWRFFXUVUHVSRQVHDQGSURJUHVVLRQZLOOEHHYDOXDWHGLQWKLVVWXG\
XVLQJERWKWKHQHZLQWHUQDWLRQDOFULWHULDSURSRVHGE\WKHUHYLVHG5HVSRQVH(YDOXDWLRQ&ULWHULDLQ
6ROLG 7XPRUV 5(&,67 JXLGHOLQH YHUVLRQ >Eur J Ca  @ DV ZHOO DV
LPPXQHUHODWHG UHVSRQVH FULWHULD LU5&  &KDQJHV LQ WKH ODUJHVW GLDPHWHU XQLGLPHQVLRQDO
PHDVXUHPHQWRIWKHWXPRUOHVLRQVDQGWKHVKRUWHVWGLDPHWHULQWKHFDVHRIPDOLJQDQWO\PSKQRGHV
DUHXVHGLQWKH5(&,67FULWHULD&ULWHULDIRULPPXQHUHODWHGUHVSRQVHFULWHULDDUHGHVFULEHGODWHU
LQWKLVVHFWLRQ

7XPRUDVVHVVPHQWVZLOOEHSHUIRUPHGDSSUR[LPDWHO\HYHU\PRQWKVLQDOOWUHDWPHQWDUPV

'HILQLWLRQV
(YDOXDEOHIRUWR[LFLW\$OOSDWLHQWVZLOOEHHYDOXDEOHIRUWR[LFLW\IURPWKHWLPHRIWKHLUILUVW
WUHDWPHQWZLWKLSLOLPXPDERUGRUJHQPHOWXFHO/

(YDOXDEOHIRUREMHFWLYHUHVSRQVH2QO\WKRVHSDWLHQWVZKRKDYHPHDVXUDEOHGLVHDVHSUHVHQWDW
EDVHOLQHKDYHUHFHLYHGDWOHDVWRQHF\FOHRIWKHUDS\DQGKDYHKDGWKHLUGLVHDVHUHHYDOXDWHGZLOO
EHFRQVLGHUHGHYDOXDEOHIRUUHVSRQVH7KHVHSDWLHQWVZLOOKDYHWKHLUUHVSRQVHFODVVLILHGDFFRUGLQJ
WRWKHGHILQLWLRQVVWDWHGEHORZ1RWH3DWLHQWVZKRH[KLELWREMHFWLYHGLVHDVHSURJUHVVLRQSULRUWR
WKHHQGRIF\FOHZLOODOVREHFRQVLGHUHGHYDOXDEOH

(YDOXDEOH1RQ7DUJHW'LVHDVH5HVSRQVH3DWLHQWVZKRKDYHOHVLRQVSUHVHQWDWEDVHOLQHWKDWDUH
HYDOXDEOHEXWGRQRWPHHWWKHGHILQLWLRQVRIPHDVXUDEOHGLVHDVHKDYHUHFHLYHGDWOHDVWRQHF\FOH
RIWKHUDS\DQGKDYHKDGWKHLUGLVHDVHUHHYDOXDWHGZLOOEHFRQVLGHUHGHYDOXDEOHIRUQRQWDUJHW
GLVHDVH7KHUHVSRQVHDVVHVVPHQWLVEDVHGRQWKHSUHVHQFHDEVHQFHRUXQHTXLYRFDOSURJUHVVLRQ
RIWKHOHVLRQV

'LVHDVH3DUDPHWHUV
0HDVXUDEOHGLVHDVH0HDVXUDEOHOHVLRQVDUHGHILQHGDVWKRVHWKDWFDQEHDFFXUDWHO\PHDVXUHGLQ
DWOHDVWRQHGLPHQVLRQORQJHVWGLDPHWHUWREHUHFRUGHGDV!PPE\FKHVW[UD\RUDV!PP
ZLWK&7VFDQ05,RUFDOLSHUVE\FOLQLFDOH[DP$OOWXPRUPHDVXUHPHQWVPXVWEHUHFRUGHGLQ
PLOOLPHWHUVRUGHFLPDOIUDFWLRQVRIFHQWLPHWHUV

0DOLJQDQWO\PSKQRGHV7REHFRQVLGHUHGSDWKRORJLFDOO\HQODUJHGDQGPHDVXUDEOHDO\PSKQRGH
PXVWEH!PPLQVKRUWD[LVZKHQDVVHVVHGE\&7VFDQ&7VFDQVOLFHWKLFNQHVVUHFRPPHQGHG
WREHQRJUHDWHUWKDQPP$WEDVHOLQHDQGLQIROORZXSRQO\WKHVKRUWD[LVZLOOEHPHDVXUHG
DQGIROORZHG

1RQPHDVXUDEOHGLVHDVH$OORWKHUOHVLRQVRUVLWHVRIGLVHDVHLQFOXGLQJVPDOOOHVLRQVORQJHVW
GLDPHWHUPPRUSDWKRORJLFDOO\PSKQRGHVZLWKWRPPVKRUWD[LVDUHFRQVLGHUHG
QRQPHDVXUDEOH GLVHDVH  %RQH OHVLRQV OHSWRPHQLQJHDO GLVHDVH DVFLWHV SOHXUDOSHULFDUGLDO
HIIXVLRQVO\PSKDQJLWLVFXWLVSXOPRQLWLVLQIODPPDWRU\EUHDVWGLVHDVHDQGDEGRPLQDOPDVVHVQRW
IROORZHGE\&7RU05,DUHFRQVLGHUHGDVQRQPHDVXUDEOH



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

1RWH&\VWLFOHVLRQVWKDWPHHWWKHFULWHULDIRUUDGLRJUDSKLFDOO\GHILQHGVLPSOHF\VWVVKRXOGQRWEH
FRQVLGHUHG DV PDOLJQDQW OHVLRQV QHLWKHU PHDVXUDEOH QRU QRQPHDVXUDEOH VLQFH WKH\ DUH E\
GHILQLWLRQVLPSOHF\VWV

µ&\VWLFOHVLRQV¶WKRXJKWWRUHSUHVHQWF\VWLFPHWDVWDVHVFDQEHFRQVLGHUHGDVPHDVXUDEOHOHVLRQVLI
WKH\ PHHW WKHGHILQLWLRQRI PHDVXUDELOLW\ GHVFULEHG DERYH +RZHYHULIQRQF\VWLFOHVLRQV DUH
SUHVHQWLQWKHVDPHSDWLHQWWKHVHDUHSUHIHUUHGIRUVHOHFWLRQDVWDUJHWOHVLRQV

7DUJHWOHVLRQV$OOPHDVXUDEOHOHVLRQVXSWRDPD[LPXPRIOHVLRQVSHURUJDQDQGOHVLRQVLQ
WRWDOUHSUHVHQWDWLYHRIDOOLQYROYHGRUJDQVVKRXOGEHLGHQWLILHGDVWDUJHWOHVLRQVDQGUHFRUGHGDQG
PHDVXUHGDWEDVHOLQH7DUJHWOHVLRQVVKRXOGEHVHOHFWHGRQWKHEDVLVRIWKHLUVL]HOHVLRQVZLWKWKH
ORQJHVWGLDPHWHUEHUHSUHVHQWDWLYHRIDOOLQYROYHGRUJDQVEXWLQDGGLWLRQVKRXOGEHWKRVHWKDW
OHQGWKHPVHOYHVWRUHSURGXFLEOHUHSHDWHGPHDVXUHPHQWV,WPD\EHWKHFDVHWKDWRQRFFDVLRQWKH
ODUJHVWOHVLRQGRHVQRWOHQGLWVHOIWRUHSURGXFLEOHPHDVXUHPHQWLQZKLFKFLUFXPVWDQFHWKHQH[W
ODUJHVWOHVLRQZKLFKFDQEHPHDVXUHGUHSURGXFLEO\VKRXOGEHVHOHFWHG$VXPRIWKHGLDPHWHUV
ORQJHVWIRUQRQQRGDOOHVLRQVVKRUWD[LVIRUQRGDOOHVLRQVIRUDOOWDUJHWOHVLRQVZLOOEHFDOFXODWHG
DQGUHSRUWHGDVWKHEDVHOLQHVXPGLDPHWHUV,IO\PSKQRGHVDUHWREHLQFOXGHGLQWKHVXPWKHQ
RQO\WKHVKRUWD[LVLVDGGHGLQWRWKHVXP7KHEDVHOLQHVXPGLDPHWHUVZLOOEHXVHGDVUHIHUHQFHWR
IXUWKHUFKDUDFWHUL]HDQ\REMHFWLYHWXPRUUHJUHVVLRQLQWKHPHDVXUDEOHGLPHQVLRQRIWKHGLVHDVH

1RQWDUJHWOHVLRQV$OORWKHUOHVLRQVRUVLWHVRIGLVHDVHLQFOXGLQJDQ\PHDVXUDEOHOHVLRQVRYHU
DQG DERYH WKH WDUJHW OHVLRQV VKRXOG EH LGHQWLILHG DV QRQWDUJHW OHVLRQV DQG VKRXOG DOVR EH
UHFRUGHGDWEDVHOLQH0HDVXUHPHQWVRIWKHVHOHVLRQVDUHQRWUHTXLUHGEXWWKHSUHVHQFHDEVHQFH
RULQUDUHFDVHVXQHTXLYRFDOSURJUHVVLRQRIHDFKVKRXOGEHQRWHGWKURXJKRXWIROORZXS

0HWKRGVIRU(YDOXDWLRQRI0HDVXUDEOH'LVHDVH
$OOPHDVXUHPHQWVVKRXOGEHWDNHQDQGUHFRUGHGLQPHWULFQRWDWLRQXVLQJDUXOHURUFDOLSHUV$OO
EDVHOLQHHYDOXDWLRQVVKRXOGEHSHUIRUPHGDVFORVHO\DVSRVVLEOHWRWKHEHJLQQLQJRIWUHDWPHQWDQG
QHYHUPRUHWKDQZHHNVEHIRUHWKHEHJLQQLQJRIWKHWUHDWPHQW

7KHVDPH PHWKRG RI DVVHVVPHQW DQG WKH VDPH WHFKQLTXH VKRXOG EHXVHG WR FKDUDFWHUL]H HDFK
LGHQWLILHG DQG UHSRUWHG OHVLRQ DW EDVHOLQH DQG GXULQJ IROORZXS ,PDJLQJEDVHG HYDOXDWLRQ LV
SUHIHUUHG WR HYDOXDWLRQ E\ FOLQLFDO H[DPLQDWLRQ XQOHVV WKH OHVLRQV EHLQJ IROORZHG FDQQRW EH
LPDJHGEXWDUHDVVHVVDEOHE\FOLQLFDOH[DP

&OLQLFDOOHVLRQV&OLQLFDOOHVLRQVZLOORQO\EHFRQVLGHUHGPHDVXUDEOHZKHQWKH\DUHVXSHUILFLDO
e.g.VNLQQRGXOHVDQGSDOSDEOHO\PSKQRGHVDQGtPPGLDPHWHUDVDVVHVVHGXVLQJFDOLSHUV
e.g.VNLQQRGXOHV,QWKHFDVHRIVNLQOHVLRQVGRFXPHQWDWLRQE\FRORUSKRWRJUDSK\LQFOXGLQJD
UXOHUWRHVWLPDWHWKHVL]HRIWKHOHVLRQLVUHFRPPHQGHG

&KHVW[UD\/HVLRQVRQFKHVW[UD\DUHDFFHSWDEOHDVPHDVXUDEOHOHVLRQVZKHQWKH\DUHFOHDUO\
GHILQHGDQGVXUURXQGHGE\DHUDWHGOXQJ+RZHYHU&7LVSUHIHUDEOH

&RQYHQWLRQDO&7DQG05,7KLVJXLGHOLQHKDVGHILQHGPHDVXUDELOLW\RIOHVLRQVRQ&7VFDQEDVHG
RQWKHDVVXPSWLRQWKDW&7VOLFHWKLFNQHVVLVPPRUOHVV,I&7VFDQVKDYHVOLFHWKLFNQHVVJUHDWHU
WKDQPPWKHPLQLPXPVL]HIRUDPHDVXUDEOHOHVLRQVKRXOGEHWZLFHWKHVOLFHWKLFNQHVV05,LV
DOVRDFFHSWDEOHLQFHUWDLQVLWXDWLRQVe.g.IRUERG\VFDQV



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

8VHRI05,UHPDLQVDFRPSOH[LVVXH05,KDVH[FHOOHQWFRQWUDVWVSDWLDODQGWHPSRUDOUHVROXWLRQ
KRZHYHUWKHUHDUHPDQ\LPDJHDFTXLVLWLRQYDULDEOHVLQYROYHGLQ05,ZKLFKJUHDWO\LPSDFWLPDJH
TXDOLW\ OHVLRQ FRQVSLFXLW\ DQG PHDVXUHPHQW  )XUWKHUPRUH WKH DYDLODELOLW\ RI 05, YDULHV
JOREDOO\  $V ZLWK &7 LI DQ 05, LV SHUIRUPHG WKH WHFKQLFDO VSHFLILFDWLRQV RI WKH VFDQQLQJ
VHTXHQFHVXVHGVKRXOGEHRSWLPL]HGIRUWKHHYDOXDWLRQRIWKHW\SHDQGVLWHRIGLVHDVH)XUWKHUPRUH
DVZLWK&7WKHPRGDOLW\XVHGDWIROORZXSVKRXOGEHWKHVDPHDVZDVXVHGDWEDVHOLQHDQGWKH
OHVLRQVVKRXOGEHPHDVXUHGDVVHVVHGRQWKHVDPHSXOVHVHTXHQFH,WLVEH\RQGWKHVFRSHRIWKH
5(&,67JXLGHOLQHVWRSUHVFULEHVSHFLILF05,SXOVHVHTXHQFHSDUDPHWHUVIRUDOOVFDQQHUVERG\
SDUWVDQGGLVHDVHV,GHDOO\WKHVDPHW\SHRIVFDQQHUVKRXOGEHXVHGDQGWKHLPDJHDFTXLVLWLRQ
SURWRFROVKRXOGEHIROORZHGDVFORVHO\DVSRVVLEOHWRSULRUVFDQV%RG\VFDQVVKRXOGEHSHUIRUPHG
ZLWKEUHDWKKROGVFDQQLQJWHFKQLTXHVLISRVVLEOH

3(7&7$WSUHVHQWWKHORZGRVHRUDWWHQXDWLRQFRUUHFWLRQ&7SRUWLRQRIDFRPELQHG3(7&7LV
QRWDOZD\VRIRSWLPDOGLDJQRVWLF&7TXDOLW\IRUXVHZLWK5(&,67PHDVXUHPHQWV+RZHYHULIWKH
VLWHFDQGRFXPHQWWKDWWKH&7SHUIRUPHGDVSDUWRID3(7&7LVRILGHQWLFDOGLDJQRVWLFTXDOLW\WR
DGLDJQRVWLF&7ZLWK,9DQGRUDOFRQWUDVWWKHQWKH&7SRUWLRQRIWKH3(7&7FDQEHXVHGIRU
5(&,67 PHDVXUHPHQWV DQG FDQ EH XVHG LQWHUFKDQJHDEO\ ZLWK FRQYHQWLRQDO &7 LQ DFFXUDWHO\
PHDVXULQJFDQFHUOHVLRQVRYHUWLPH1RWHKRZHYHUWKDWWKH3(7SRUWLRQRIWKH&7LQWURGXFHV
DGGLWLRQDOGDWDZKLFKPD\ELDVDQLQYHVWLJDWRULILWLVQRWURXWLQHO\RUVHULDOO\SHUIRUPHG

8OWUDVRXQG8OWUDVRXQGLVQRWXVHIXOLQDVVHVVPHQWRIOHVLRQVL]HDQGVKRXOGQRWEHXVHGDVD
PHWKRG RI PHDVXUHPHQW  8OWUDVRXQG H[DPLQDWLRQV FDQQRW EH UHSURGXFHG LQ WKHLU HQWLUHW\ IRU
LQGHSHQGHQW UHYLHZ DW D ODWHU GDWH DQG EHFDXVH WKH\ DUH RSHUDWRU GHSHQGHQW LW FDQQRW EH
JXDUDQWHHGWKDWWKHVDPHWHFKQLTXHDQGPHDVXUHPHQWVZLOOEHWDNHQIURPRQHDVVHVVPHQWWRWKH
QH[W,IQHZOHVLRQVDUHLGHQWLILHGE\XOWUDVRXQGLQWKHFRXUVHRIWKHVWXG\FRQILUPDWLRQE\&7RU
05,LVDGYLVHG,IWKHUHLVFRQFHUQDERXWUDGLDWLRQH[SRVXUHDW&705,PD\EHXVHGLQVWHDGRI
&7LQVHOHFWHGLQVWDQFHV

(QGRVFRS\/DSDURVFRS\7KHXWLOL]DWLRQRIWKHVHWHFKQLTXHVIRUREMHFWLYHWXPRUHYDOXDWLRQLVQRW
DGYLVHG+RZHYHUVXFKWHFKQLTXHVPD\EHXVHIXOWRFRQILUPFRPSOHWHSDWKRORJLFDOUHVSRQVH
ZKHQELRSVLHVDUHREWDLQHGRUWRGHWHUPLQHUHODSVHLQWULDOVZKHUHUHFXUUHQFHIROORZLQJFRPSOHWH
UHVSRQVH&5RUVXUJLFDOUHVHFWLRQLVDQHQGSRLQW

7XPRUPDUNHUV7XPRUPDUNHUVDORQHFDQQRWEHXVHGWRDVVHVVUHVSRQVH,IPDUNHUVDUHLQLWLDOO\
DERYHWKHXSSHUQRUPDOOLPLWWKH\PXVWQRUPDOL]HIRUDSDWLHQWWREHFRQVLGHUHGLQFRPSOHWH
FOLQLFDOUHVSRQVH6SHFLILFJXLGHOLQHVIRUERWK&$UHVSRQVHLQUHFXUUHQWRYDULDQFDQFHUDQG
36$UHVSRQVHLQUHFXUUHQWSURVWDWHFDQFHUKDYHEHHQSXEOLVKHG>JNCIJ Clin 
OncolJ Clin Oncol@,QDGGLWLRQWKH*\QHFRORJLF
&DQFHU,QWHUJURXSKDVGHYHORSHG&$SURJUHVVLRQFULWHULDZKLFKDUHWREHLQWHJUDWHGZLWK
REMHFWLYHWXPRUDVVHVVPHQWIRUXVHLQILUVWOLQHWULDOVLQRYDULDQFDQFHU>JNCI@

&\WRORJ\+LVWRORJ\7KHVHWHFKQLTXHVFDQEHXVHGWRGLIIHUHQWLDWHEHWZHHQSDUWLDOUHVSRQVHV35
DQGFRPSOHWHUHVSRQVHV&5LQUDUHFDVHVe.g.UHVLGXDOOHVLRQVLQWXPRUW\SHVVXFKDVJHUPFHOO
WXPRUVZKHUHNQRZQUHVLGXDOEHQLJQWXPRUVFDQUHPDLQ

7KHF\WRORJLFDOFRQILUPDWLRQRIWKHQHRSODVWLFRULJLQRIDQ\HIIXVLRQWKDWDSSHDUVRUZRUVHQV
GXULQJWUHDWPHQWZKHQWKHPHDVXUDEOHWXPRUKDVPHWFULWHULDIRUUHVSRQVHRUVWDEOHGLVHDVHLV


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

PDQGDWRU\WRGLIIHUHQWLDWHEHWZHHQUHVSRQVHRUVWDEOHGLVHDVHDQHIIXVLRQPD\EHDVLGHHIIHFWRI
WKHWUHDWPHQWDQGSURJUHVVLYHGLVHDVH

)'*3(7  :KLOH )'*3(7 UHVSRQVH DVVHVVPHQWV QHHG DGGLWLRQDO VWXG\ LW LV VRPHWLPHV
UHDVRQDEOHWRLQFRUSRUDWHWKHXVHRI)'*3(7VFDQQLQJWRFRPSOHPHQW&7VFDQQLQJLQDVVHVVPHQW
RISURJUHVVLRQSDUWLFXODUO\SRVVLEOH
QHZ
GLVHDVH1HZOHVLRQVRQWKHEDVLVRI)'*3(7LPDJLQJ
FDQEHLGHQWLILHGDFFRUGLQJWRWKHIROORZLQJDOJRULWKP
D 1HJDWLYH)'*3(7DWEDVHOLQHZLWKDSRVLWLYH)'*3(7DWIROORZXSLVDVLJQRI3'
EDVHGRQDQHZOHVLRQ
E 1R)'*3(7DWEDVHOLQHDQGDSRVLWLYH)'*3(7DWIROORZXS,IWKHSRVLWLYH)'*3(7
DWIROORZXSFRUUHVSRQGVWRDQHZVLWHRIGLVHDVHFRQILUPHGE\&7WKLVLV3',IWKH
SRVLWLYH)'*3(7DWIROORZXSLVQRWFRQILUPHGDVDQHZVLWHRIGLVHDVHRQ&7DGGLWLRQDO
IROORZXS&7VFDQVDUHQHHGHGWRGHWHUPLQHLIWKHUHLVWUXO\SURJUHVVLRQRFFXUULQJDWWKDW
VLWHLIVRWKHGDWHRI3'ZLOOEHWKHGDWHRIWKHLQLWLDODEQRUPDO)'*3(7VFDQ,IWKH
SRVLWLYH)'*3(7DWIROORZXSFRUUHVSRQGVWRDSUHH[LVWLQJVLWHRIGLVHDVHRQ&7WKDWLV
QRWSURJUHVVLQJRQWKHEDVLVRIWKHDQDWRPLFLPDJHVWKLVLVQRW3'
F )'*3(7PD\EHXVHGWRXSJUDGHDUHVSRQVHWRD&5LQDPDQQHUVLPLODUWRDELRSV\LQ
FDVHVZKHUHDUHVLGXDOUDGLRJUDSKLFDEQRUPDOLW\LVWKRXJKWWRUHSUHVHQWILEURVLVRUVFDUULQJ
7KHXVHRI)'*3(7LQWKLVFLUFXPVWDQFHVKRXOGEHSURVSHFWLYHO\GHVFULEHGLQWKHSURWRFRO
DQGVXSSRUWHGE\GLVHDVHVSHFLILFPHGLFDOOLWHUDWXUHIRUWKHLQGLFDWLRQ+RZHYHULWPXVW
EHDFNQRZOHGJHGWKDWERWKDSSURDFKHVPD\OHDGWRIDOVHSRVLWLYH&5GXHWROLPLWDWLRQVRI
)'*3(7DQGELRSV\UHVROXWLRQVHQVLWLYLW\

1RWH$µSRVLWLYH¶)'*3(7VFDQOHVLRQPHDQVRQHZKLFKLV)'*DYLGZLWKDQXSWDNHJUHDWHU
WKDQWZLFHWKDWRIWKHVXUURXQGLQJWLVVXHRQWKHDWWHQXDWLRQFRUUHFWHGLPDJH

5HVSRQVH&ULWHULD

(YDOXDWLRQRI7DUJHW/HVLRQV

&RPSOHWH5HVSRQVH&5 'LVDSSHDUDQFHRIDOOWDUJHWOHVLRQV$Q\SDWKRORJLFDOO\PSKQRGHV
ZKHWKHUWDUJHWRUQRQWDUJHWPXVWKDYHUHGXFWLRQLQVKRUWD[LVWR
PP

3DUWLDO5HVSRQVH35
$WOHDVWDGHFUHDVHLQWKHVXPRIWKHGLDPHWHUVRIWDUJHWOHVLRQV
WDNLQJDVUHIHUHQFHWKHEDVHOLQHVXPGLDPHWHUV

3URJUHVVLYH'LVHDVH3' $WOHDVWDLQFUHDVHLQWKHVXPRIWKHGLDPHWHUVRIWDUJHWOHVLRQV
WDNLQJ DV UHIHUHQFH WKH VPDOOHVW VXP RQ VWXG\ WKLV LQFOXGHV WKH
EDVHOLQHVXPLIWKDWLVWKHVPDOOHVWRQVWXG\,QDGGLWLRQWRWKHUHODWLYH
LQFUHDVHRIWKHVXPPXVWDOVRGHPRQVWUDWHDQDEVROXWHLQFUHDVH
RIDWOHDVWPP1RWHWKHDSSHDUDQFHRIRQHRUPRUHQHZOHVLRQV
LVDOVRFRQVLGHUHGSURJUHVVLRQV

6WDEOH'LVHDVH6'
1HLWKHUVXIILFLHQWVKULQNDJHWRTXDOLI\IRU35QRUVXIILFLHQWLQFUHDVH
WRTXDOLI\IRU3'WDNLQJDVUHIHUHQFHWKHVPDOOHVWVXPGLDPHWHUVZKLOH
RQVWXG\



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

(YDOXDWLRQRI1RQ7DUJHW/HVLRQV

&RPSOHWH5HVSRQVH&5 'LVDSSHDUDQFHRIDOOQRQWDUJHWOHVLRQVDQGQRUPDOL]DWLRQRIWXPRU
PDUNHU OHYHO  $OO O\PSK QRGHV PXVW EH QRQSDWKRORJLFDO LQ VL]H
PPVKRUWD[LV

1RWH,IWXPRUPDUNHUVDUHLQLWLDOO\DERYHWKHXSSHUQRUPDOOLPLWWKH\
PXVW QRUPDOL]H IRU D SDWLHQW WR EH FRQVLGHUHG LQ FRPSOHWH FOLQLFDO
UHVSRQVH

1RQ&51RQ3'
3HUVLVWHQFHRIRQHRUPRUHQRQWDUJHWOHVLRQVDQGRUPDLQWHQDQFHRI
WXPRUPDUNHUOHYHODERYHWKHQRUPDOOLPLWV

3URJUHVVLYH'LVHDVH3' $SSHDUDQFH RI RQH RU PRUH QHZ OHVLRQV DQGRU unequivocal
progressionRIH[LVWLQJQRQWDUJHWOHVLRQVUnequivocal progression
VKRXOG QRW QRUPDOO\ WUXPS WDUJHW OHVLRQ VWDWXV  ,W PXVW EH
UHSUHVHQWDWLYH RI RYHUDOO GLVHDVH VWDWXV FKDQJH QRW D VLQJOH OHVLRQ
LQFUHDVH

$OWKRXJKDFOHDUSURJUHVVLRQRI³QRQWDUJHW´OHVLRQVRQO\LVH[FHSWLRQDOWKHRSLQLRQRIWKHWUHDWLQJ
SK\VLFLDQVKRXOGSUHYDLOLQVXFKFLUFXPVWDQFHVDQGWKHSURJUHVVLRQVWDWXVVKRXOGEHFRQILUPHGDW
DODWHUWLPHE\WKHUHYLHZSDQHORU3ULQFLSDO,QYHVWLJDWRU

$Q\ UHVSRQVHV PXVW EH FRQILUPHG E\ UHSHDW WXPRU DVVHVVPHQW DW OHDVW ZHHNV DIWHU LQLWLDO
GRFXPHQWDWLRQ$Q\VXVSHFWHGSURJUHVVLRQZLWKLQFUHDVHLQWXPRUVL]HRUWKHDSSHDUDQFH
RIQHZOHVLRQVZLOOQRWLPPHGLDWHO\FRXQWDVSURJUHVVLRQEXWZLOOEHHYDOXDWHGDFFRUGLQJWRLU5&
VHHEHORZ

(YDOXDWLRQRI%HVW2YHUDOO5HVSRQVH
7KHEHVWRYHUDOOUHVSRQVHLVWKHEHVWUHVSRQVHUHFRUGHGIURPWKHVWDUWRIWKHWUHDWPHQWXQWLOGLVHDVH
SURJUHVVLRQUHFXUUHQFHWDNLQJDVUHIHUHQFHIRUSURJUHVVLYHGLVHDVHWKHVPDOOHVWPHDVXUHPHQWV
UHFRUGHGVLQFHWKHWUHDWPHQWVWDUWHG7KHSDWLHQW
VEHVWUHVSRQVHDVVLJQPHQWZLOOGHSHQGRQWKH
DFKLHYHPHQWRIERWKPHDVXUHPHQWDQGFRQILUPDWLRQFULWHULD

)RU3DWLHQWVZLWK0HDVXUDEOH'LVHDVHLH7DUJHW'LVHDVH

7DUJHW
/HVLRQV
1RQ7DUJHW/HVLRQV
1HZ
/HVLRQV
2YHUDOO
5HVSRQVH
%HVW2YHUDOO5HVSRQVH
ZKHQ&RQILUPDWLRQLV
5HTXLUHG
&5
&5
1R
&5
!ZNV&RQILUPDWLRQ
&5
1RQ&51RQ3'
1R
35

!ZNV&RQILUPDWLRQ
&5
1RWHYDOXDWHG
1R
35
35
1RQ&51RQ3'QRW
HYDOXDWHG
1R
35
6'
1RQ&51RQ3'QRW
HYDOXDWHG
1R
6'
GRFXPHQWHGDWOHDVWRQFH
!ZNVIURPEDVHOLQH
3'
$Q\
<HVRU1R
3'

QRSULRU6'35RU&5
$Q\
3'
<HVRU1R
3'
$Q\
$Q\
<HV
3'
6HH5(&,67PDQXVFULSWIRUIXUWKHUGHWDLOVRQZKDWLVHYLGHQFHRIDQHZOHVLRQ


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

2QO\IRUQRQUDQGRPL]HGWULDOVZLWKUHVSRQVHDVSULPDU\HQGSRLQW
,QH[FHSWLRQDOFLUFXPVWDQFHVXQHTXLYRFDOSURJUHVVLRQLQQRQWDUJHWOHVLRQVPD\EHDFFHSWHGDV
GLVHDVHSURJUHVVLRQ

1RWH
3DWLHQWVZLWKDJOREDOGHWHULRUDWLRQRIKHDOWKVWDWXVUHTXLULQJGLVFRQWLQXDWLRQRIWUHDWPHQW
ZLWKRXWREMHFWLYHHYLGHQFHRIGLVHDVHSURJUHVVLRQDWWKDWWLPHVKRXOGEHUHSRUWHGDV³symptomatic
deterioration.”(YHU\HIIRUWVKRXOGEHPDGHWRGRFXPHQWWKHREMHFWLYHSURJUHVVLRQHYHQDIWHU
GLVFRQWLQXDWLRQRIWUHDWPHQW

)RU3DWLHQWVZLWK1RQ0HDVXUDEOH'LVHDVHLH1RQ7DUJHW'LVHDVH

1RQ7DUJHW/HVLRQV
1HZ/HVLRQV
2YHUDOO5HVSRQVH
&5
1R
&5
1RQ&5QRQ3'
1R
1RQ&5QRQ3'
1RWDOOHYDOXDWHG
1R
QRWHYDOXDWHG
8QHTXLYRFDO3'
<HVRU1R
3'
$Q\
<HV
3'
µ1RQ&5QRQ3'¶LVSUHIHUUHGRYHUµVWDEOHGLVHDVH¶IRUQRQWDUJHWGLVHDVHVLQFH6'LV
LQFUHDVLQJO\XVHGDVDQHQGSRLQWIRUDVVHVVPHQWRIHIILFDF\LQVRPHWULDOVVRWRDVVLJQWKLV
FDWHJRU\ZKHQQROHVLRQVFDQEHPHDVXUHGLVQRWDGYLVHG


'XUDWLRQRI5HVSRQVH
'XUDWLRQ RI RYHUDOO UHVSRQVH  7KH GXUDWLRQ RI RYHUDOO UHVSRQVH LV PHDVXUHG IURP WKH WLPH
PHDVXUHPHQWFULWHULDDUHPHWIRU&5RU35ZKLFKHYHULVILUVWUHFRUGHGXQWLOWKHILUVWGDWHWKDW
UHFXUUHQWRUSURJUHVVLYHGLVHDVHLVREMHFWLYHO\GRFXPHQWHGWDNLQJDVUHIHUHQFHIRUSURJUHVVLYH
GLVHDVHWKHVPDOOHVWPHDVXUHPHQWVUHFRUGHGVLQFHWKHWUHDWPHQWVWDUWHG

'XUDWLRQRIVWDEOHGLVHDVH6WDEOHGLVHDVHLVPHDVXUHGIURPWKHVWDUWRIWKHWUHDWPHQWXQWLOWKH
FULWHULDIRUSURJUHVVLRQDUHPHWWDNLQJDVUHIHUHQFHWKHVPDOOHVWPHDVXUHPHQWVUHFRUGHGVLQFHWKH
WUHDWPHQWVWDUWHGLQFOXGLQJWKHEDVHOLQHPHDVXUHPHQWV

,PPXQHUHODWHG(QGSRLQWV
7KHLU5&LQFRUSRUDWHVVHYHUDOHOHPHQWVUHIOHFWLQJWKHFRPSOH[WXPRUG\QDPLFVRILSLOLPXPDE
WUHDWPHQW 8QGHU WKHVH FULWHULD D PHDVXUH RI WXPRU YROXPH LV XVHG WKDW LQFRUSRUDWHV WKH
FRQWULEXWLRQ RI QHZ PHDVXUDEOH OHVLRQV (DFK QHW SHUFHQWDJH FKDQJH LQ WXPRU EXUGHQ SHU
DVVHVVPHQWXVLQJLU5&DFFRXQWVIRUWKHVL]HDQGJURZWKNLQHWLFVRIERWKROGDQGQHZOHVLRQVDV
WKH\DSSHDU1HZOHVLRQVDORQHGRQRWTXDOLI\DVLU3'

,QWKLVVWXG\LU5&ZLOOEHXVHGWRDVVHVVVXEMHFWUHVSRQVHWRVWXG\WUHDWPHQWSHULQYHVWLJDWRU
DVVHVVPHQW7KHHQGSRLQWLU3)6ZLOOEHGHWHUPLQHGEDVHGRQLQYHVWLJDWRUDVVHVVPHQW,QRUGHUWR
DGHTXDWHO\DGGUHVVWKLVREMHFWLYHLQYHVWLJDWRUVZLOOREWDLQFRQILUPDWRU\VFDQVEH\RQG5(&,67
3'DQGIROORZWKHLQVWUXFWLRQVLQWKLVVHFWLRQIRUWKHGHWHUPLQDWLRQRILPPXQHUHODWHGUHVSRQVH


1HZ/HVLRQ0HDVXUHPHQW
7KHLU5&DUHWXPRUDVVHVVPHQWFULWHULDWKDWKDYHEHHQGHYHORSHGWREHWWHUFDSWXUHWKHDFWLYLW\RI
LPPXQRWKHUDSHXWLFDJHQWV7KHVHFULWHULDKDYHEHHQXVHGZLWKVXFFHVVLQFOLQLFDOVWXGLHVWKDW
ZHUHSHUIRUPHGZLWKLSLOLPXPDELQDGYDQFHGPHWDVWDWLFPHODQRPDDQGLQOXQJFDQFHU



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

$GGLWLRQDOWXPRUUHVSRQVHGDWDZLOOEHFROOHFWHGEH\RQGZKDWLVUHTXLUHGWRDSSO\WKH5(&,67
FULWHULD0RUHVSHFLILFDOO\WKHLQYHVWLJDWRUZLOOKDYHWRUHFRUGLQWKH&5)WKHELGLPHQVLRQDO
PHDVXUHPHQWVIRUHDFKQHZOHVLRQZKLFKKDVEHFRPHPHDVXUDEOHLQHDFKWXPRUDVVHVVPHQW

7RVXSSRUWHYDOXDWLRQRISURJUHVVLRQIUHHVXUYLYDOEDVHGRQLU5&FULWHULDLU3)6LQWKLVLQGLFDWLRQ
LQYHVWLJDWRUVPXVWSHUIRUPWXPRUDVVHVVPHQWVLQFOXGLQJQHZOHVLRQPHDVXUHPHQWVGXULQJWKH
7R[LFLW\3URJUHVVLRQ)ROORZXS3KDVHLQVXEMHFWVZKRKDYHH[SHULHQFHG5(&,67SURJUHVVLRQ
XQWLOWKHWRWDOVXPRISURGXFWGLDPHWHUV63'LQFOXGLQJQHZOHVLRQVKDVLQFUHDVHGRUPRUH
IURPWKHQDGLURUXQWLOVXEMHFWVGLVFRQWLQXHVWXG\WKHUDS\UHJDUGOHVVRIZKHWKHUWKHVXEMHFWLV
LQLWLDWLQJ VXEVHTXHQW WKHUDS\ $OO DYDLODEOH SRVW 5(&,67 SURJUHVVLRQ WXPRU LPDJLQJ EDVHG
DVVHVVPHQWVGXULQJWKLVSKDVHLQWKHVWXG\PXVWEHHQWHUHGLQWRWKH&5)LQFOXGLQJDQ\VWDQGDUG
RIFDUHDVVHVVPHQWVDQGDQ\DVVHVVPHQWVSHUIRUPHGZKLOHXQGHUQRQVWXG\VXEVHTXHQWFDQFHU
WKHUDS\

$Q\VXEMHFWZKRGHYHORSVDQREMHFWLYHWXPRUUHVSRQVH&5RU35RUSURJUHVVLRQ3'LVUHTXLUHG
WRXQGHUJRFRQILUPDWRU\VFDQVQROHVVWKDQZHHNVVLQFHWKHSULRUVFDQLQRUGHUWRYHULI\WKH
UHOLDELOLW\ RI WKH UDGLRORJLF ILQGLQJ 6LWHV DUH HQFRXUDJHG WR FROOHFW DGGLWLRQDO &7 VFDQV DIWHU
5(&,673'KDVEHHQFRQILUPHGDVORQJDVDVXEVHTXHQWOLQHRIWKHUDS\KDVQRWEHHQLQLWLDWHG

'HILQLWLRQRI7XPRU5HVSRQVH8VLQJLU5&
&DOFXODWLRQRI,PPXQHUHODWHG6XPRI3URGXFWVRI'LDPHWHUVLU63'

7KHLU63'LQFRUSRUDWHVPHDVXUDEOHQHZOHVLRQVWKDWPD\KDYHGHYHORSHGRQVWXG\SURYLGLQJDQ
DVVHVVPHQWWKDWLQFOXGHVERWKLQGH[DQGQHZOHVLRQV7KHWXPRUDVVHVVPHQWSHUIRUPHGGXULQJ
6FUHHQLQJZLOOVHUYHDVWKHEDVHOLQHIRUGHWHUPLQDWLRQRIWXPRUUHVSRQVHXVLQJLU5&

LU63'DW%DVHOLQH7KHVXPRIWKHSURGXFWRIWKHGLDPHWHUVIRUDOOLQGH[OHVLRQVLGHQWLILHGSULRUWR
UDQGRPL]DWLRQ$WEDVHOLQHLU63'DQG63'DUHWKHVDPH

LU63'DW7$)RUHYHU\SRVWUDQGRPL]DWLRQ7$FROOHFWHGSHUSURWRFRO6HFWLRQRUDVFOLQLFDOO\
LQGLFDWHGLQFOXGLQJSRVWP:+23'7$WKHLU63'DW7$ZLOOEHFDOFXODWHGXVLQJWXPRULPDJLQJ
VFDQV%RWKLQGH[OHVLRQVDQGDQ\PHDVXUDEOHQHZOHVLRQVWKDWKDYHGHYHORSHGRQVWXG\ZLOOEH
LQFOXGHG

LU63'1DGLU)RUWXPRUVWKDWDUHDVVHVVHGPRUHWKDQRQHWLPHDIWHUEDVHOLQHWKHORZHVWYDOXHRI
WKHLU63'LU63'%DVHOLQHRULU63'DW7$LVXVHGWRFODVVLI\VXEVHTXHQW7$VIRUHDFKVXEMHFW
%HFDXVHLSLOLPXPDEWUHDWPHQWPD\UHVXOWLQFRPSOH[WXPRUG\QDPLFVLQZKLFKLQGH[OHVLRQVPD\
VKULQNZKLOHQHZOHVLRQVDSSHDUWKHLU63'QDGLUPD\EHGLIIHUHQWIURPWKH63'QDGLUDQGPD\
RFFXUHLWKHUEHIRUHRUDIWHUWKH63'QDGLU

$WEDVHOLQHWKHLU63'LVPHDVXUHGDQGUHFRUGHG

$WHDFKVXEVHTXHQWDVVHVVPHQWWLPHSRLQWDVHSDUDWHDVVHVVPHQWRIWLPHSRLQWRYHUDOOUHVSRQVHZLOO
EHREWDLQHGIRUWKDWWLPHSRLQW7KHVXPRISURGXFWVRISHUSHQGLFXODUGLDPHWHUVFDOFXODWHGDQG
UHFRUGHGDWHDFKSRVWEDVHOLQHWLPHSRLQWIRULPPXQHUHODWHGUHVSRQVHSXUSRVHVLU63'LQFOXGH
PHDVXUHPHQWVRILQGH[OHVLRQVDQGDOVRLQFOXGHPHDVXUDEOHQHZOHVLRQVZKLFKDUHQRWWRRVPDOO
WRPHDVXUHDWWKLVWLPHSRLQW$YDOXHRIPPPP[PPLVLPSXWHGIRUHDFKLQGH[DQG
SUHYLRXVO\PHDVXUDEOHQHZOHVLRQZKLFKLVSUHVHQWEXWWRRVPDOOWRPHDVXUH


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO


7LPHSRLQW2YHUDOO5HVSRQVH8VLQJLU5&
x 7KHRYHUDOODVVHVVPHQWRILPPXQHUHODWHGUHVSRQVHUHSRUWHGDWHDFKWLPHSRLQWZLOOEH
EDVHGRQWKHIROORZLQJFULWHULD
x ,PPXQHUHODWHG&5LU&5&RPSOHWHGLVDSSHDUDQFHRIDOOWXPRUOHVLRQVLQGH[DQG
QRQLQGH[WRJHWKHUZLWKQRQHZPHDVXUDEOHXQPHDVXUDEOHOHVLRQV
x ,PPXQHUHODWHG35LU35$GHFUHDVHUHODWLYHWREDVHOLQHRIWKHLU63'DVGHILQHG
DERYHRIRUJUHDWHULVFRQVLGHUHGDQLU35
x ,PPXQHUHODWHG6'LU6'LU6'LVGHILQHGDVDQHYDOXDEOHUHVSRQVHWKDWIDLOVWRPHHW
FULWHULDIRULPPXQHUHODWHG&5RULPPXQHUHODWHG35LQWKHDEVHQFHRILU3'
x ,PPXQHUHODWHG3URJUHVVLYH'LVHDVHLU3'͒$WOHDVWDLQFUHDVHLQWKHLU63'EDVHG
RQLU63'RIDOOLQGH[OHVLRQVDQGDQ\PHDVXUDEOHQHZOHVLRQVDVGHILQHGDERYHRYHUWKH
QDGLULU63'RUWKHRFFXUUHQFHRIDQ\QHZPHDVXUDEOHOHVLRQVLIWKH63'QDGLULV³´
LQFOXGLQJZKHQQRPHDVXUDEOHOHVLRQVDUHSUHVHQWDWEDVHOLQH
x ,PPXQHUHODWHG8QNQRZQ5HVSRQVHLU817XPRUDVVHVVPHQWVZKLFKFDQQRWEH
HYDOXDWHGHJGXHWRLPDJHTXDOLW\LQDELOLW\WRDVVHVVDOOUHOHYDQWOHVLRQVHWFZLOOEH
UHSRUWHGDVLU81

 5(*8/$725<$1'5(3257,1*5(48,5(0(176
10.1 Subject Data

6XEMHFWGDWDDFFUXHGRQWKLVVWXG\ZLOOEHUHSRUWHGLQDFFRUGDQFHZLWK&)5
10.2 CTCAE
7KLVVWXG\ZLOOXWLOL]HWKH&7&$(9HUVLRQIRU$GYHUVH(YHQW$(5HSRUWLQJ7KH&7&$(
YFDQEHGRZQORDGHGIURPWKH&7(3KRPHSDJHKWWSFWHSLQIRQLKJRY
10.3 Notifications

7KH3,ZLOOQRWLI\WKH,5%2%$DQG1HZ/LQN*HQHWLFV6WXG\6SRQVRUZKRLQWXUQZLOOQRWLI\
WKH )'$ DQG RWKHU UHJXODWRU\ DJHQFLHV RI DOO VHULRXV DGYHUVH HYHQWV DV UHTXLUHG E\ ODZ RU
UHJXODWLRQ$OOSDUWLFLSDWLQJLQYHVWLJDWRUVZLOOEHQRWLILHGRI,1'6DIHW\5HSRUWVE\Investigator
AlertsVHQWWKURXJKHPDLO
10.4 Definitions for Reporting Purposes


,QWKLVSURWRFROWKHVWXG\GUXJGRUJHQPHOWXFHO/LVEHLQJFRPELQHGZLWKRQHRIWKUHHGLIIHUHQW
LPPXQHFKHFNSRLQWLPPXQRWKHUDSLHVGUXJVZLWKDQHVWDEOLVKHGVDIHW\SURILOH$GYHUVHHYHQWV
DQGVHULRXVDGYHUVHHYHQWVREVHUYHGGXULQJWKHFRXUVHRIWKLVWULDODQGSUHYLRXVO\UHSRUWHGDV
UHODWHGWRLSLOLPXPDEQLYROXPDERUSHPEUROL]XPDEZLOOEHDWWULEXWHGWRVXFK$GYHUVHHYHQWV
SUHYLRXVO\ VHHQ ZLWK GRUJHQPHOWXFHO/ RU RWKHU +\SHU$FXWH WKHUDSLHV ZLOO EH DWWULEXWHG WR
GRUJHQPHOWXFHO/1RYHOVHULRXVDGYHUVHHYHQWVQRWSUHYLRXVO\VHHQZLWKDQ\VWXG\DJHQWZLOO
LQLWLDOO\EHFRQVLGHUHGUHJLPHQDVVRFLDWHGDQGZLOOUHTXLUHDQHYDOXDWLRQE\WKH3,DQGWKHVSRQVRU


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

WRGHWHUPLQHDWWULEXWLRQ7KLVZLOOEHGRQHYLDWHOHFRQIHUHQFHZLWKLQWKUHHEXVLQHVVGD\VRIWKH
UHSRUW

$Qadverse event$(LVDQ\V\PSWRPVLJQLOOQHVVRUH[SHULHQFHWKDWGHYHORSVRUZRUVHQVLQ
VHYHULW\GXULQJWKHFRXUVHRIWKHVWXG\,QWHUFXUUHQWLOOQHVVHVRULQMXULHVVKRXOGEHUHJDUGHGDV
DGYHUVHHYHQWV$EQRUPDOUHVXOWVRIGLDJQRVWLFSURFHGXUHVDUHFRQVLGHUHGWREHDGYHUVHHYHQWVLI
WKHDEQRUPDOLW\
x UHVXOWVLQVWXG\ZLWKGUDZDO
x LVDVVRFLDWHGZLWKDVHULRXVDGYHUVHHYHQW
x LVDVVRFLDWHGZLWKFOLQLFDOVLJQVRUV\PSWRPV
x OHDGVWRDGGLWLRQDOWUHDWPHQWRUWRIXUWKHUGLDJQRVWLFWHVWV
x LVFRQVLGHUHGE\WKHLQYHVWLJDWRUWREHRIFOLQLFDOVLJQLILFDQFH

RelatedWRWKHXVHRIWKHGUXJ7KHUHLVDUHDVRQDEOHSRVVLELOLW\PRUHOLNHO\WKDQQRWWKDWWKH
H[SHULHQFHPD\KDYHEHHQFDXVHGE\WKHLQYHVWLJDWLRQDOGUXJ

$serious adverse eventLVDQ\$(WKDWLV
x IDWDO
x OLIHWKUHDWHQLQJ
x UHTXLUHVRUSURORQJVKRVSLWDOVWD\
x UHVXOWVLQSHUVLVWHQWRUVLJQLILFDQWGLVDELOLW\RULQFDSDFLW\
x DFRQJHQLWDODQRPDO\RUELUWKGHIHFW
x DQLPSRUWDQWPHGLFDOHYHQW
10.5 Reporting Form and Content

)RUWKRVHHYHQWVWKDWPHHWWKHFULWHULDLQ6HFWLRQEHORZSOHDVHFRPSOHWHWKH6HULRXV$GYHUVH
(YHQW5HSRUWLQJ)RUP7KLVIRUPZLOOEHSURYLGHGE\1HZ/LQN*HQHWLFV3OHDVHVHQGWR
1HZ/LQN*HQHWLFVZLWKLQWKHWLPHIUDPHVOLVWHGEHORZ3OHDVH)$;WRRU(0$,/
WR6$(B5HSRUWLQJ#OLQNSFRP3OHDVHFDOOZLWKDQ\UHSRUWLQJTXHVWLRQV<RX
PD\DOVRFRQWDFWDQGVHQGWKLVIRUPWRWKH&5$GHVLJQDWHGIRU\RXUVLWH

10.6 Reporting Requirements for Serious Adverse Events (21 CFR Part 312) 

,QYHVWLJDWRUV0867LPPHGLDWHO\UHSRUWWRWKHVSRQVRU$1<6HULRXV$GYHUVH(YHQWVZLWKLQ
KRXUVRIOHDUQLQJRIWKH6$(ZKHWKHURUQRWWKH\DUHFRQVLGHUHGUHODWHGWRWKHLQYHVWLJDWLRQDO
DJHQWVLQWHUYHQWLRQ&)5

$QDGYHUVHHYHQWLVFRQVLGHUHG6(5,286LILWUHVXOWVLQ$1<RIWKHIROORZLQJRXWFRPHV
 'HDWK
 $OLIHWKUHDWHQLQJDGYHUVHHYHQW
 $QDGYHUVHHYHQWWKDWUHVXOWVLQLQSDWLHQWKRVSLWDOL]DWLRQRUSURORQJDWLRQRIH[LVWLQJ
KRVSLWDOL]DWLRQIRU!KRXUV
 $SHUVLVWHQWRUVLJQLILFDQWLQFDSDFLW\RUVXEVWDQWLDOGLVUXSWLRQRIWKHDELOLW\WRFRQGXFW
QRUPDOOLIHIXQFWLRQV
 $FRQJHQLWDODQRPDO\ELUWKGHIHFW


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

 ,PSRUWDQW0HGLFDO(YHQWV,0(WKDWPD\QRWUHVXOWLQGHDWKEHOLIHWKUHDWHQLQJRUUHTXLUH
KRVSLWDOL]DWLRQPD\EHFRQVLGHUHGVHULRXVZKHQEDVHGXSRQPHGLFDOMXGJPHQWWKH\PD\
MHRSDUGL]HWKHSDWLHQWRUVXEMHFWDQGPD\UHTXLUHPHGLFDORUVXUJLFDOLQWHUYHQWLRQWRSUHYHQW
RQHRIWKHRXWFRPHVOLVWHGLQWKLVGHILQLWLRQ)'$&)5,&+($DQG,&+(

6$(UHSRUWLQJWLPHOLQHVDUHGHILQHGDV
o ³+RXU&DOHQGDU'D\V´±7KH6$(PXVWLQLWLDOO\EHUHSRUWHGZLWKLQKRXUVRI
OHDUQLQJRIWKH6$(IROORZHGE\DFRPSOHWH6$(UHSRUWZLWKLQFDOHQGDUGD\VRIWKH
LQLWLDOKRXUUHSRUW

6HULRXVDGYHUVHHYHQWVWKDWRFFXUPRUHWKDQGD\VDIWHUWKHODVWDGPLQLVWUDWLRQRILQYHVWLJDWLRQDO
DJHQWLQWHUYHQWLRQDQGKDYHDQDWWULEXWLRQRISRVVLEOHSUREDEOHRUGHILQLWHWRGRUJHQPHOWXFHO/
UHTXLUHUHSRUWLQJRQWKHVDPHWLPHOLQHVDVQRWHGDERYH

'HDWKVFOHDUO\GXHWRSURJUHVVLYHGLVHDVHVKRXOG127EHUHSRUWHGH[SHGLWLRXVO\EXWUDWKHUVKRXOG
EHUHSRUWHGYLDURXWLQHUHSRUWLQJ

+RVSLWDOL]DWLRQ3URORQJHG+RVSLWDOL]DWLRQRU6XUJHU\
$Q\ DGYHUVH HYHQW WKDW UHVXOWV LQ KRVSLWDOL]DWLRQ RU SURORQJHG KRVSLWDOL]DWLRQ VKRXOG EH
GRFXPHQWHGDQGUHSRUWHGDVDVHULRXVDGYHUVHHYHQWXQOHVVVSHFLILFDOO\LQVWUXFWHGRWKHUZLVHLQWKLV
SURWRFRO$Q\FRQGLWLRQUHVSRQVLEOHIRUVXUJHU\VKRXOGEHGRFXPHQWHGDVDQDGYHUVHHYHQWLIWKH
FRQGLWLRQPHHWVWKHFULWHULDIRUDQGDGYHUVHHYHQW
1HLWKHUWKHFRQGLWLRQKRVSLWDOL]DWLRQSURORQJHGKRVSLWDOL]DWLRQQRUVXUJHU\DUHUHSRUWHGDVDQ
DGYHUVHHYHQWLQWKHIROORZLQJFLUFXPVWDQFHV
x +RVSLWDOL]DWLRQRUSURORQJHGKRVSLWDOL]DWLRQIRUGLDJQRVWLFRUHOHFWLYHVXUJLFDOSURFHGXUHV
IRUDSUHH[LVWLQJFRQGLWLRQ6XUJHU\VKRXOGnotEHUHSRUWHGDVDQRXWFRPHRIDQDGYHUVH
HYHQW LI WKH SXUSRVH RI WKH VXUJHU\ ZDV HOHFWLYH RU GLDJQRVWLF DQG WKH RXWFRPH ZDV
XQHYHQWIXO
x +RVSLWDOL]DWLRQRUSURORQJHGKRVSLWDOL]DWLRQUHTXLUHGWRDOORZHIILFDF\PHDVXUHPHQWIRUWKH
VWXG\
x +RVSLWDOL]DWLRQRUSURORQJHGKRVSLWDOL]DWLRQIRUWKHUDS\RIWKHWDUJHWGLVHDVHRIWKHVWXG\
XQOHVVLWLVDZRUVHQLQJRULQFUHDVHLQIUHTXHQF\RIKRVSLWDODGPLVVLRQVDVMXGJHGE\WKH
FOLQLFDOLQYHVWLJDWRU

5RXWLQH$GYHUVH(YHQW5HSRUWLQJ
$OO$GYHUVH(YHQWVPXVWEHUHSRUWHGLQURXWLQHVWXG\GDWDVXEPLVVLRQV$(VUHSRUWHGWKURXJK
H[SHGLWHG6$(UHSRUWVPXVWDOVREHUHSRUWHGLQURXWLQHVWXG\GDWDVXEPLVVLRQV&5)V

$GYHUVH(YHQW&DVH5HSRUW)RUP
$OODGYHUVHHYHQWVUHJDUGOHVVRIJUDGHDQGDWWULEXWLRQREVHUYHGZKLOHRQVWXG\DQGIRUGD\V
DIWHUODVWGRVHRIWUHDWPHQWPXVWEHUHFRUGHGRQWKHDGYHUVHHYHQWFDVHUHSRUWIRUP$IWHUGD\V
IURPODVWGRVHRIWUHDWPHQWRQO\DGYHUVHHYHQWVWKDWDUHUHODWHGWRWKHVWXG\GUXJFRPELQDWLRQDUH
UHTXLUHGWREHUHFRUGHGRQWKHDGYHUVHHYHQWIRUPV

5HSRUWLQJ5HTXLUHPHQWVIRU%DVHOLQH$GYHUVH(YHQWV
$SHUWLQHQWSRVLWLYHILQGLQJLGHQWLILHGRQEDVHOLQHDVVHVVPHQWLVWREHGRFXPHQWHGDVD%DVHOLQH
$GYHUVH(YHQWXVLQJ&7&$(WHUPLQRORJ\DQGJUDGHRQWKHSURYLGHG%DVHOLQH&5)$QH[SHGLWHG


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

$(UHSRUWLVQRWUHTXLUHGLIDSDWLHQWLVHQWHUHGRQWRWKHVWXG\ZLWKDSUHH[LVWLQJFRQGLWLRQHJ
HOHYDWHGODERUDWRU\YDOXHGLDUUKHD7KHEDVHOLQH$(PXVWEHUHDVVHVVHGWKURXJKRXWWKHWULDODQG
UHSRUWHGLILWIXOILOOVH[SHGLWHG$(UHSRUWLQJJXLGHOLQHV

,IWKHSUHH[LVWLQJFRQGLWLRQZRUVHQVLQVHYHULW\WKHLQYHVWLJDWRUPXVWUHDVVHVVWKHHYHQW
WRGHWHUPLQHLIDQH[SHGLWHGUHSRUWLVUHTXLUHG

,IWKH$(UHVROYHGDQGWKHQUHFXUVWKHLQYHVWLJDWRUPXVWUHDVVHVVWKHHYHQWWRGHWHUPLQH
LIDQH[SHGLWHGUHSRUWLVUHTXLUHG

1RPRGLILFDWLRQLQJUDGLQJLVWREHPDGHWRDFFRXQWIRUDEQRUPDOLWLHVH[LVWLQJDWEDVHOLQH

2WKHU5HSRUWLQJ5HTXLUHPHQWV
,QDGGLWLRQWRWKHFOLQLFDOPRQLWRULQJDVRXWOLQHGLQWKH6WXG\&DOHQGDUVPRQLWRULQJIRUORQJWHUP
RUGHOD\HGDGYHUVHHYHQWVUHODWHGWRJHQHWUDQVIHUUHTXLUHGDWOHDVW\HDUO\IRU\HDUVE\WKH
)'$%50$&ZLOOEHWKHUHVSRQVLELOLW\RIWKH3ULQFLSDO,QYHVWLJDWRUDWHDFKVLWH(DFK3,ZLOO
EHUHVSRQVLEOHIRUWKHUHFRUGLQJDQGUHSRUWLQJRIWKLVLQIRUPDWLRQWRWKHVSRQVRU,QYHVWLJDWRUV
PXVWUHSRUWWKHHPHUJHQFHRIQHZFOLQLFDOFRQGLWLRQVVSHFLILFDOO\

1HZPDOLJQDQF\LHV

1HZLQFLGHQFHRUH[DFHUEDWLRQRIDSUHH[LVWLQJQHXURORJLFGLVRUGHU

1HZLQFLGHQFHRUH[DFHUEDWLRQRIDSULRUUKHXPDWRORJLFRURWKHUDXWRLPPXQHGLVRUGHU

1HZLQFLGHQFHRIDKHPDWRORJLFGLVRUGHU

8QH[SHFWHGLOOQHVVDQGKRVSLWDOL]DWLRQV

([SHFWHGRUXQH[SHFWHGGHDWKDQGFDXVHRIGHDWK

)RUWKHILUVW\HDUVZHUHFRPPHQGWKDW3ULQFLSDO,QYHVWLJDWRUVVFKHGXOHDYLVLWZLWKHDFKVWXG\
VXEMHFWWRUHFRUGQHZILQGLQJVLQFOXGLQJKLVWRU\SK\VLFDOH[DPLQDWLRQRUODERUDWRU\WHVWLQJDW
OHDVWRQFHD\HDUHYHQLIWKHVXEMHFWLVRIIVWXG\)RUWKHVXEVHTXHQW\HDUVZHUHFRPPHQGWKDW
,QYHVWLJDWRUVFRQWDFWVXEMHFWVE\WHOHSKRQHRUZULWWHQTXHVWLRQQDLUHDWOHDVWRQFHD\HDUWRJDWKHU
QHZLQIRUPDWLRQ

 +XPDQ6XEMHFWV3URWHFWLRQV
11.1 Rationale for Subject Selection

0HODQRPDLVDFRPPRQFDQFHUWKDWDIIHFWVERWKJHQGHUVDQGDOOUDFLDOHWKQLFJURXSV6XEMHFWVIURP
ERWKJHQGHUVDQGDOOUDFLDOHWKQLFJURXSVDUHHOLJLEOHIRUWKLVVWXG\LIWKH\PHHWWKHHOLJLELOLW\
FULWHULD:HZLOOPDNHDQDWWHPSWDWHQUROOLQJUHSUHVHQWDWLYHSURSRUWLRQVRIZRPHQDQGPLQRULWLHV
RQ WKLV VWXG\ +RZHYHU GDUNHU VNLQ SLJPHQWDWLRQ LV D VLJQLILFDQW SURWHFWLYH IDFWRU IRU WKH
GHYHORSPHQWRIPHODQRPD7KHLQFLGHQFHRIPHODQRPDLQ%ODFNVLVPRUHWKDQIROGORZHUWKDQ
&DXFDVLDQV7KLVZRXOGQHFHVVDULO\PHDQWKDW$IULFDQ$PHULFDQVDQGRWKHUHWKQLFJURXSVZLWK
GDUNHUVNLQSLJPHQWDWLRQZLOOEHXQGHUUHSUHVHQWHGLQSDWLHQWVHOLJLEOHIRUWKLVVWXG\

7RGDWHWKHUHLVQRLQIRUPDWLRQWKDWVXJJHVWVGLIIHUHQFHVLQLPPXQL]DWLRQRUGLVHDVHUHVSRQVH
ZRXOGEHH[SHFWHGLQRQHJURXSFRPSDUHGWRDQRWKHU(IIRUWVZLOOEHPDGHWRH[WHQGDFFUXDOWRD
UHSUHVHQWDWLYHSRSXODWLRQEXWLQWKLVSKDVHVWXG\DEDODQFHPXVWEHVWUXFNEHWZHHQSDWLHQWVDIHW\
FRQVLGHUDWLRQVDQGOLPLWDWLRQVRQWKHQXPEHURILQGLYLGXDOVH[SRVHGWRSRWHQWLDOO\WR[LFDQGRU
LQHIIHFWLYHWUHDWPHQWVRQWKHRQHKDQGDQGWKHQHHGWRH[SORUHJHQGHUDQGHWKQLFDVSHFWVRIFOLQLFDO
UHVHDUFKRQWKHRWKHUKDQG,QWKLVVPDOOSKDVHWULDOLWLVXQOLNHO\WKDWVLJQLILFDQWGLIIHUHQFHVLQ
RXWFRPHZRXOGEHGHWHFWHGWKDWFRUUHODWHZLWKJHQGHURUUDFLDOHWKQLFLGHQWLW\,IGLIIHUHQFHVLQ


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

RXWFRPHWKDWFRUUHODWHWRJHQGHURUWRUDFLDOHWKQLFLGHQWLW\DUHQRWHGDIROORZXSVWXG\PD\EH
ZULWWHQWRLQYHVWLJDWHWKRVHGLIIHUHQFHVPRUHIXOO\
11.2 Participation of Children

7KHRFFXUUHQFHRIPHODQRPDLQLQGLYLGXDOVOHVVWKDQ\HDUVRIDJHLVUDUHDQGXVXDOO\DVVRFLDWHG
ZLWKFRQJHQLWDOG\VSODVWLFQHYXVV\QGURPHV0LQRUVEHORZWKHDJHRIZLOOQRWEHHOLJLEOHIRU
WKLVSURWRFROEHFDXVHRIWKHOLPLWHGLQIRUPDWLRQDYDLODEOHRQWKHHIIHFWVDQGWR[LFLW\RIDQWLWXPRU
YDFFLQHV LQ FKLOGUHQ LQ SDUWLFXODU WKH H[WUHPHO\ OLPLWHG LQIRUPDWLRQ FRQFHUQLQJ DOORJHQHLF
H[SUHVVLRQRID*7LQDGXOWVDQGWKHFRPSOHWHODFNRIVDIHW\LQIRUPDWLRQRQWKHVHUHDJHQWVLQ
FKLOGUHQ
11.3 Evaluation of Benefits and Risks

7KHEHQHILWVRIWKLVLPPXQL]DWLRQDSSURDFKDUHWKHRUHWLFDODQGLWLVKRSHGWKDWWKHLQGXFWLRQRIDQ
DFXWHUHMHFWLRQUHVSRQVHWRWKHĮJDODFWRV\ODWHGUHVLGXHVRQWKHDOORJHQLFPHODQRPDFDQFHU
FHOOVXVHGWRLPPXQL]HWKHSDWLHQWZLOOOHDGWRFURVVUHFRJQLWLRQRIZHDNQDWLYHWXPRUDQWLJHQVRQ
WKHSDWLHQW¶VPHODQRPDFHOOVWKDWPD\EHVKDUHGZLWKWKHJHQHWLFDOO\HQJLQHHUHGLPPXQRWKHUDS\
FHOOV%\JHQHUDWLQJDQDQWLERG\DQGFHOOXODULPPXQHUHVSRQVHDJDLQVWWKHSDWLHQW
VWXPRULWLV
KRSHGWKDWWKHSDWLHQWPD\EHQHILWE\DWXPRUUHVSRQVH


*LYHQWKHVDIHW\GHPRQVWUDWHGZLWKWUDQVIHURIPXULQHUHWURYLUDOYHFWRUSURGXFHUFHOOVLQVHYHUDO
VWXGLHVWKDWQDWXUDOO\H[SUHVVWKHĮ*7HQ]\PHDQGKDYHĮJDODFWRV\ODWHGUHVLGXHVDQG
WKHSRRUSURJQRVLVRIWKLVSDWLHQWSRSXODWLRQLWLVEHOLHYHGWKDWWKHSRVVLEOHEHQHILWVIURPWXPRU
UHVSRQVHDQGLPSURYHGVXUYLYDOSUREDELOLW\IDURXWZHLJKWKHULVNWRWKHSDWLHQW7KHLQIRUPDWLRQ
REWDLQHG LQ WKLV VWXG\ PD\ EH H[WUHPHO\ YDOXDEOH LQ WKH WUHDWPHQW RI PHODQRPD DQG RWKHU
PDOLJQDQFLHVLQWKHIXWXUH7KHSDWLHQWVWREHHQWHUHGLQWKLVSURWRFROKDYHUHIUDFWRU\RUUHFXUUHQW
PHODQRPDDQGOLPLWHGOLIHH[SHFWDQFLHV7KHFKDQFHRIWKLVH[SHULPHQWDOWUHDWPHQWWRSURYLGH
FOLQLFDOEHQHILWLVXQNQRZQ$OOSRVVLEOHEHQHILWVDQGNQRZQULVNVZLOOEHFDUHIXOO\H[SODLQHGWR
DOOSDWLHQWVDQGDQ,QIRUPHG&RQVHQW'RFXPHQWZLOOEHVLJQHGE\WKHSDWLHQWSULRUWRHQWUDQFHLQWR
WKHSURWRFRO

7KHUHDUHQRDQWLFLSDWHGVHULRXVDGYHUVHVLGHHIIHFWVWRWKHLPPXQL]DWLRQWHFKQLTXHHPSOR\HGLQ
WKLVVWXG\7KHRUHWLFDOULVNVPD\LQFOXGHWKHLQGXFWLRQRIXQDQWLFLSDWHGDXWRLPPXQHGLVHDVHDQGRU
OLYHU NLGQH\ OXQJ KHDUW DQG &16 GDPDJH DQGRU FRDJXORSDWK\ DQG EOHHGLQJ DV D UHVXOW RI
H[FHVVLYHDFWLYDWLRQRIWKHFRPSOHPHQW&¶V\VWHP([SHFWHGULVNVDQGGLVFRPIRUWVWRWKHSDWLHQWV
DUHPLQLPDODQGZLOOEHWKRVHRIQHHGOHVWLFNVDQGSKOHERWRP\$QDFFHSWDEOHDGYHUVHHYHQWSURILOH
ZDVGHYHORSHGLQWKH3KDVH,SDUWRIWKHWULDO3DWLHQWVZLOOEHREVHUYHGIRURQHKRXUDIWHUHDFK
LPPXQL]DWLRQIRUDOOHUJLFK\SHUVHQVLWLYLW\UHDFWLRQV3DWLHQWVZLOOEHWUHDWHGDVGHHPHGPHGLFDOO\
DSSURSULDWHIRUDQ\LPPHGLDWHRUGHOD\HGDGYHUVHHYHQWUHODWHGWRWKHLPPXQL]DWLRQ

)LYH VLPLODU LQVWDQFHV LQYROYHG WKH GHYHORSPHQW RI DQ DJJUHVVLYH 7FHOO DFXWH O\PSKRF\WLF
OHXNHPLD 7$// WKDW FRQWDLQ D YHFWRU SURYLUDO LQVHUWLRQ DW D FKURPRVRPDO WUDQVORFDWLRQ
EUHDNSRLQWLQWKUHHFKLOGUHQWKDWXQGHUZHQWex vivoWUDQVGXFWLRQRI&'KHPDWRSRHLWLFVWHP
FHOOVZLWKD0RORQH\EDVHGUHWURYLUDOYHFWRULQDFOLQLFDOWULDOIRUWKHWUHDWPHQWRI;6&,':KLOH
PRVWFKLOGUHQZKRSDUWLFLSDWHGLQWKLVFOLQLFDOWULDODSSHDUWRKDYHEHHQFXUHGRIWKHLUGLVHDVH
RXWRIILYHFKLOGUHQGHYHORSHGWKHOHXNHPLDDSSUR[LPDWHO\WR\HDUVDIWHUWKHLUJHQH


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

WKHUDS\WUHDWPHQW([WHQVLYHWHVWLQJZDVGRQHWRGHWHUPLQHWKHFDXVHRIWKHOHXNHPLDDQGLWZDV
IRXQGWKDWWKHYLUXVXVHGWRGHOLYHUWKH;6&,'JHQHGLVUXSWHGDQRUPDOJHQHLQWKHERQHPDUURZ
FHOOVWKDWWKHQOHDGWRWKHGHYHORSPHQWRIOHXNHPLD2QHRIWKHVHFKLOGUHQKDVVLQFHGLHGRIWKHLU
OHXNHPLDDQGWKHORQJWHUPSURJQRVLVRIWKHRWKHUFKLOGUHQLVXQNQRZQDWWKLVWLPH

7KHVH$(¶VDUHQRWEHOLHYHGWREHUHOHYDQWWRWKHSUHVHQWWULDO7KLVWULDOLQYROYHVQHLWKHUWKHXVH
RIDGHQRYLUXVHVWKHGLUHFWDGPLQLVWUDWLRQRIOLYHUHWURYLUXVRUOLYHWUDQVGXFHGFHOOVWRWKHSDWLHQW
7KHex vivoDOORJHQHLFLPPXQRWKHUDS\FHOOVWUDQVGXFHGE\RXUYHFWRUDUHQRQYLDEOHDIWHUEHLQJ
LUUDGLDWHG
11.4 Consent Processes and Documents

$OOSDWLHQWVZLOOEHWKRURXJKO\VFUHHQHGSULRUWRDGPLVVLRQRQWRWKLVVWXG\'XULQJWKLVWLPHWKH
SDWLHQWDORQJZLWKIDPLO\PHPEHUVZLOOEHSUHVHQWHGZLWKDGHWDLOHGGHVFULSWLRQRIWKHSURWRFRO
WUHDWPHQW7KHVSHFLILFUHTXLUHPHQWVREMHFWLYHVULVNVDQGEHQHILWVZLOOEHUHYLHZHGZLWKWKH
SDWLHQW7KH,QIRUPHG&RQVHQWGRFXPHQWZLOOEHJLYHQWRWKHSDWLHQWDQGWKH\DUHDVNHGWRUHYLHZ
LWDQGDVNTXHVWLRQVSULRUWRDJUHHLQJWRSDUWLFLSDWHLQWKLVSURWRFRO7KHSDWLHQWZLOOEHUHDVVXUHG
WKDWSDUWLFLSDWLRQRQWKLVWULDOLVHQWLUHO\YROXQWDU\DQGWKDWWKH\FDQZLWKGUDZRUGHFLGHDJDLQVW
WUHDWPHQWDWDQ\WLPHZLWKRXWDGYHUVHFRQVHTXHQFHV7KH3ULQFLSDO,QYHVWLJDWRURUWKHLUGHVLJQHH
LVUHVSRQVLEOHIRUFRPSOHWLQJWKHFRQVHQWSURFHVVDQGDFRS\RIWKHFRPSOHWHG&RQVHQW'RFXPHQW
LVRIIHUHGWRWKHSDWLHQW
11.5 Recruitment Strategy

3DWLHQWVWKHLUSK\VLFLDQVRUIDPLO\PHPEHUVPD\FRQWDFWWKH3ULQFLSDO,QYHVWLJDWRURUDGHVLJQDWHG
DVVRFLDWH LQYHVWLJDWRU UHVSRQVLEOH IRU WKLV SURWRFRO  *LYHQ WKH ODUJH QXPEHU RI SDWLHQWV ZLWK
PHODQRPDDQGWKHOLPLWHGWKHUDS\DYDLODEOHIRUDGYDQFHGGLVHDVHZHEHOLHYHUHFUXLWPHQWIRUWKLV
WULDOZLOOEHUDSLG$Q,5%DSSURYHGLQIRUPDWLRQDOPDLOLQJDQQRXQFLQJWKHDYDLODELOLW\RIWKLV
VWXG\ ZLOO EH VHQW WR WKH FOLQLFDO RQFRORJ\ FRPPXQLW\ 7KH VWXG\ ZLOO EH UHJLVWHUHG ZLWK WKH
FOLQLFDOWULDOVJRYZHEVLWHGDWDEDVH
11.6 Patient Confidentiality

6WULFWSDWLHQWFRQILGHQWLDOLW\LVVWDQGDUGSROLF\DWWKHSDUWLFLSDWLQJFOLQLFDOVLWHV6WDQGDUGSUDFWLFHV
ZLOOEHVWULFWO\IROORZHGDQGDGKHUHGWR
 67$7,67,&$/&216,'(5$7,216
12.1 Sample Size

7KLV VWXG\ ZDV RULJLQDOO\ GHVLJQHG WR FRPSDUH WKH UHVSRQVH UDWHV EHWZHHQ WKH FRPELQHG
GRUJHQPHOWXFHO/SOXVLPPXQHFKHFNSRLQWWKHUDS\DUPWRWKHLPPXQHFKHFNSRLQWWKHUDS\DUP
DORQH  'XULQJ WKLV VWXG\ HQUROOPHQW ZLOO LQFOXGH D WRWDO RI HYDOXDEOH SDWLHQWV DFURVV
WUHDWPHQWDUPV



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

$VVXPLQJDGLVHDVHFRQWUROUDWHRI:ROFKRNet al.LQWKHLPPXQHFKHFNSRLQWPRQRWKHUDS\
DUPDQGDFRPELQHGDUPUHVSRQVHUDWHRIDWRWDORISDWLHQWVUDWLRZLOOEHUHTXLUHG
WRDVVHVVVXSHULRULW\RIUHVSRQVHUDWHZLWKSRZHUDQGWZRVLGHGDOSKDRI

$VWKHSULPDU\HQGSRLQWKDVEHHQFKDQJHGIURPRYHUDOOUHVSRQVHUDWHWR3)6SDWLHQWVSHU
WUHDWPHQWDUPSDWLHQWVWRWDOZLOOSURYLGHSRZHUWRGHWHFWDKD]DUGUDWLRRIDQG
SRZHUWRGHWHFWDKD]DUGUDWLRRIDVVXPLQJWKHLPPXQHFKHFNSRLQWPRQRWKHUDS\
FRQWURODUPKDVDPHGLDQWLPHWRGLVHDVHSURJUHVVLRQRIPRQWKVDQGDWZRVLGHGW\SH,HUURUUDWH
RI$WRWDORIHYHQWVDUHUHTXLUHGIRUDQDO\VLV

12.2 Blinding and Randomization 
7KLV LV DQ RSHQODEHO UDQGRPL]HG VWXG\ 3DWLHQWV ZLOO EH UDQGRPL]HG WR UHFHLYH LPPXQH
FKHFNSRLQWWKHUDS\SOXVGRUJHQPHOWXFHO/RULPPXQHFKHFNSRLQWWKHUDS\DORQHLQDUDWLR
3DWLHQWVHQUROOHGLQWKLVDQGODWHUSURWRFRODPHQGPHQWVZLOOEHVWUDWLILHGE\WUHDWPHQWFKRLFHDQG
GLVHDVHVWDWXVDQGFDWHJRUL]HGDVIROORZV
 3DWLHQWVZLWKXQUHVHFWDEOHDGYDQFHGGLVHDVH
 3DWLHQWV ZLWK UHVHFWDEOH DGYDQFHG GLVHDVH ZKR UHFHLYH WKH LPPXQRWKHUDS\ LQ
DGYDQFHRIUHVHFWLRQ
 3DWLHQWVZLWKUHVHFWHGLVRODWHGDGYDQFHGGLVHDVHZKRDUHWUHDWHGLQDQRDSSDUHQW
GLVHDVH1$'VWDWH

:LWKVXIILFLHQWVDPSOHVL]HHQUROOHGSHUGLVHDVHVWDWXVFDWHJRU\WKHUDQGRPL]DWLRQSURFHVVLV
GHVLJQHGWRSURYLGHEDODQFHEHWZHHQWKHWZRWUHDWPHQWDUPVZLWKLQHDFKRIWKHGLVHDVHVWDWXV
FDWHJRULHV7KHQXPEHURISDWLHQWVLQHDFKVWUDWXPZLOOQRWEHUHVWULFWHG

3DWLHQWVHQUROOHGLQ3URWRFRO9HUVLRQZHUHQRWVWUDWLILHGKRZHYHUWKHGLVHDVHVWDWXVFULWHULDRI
WKHVHSDWLHQWVZLOOEHFROOHFWHGWRSURSHUO\DFFRXQWIRUWKHUDQGRPL]DWLRQVWUDWDLQWKHVWDWLVWLFDO
DQDO\VLV)XUWKHUGHWDLOVUHJDUGLQJWKHUDQGRPL]DWLRQSURFHGXUHDUHDYDLODEOHLQWKH5DQGRPL]DWLRQ
3ODQ

12.3 Statistical Methodology

7DEXODWLRQV ZLOO EH SURGXFHG IRU DSSURSULDWH GHPRJUDSKLF EDVHOLQH HIILFDF\ DQG VDIHW\
SDUDPHWHUV)RUFDWHJRULFDOYDULDEOHVVXPPDU\WDEXODWLRQVRIWKHQXPEHUVDQGSHUFHQWDJHVRI
SDWLHQWVZLWKLQHDFKFDWHJRU\ZLWKDFDWHJRU\IRUPLVVLQJGDWDRIWKHSDUDPHWHUZLOOEHSUHVHQWHG
3HUFHQWDJHVZLOOEHEDVHGRQQRQPLVVLQJGDWD)RUFRQWLQXRXVYDULDEOHVWKHQXPEHURIVXEMHFWV
PHDQPHGLDQVWDQGDUGGHYLDWLRQ6WG'HYPLQLPXPDQGPD[LPXPYDOXHVZLOOEHSUHVHQWHG
7LPHWRHYHQW GDWD ZLOO EH VXPPDUL]HG XVLQJ WK WK PHGLDQ DQG WK SHUFHQWLOHV ZLWK
DVVRFLDWHG VLGHG  FRQILGHQFH LQWHUYDOV DV ZHOO DV SHUFHQWDJH RI FHQVRUHG REVHUYDWLRQV
4XDUWLOHV DQG FRQILGHQFH LQWHUYDOV ZLOO EH HVWLPDWHG XVLQJ SURGXFWOLPLW .DSODQ0HLHU
PHWKRGRORJ\

3RSXODWLRQVWREH$QDO\]HG
7KHSULPDU\SRSXODWLRQIRUHIILFDF\ZLOOEHWKHIXOODQDO\VLVVHW)$6GHILQHGDVDOOUDQGRPL]HG
VXEMHFWV,QWKH)$6SDWLHQWVZLOOEHDQDO\]HGLQWKHWUHDWPHQWJURXSWRZKLFKWKH\ZHUHDVVLJQHG


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

7KHSULPDU\SRSXODWLRQIRUVDIHW\DQDO\VHVZLOOEHWKHVDIHW\DQDO\VLVVHWGHILQHGDVDOOUDQGRPL]HG
VXEMHFWVZKRUHFHLYHDWOHDVWRQHDGPLQLVWUDWLRQRIVWXG\WUHDWPHQWGRUJHQPHOWXFHO/RULPPXQH
FKHFNSRLQWWKHUDS\

'HPRJUDSKLFDQG%DVHOLQH&KDUDFWHULVWLFV
'HPRJUDSKLFDQGEDVHOLQHGLVHDVHFKDUDFWHULVWLFGDWDVXPPDUL]DWLRQZLOOEHSHUIRUPHGLQRUGHUWR
GHVFULSWLYHO\DVVHVVWKHFRPSDUDELOLW\RIGRVHJURXSV'DWDWREHWDEXODWHGZLOOLQFOXGHVH[DJH
DQGUDFHDVZHOODVGLVHDVHVSHFLILFLQIRUPDWLRQ

(IILFDF\$QDO\VHV
7KHSULPDU\HIILFDF\HQGSRLQWLV3)6ZKHUHGLVHDVHSURJUHVVLRQLVGHILQHGDFFRUGLQJWR5(&,67
Y3URJUHVVLRQIUHHVXUYLYDOZLOOEHVXPPDUL]HGXVLQJWKH.DSODQ0HLHUPHWKRGRIHVWLPDWLRQ
LQFOXGLQJWKHWKWKDQGWKSHUFHQWLOHVRIWLPHWRSURJUHVVLRQZLWKFRQILGHQFHLQWHUYDOV
.DSODQ0HLHUSORWVZLOOEHSURGXFHGE\GLVHDVHVWDWXVVWUDWDWRH[DPLQHWKHGLIIHUHQFHLQUHVSRQVH
UDWHVEHWZHHQWUHDWPHQWJURXSV$VWUDWLILHGORJUDQNWHVWZLOOEHDSSOLHGWRWHVWIRUWUHDWPHQWHIIHFW
RQ3)6

2YHUDOOUHVSRQVHUDWHLVGHILQHGDVVXEMHFWVZLWKDEHVWRYHUDOOUHVSRQVHRIDWOHDVWVWDEOHGLVHDVH
6XEMHFWV¶ EHVW RYHUDOO UHVSRQVH DV GHWHUPLQHG E\ WKH LQYHVWLJDWRU IURP 5(&,67 ZLOO EH
VXPPDUL]HGE\SUHVHQWLQJWKHQXPEHUVDQGSHUFHQWDJHVRIVXEMHFWVLQHDFKUHVSRQVHFDWHJRU\7KH
RYHUDOOUHVSRQVHUDWHZLOOEHVXPPDUL]HGVLPLODUO\1LQHW\ILYHSHUFHQWFRQILGHQFHLQWHUYDOV&,V
ZLOOEHFRQVWUXFWHGIRUWKHRYHUDOOUHVSRQVHUDWH

7KHGXUDWLRQRIRYHUDOOUHVSRQVHLVPHDVXUHGIURPWKHWLPHPHDVXUHPHQWFULWHULDDUHPHWIRU&5
RU35ZKLFKHYHULVILUVWUHFRUGHGDFFRUGLQJWR5(&,67YXQWLOWKHILUVWGDWHWKDWUHFXUUHQWRU
SURJUHVVLYHGLVHDVHLVREMHFWLYHO\GRFXPHQWHGWDNLQJDVUHIHUHQFHIRUSURJUHVVLYHGLVHDVHWKH
VPDOOHVWPHDVXUHPHQWVUHFRUGHGVLQFHWKHWUHDWPHQWVWDUWHG'XUDWLRQRIRYHUDOOUHVSRQVHZLOOEH
DQDO\]HGLQDVLPLODUPDQQHUWR3)6

'XUDWLRQ RI VWDEOH GLVHDVH LV PHDVXUHG IURP WKH VWDUW RI WKH WUHDWPHQW XQWLO WKH FULWHULD IRU
SURJUHVVLRQDUHPHWDFFRUGLQJWR5(&,67YWDNLQJDVUHIHUHQFHWKHVPDOOHVWPHDVXUHPHQWV
UHFRUGHGVLQFHWKHWUHDWPHQWVWDUWHGLQFOXGLQJWKHEDVHOLQHPHDVXUHPHQWV'XUDWLRQRIVWDEOH
GLVHDVHZLOOEHDQDO\]HGLQDVLPLODUPDQQHUWR3)6

2YHUDOOVXUYLYDOLVGHILQHGDVWKHWLPHWRGHDWKRUODVWFRQWDFWDQGZLOOEHVXPPDUL]HGLQDVLPLODU
PDQQHUWR3)6

$VDGGLWLRQDOVHFRQGDU\HQGSRLQWVDQDO\VLVRI3)6RYHUDOOUHVSRQVHUDWHGXUDWLRQRIRYHUDOO
UHVSRQVHDQGGXUDWLRQRIVWDEOHGLVHDVHZLOOEHUHSHDWHGXVLQJWKHLU5&FULWHULDWRLGHQWLI\GLVHDVH
UHVSRQVH

/RQJLWXGLQDOLPPXQRORJLFDOPHDVXUHPHQWVZLOOEHDQDO\]HGXVLQJOLQHDUPL[HGPRGHOUHJUHVVLRQ
DQDO\VLV WR H[DPLQH WKH FKDQJHV LQ LPPXQRORJLFDO PHDVXUHPHQWV RYHU WLPH DV ZHOO DV WR
XQGHUVWDQG GLIIHUHQFHV EHWZHHQ WUHDWPHQW JURXSV LQ LPPXQRORJLFDO UHVSRQVHV RYHU WLPH  $Q
LQWHUDFWLRQWHUPEHWZHHQGLVHDVHVWDWXVFDWHJRU\DQGWUHDWPHQWJURXSZLOOEHWHVWHGWRGHWHUPLQH
LIWKHUHLVDGLIIHUHQWLDODVVRFLDWLRQEHWZHHQVWUDWD





1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

0XOWLSOLFLW\,VVXHV
1RDGMXVWPHQWVIRUPXOWLSOHFRPSDULVRQVDUHUHTXLUHGIRUWKHSULPDU\HIILFDF\DQDO\VLVVLQFHD
VLQJOHSULPDU\RXWFRPHYDULDEOHKDVEHHQVSHFLILHG1RIRUPDOK\SRWKHVLVWHVWLQJZLOOEHDSSOLHG
WRWKHVHFRQGDU\HIILFDF\HQGSRLQWV

0LVVLQJ'DWD
,QJHQHUDOWKHUHZLOOEHQRVXEVWLWXWLRQVPDGHWRDFFRPPRGDWHPLVVLQJGDWDSRLQWV$OOGDWD
UHFRUGHGRQWKHFDVHUHSRUWIRUPZLOOEHLQFOXGHGLQGDWDOLVWLQJVWKDWZLOODFFRPSDQ\WKHFOLQLFDO
VWXG\UHSRUW)RUDQDO\VLVRIWLPHWRHYHQWHQGSRLQWVVXEMHFWVZKRKDYHQRHIILFDF\HYDOXDWLRQV
ZLOOEHFRQVLGHUHGFHQVRUHGDWWLPH,PSXWDWLRQUXOHVIRUVSHFLILFHIILFDF\HQGSRLQWVZLOOEH
GHWDLOHGLQWKHVWDWLVWLFDODQDO\VLVSODQ

6DIHW\$QDO\VHV
$GYHUVHHYHQWVZLOOEHVXPPDUL]HGE\0HG'5$V\VWHPRUJDQFODVVDQGSUHIHUUHGWHUP6HSDUDWH
WDEXODWLRQVZLOOEHSURGXFHGIRUDOOWUHDWPHQWHPHUJHQWDGYHUVHHYHQWVWUHDWPHQWUHODWHGDGYHUVH
HYHQWVWKRVHFRQVLGHUHGE\WKH,QYHVWLJDWRUDVDWOHDVWSRVVLEO\GUXJUHODWHGVHULRXVDGYHUVH
HYHQWVGLVFRQWLQXDWLRQVGXHWRDGYHUVHHYHQWVDQGDGYHUVHHYHQWVRIDWOHDVW*UDGHVHYHULW\
%\SDWLHQW OLVWLQJV ZLOO EH SURYLGHG IRU GHDWKV VHULRXV DGYHUVH HYHQWV DQG HYHQWV OHDGLQJ WR
GLVFRQWLQXDWLRQRIWUHDWPHQW

'HVFULSWLYHVWDWLVWLFVZLOOEHSURYLGHGIRUFOLQLFDOODERUDWRU\GDWDDQGYLWDOVLJQVGDWDSUHVHQWHGDV
ERWKDFWXDOYDOXHVDQGFKDQJHVIURPEDVHOLQHUHODWLYHWRHDFKRQVWXG\HYDOXDWLRQDQGWRWKHODVW
HYDOXDWLRQRQVWXG\

,Q DGGLWLRQ VKLIW WDEOHV RI ODERUDWRU\ GDWD IURP EDVHOLQH WR ZRUVW YDOXH RQ WUHDWPHQW ZLOO EH
SUHVHQWHGEDVHGRQ&7&$(YJUDGLQJ
 $GPLQLVWUDWLYHDQG5HJXODWRU\&RQVLGHUDWLRQV
13.1 Regulatory Compliance/Good Clinical Practices

7KLV VWXG\ ZLOO EH FRQGXFWHG LQ DFFRUGDQFHZLWK WKH IROORZLQJ UHJXODWLRQV DQG JXLGHOLQHV WR
LQFOXGHEXWQRWOLPLWHGWR
x 'HFODUDWLRQRI+HOVLQNL2FWREHU
x &XUUHQW,&+*XLGHOLQHIRU*RRG&OLQLFDO3UDFWLFH
x &)53URWHFWLRQRI+XPDQ6XEMHFWV
x &)5)LQDQFLDO'LVFORVXUHE\&OLQLFDO,QYHVWLJDWRUV
x &)5,QVWLWXWLRQDO5HYLHZ%RDUGV
x &)5,QYHVWLJDWLRQDO1HZ'UXJ$SSOLFDWLRQ
x 'HDU*HQH7KHUDS\,1'RU0DVWHU)LOH6SRQVRU/HWWHU
x 'HDU*HQH7KHUDS\,1'6SRQVRU3ULQFLSDO,QYHVWLJDWRU/HWWHU
x /HWWHUWR6SRQVRUV5HVHDUFKHUV+XPDQ&HOOV8VHGLQ7KHUDS\,QYROYLQJWKH7UDQVIHURI
*HQHWLF0DWHULDOE\0HDQV2WKHU7KDQWKH8QLRQLI*DPHWH1XFOHL
x *XLGDQFHIRU,QGXVWU\*XLGDQFHIRU+XPDQ6RPDWLF&HOO7KHUDS\DQG*HQH
7KHUDS\


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

13.2 Regulatory Documentation

3ULRU WR VWXG\ VWDUWXS LQYHVWLJDWRUV ZLOO FROOHFW WKH IROORZLQJ GRFXPHQWV DV RXWOLQHG LQ WKH
(VVHQWLDO'RFXPHQWV6HFWLRQRIWKH,&+*XLGHOLQHVIRU*RRG&OLQLFDO3UDFWLFH

x 6LJQHG&RQILGHQWLDOLW\$JUHHPHQW
x 6LJQHG&OLQLFDO7ULDO$JUHHPHQWLIDSSOLFDEOH
x 8SWRGDWHVLJQHGDQGGDWHG&XUULFXOXP9LWDHDQGFRSLHVRIPHGLFDOOLFHQVHVIRUDOO
LQYHVWLJDWRUVWREHVXEPLWWHGSURPSWO\
x )LQDQFLDO'LVFORVXUHIRUPIRU3ULQFLSDODQGRQHVXEFRLQYHVWLJDWRUZLWKILQDQFLDO
GLVFORVXUHIRUPVIRUDOOLQYHVWLJDWRUVWREHVXEPLWWHGSURPSWO\
x )'$)RUP
x ,5%DSSURYDOWRFRQGXFWWKHVWXG\,5%DSSURYHG,QIRUPHG&RQVHQW)RUP
x 1DPHDQGDGGUHVVRIWKH,5%ZLWKWKHVWDWHPHQWWKDWLWLVRUJDQL]HGDQGRSHUDWHV
DFFRUGLQJWR*&3DQGWKHDSSOLFDEOHODZVDQGUHJXODWLRQV
x ,5%PHPEHUVKLSURVWHU
x /RFDOODERUDWRU\FHUWLILFDWLRQVLWVQDPHDQGDGGUHVV
x /RFDOODERUDWRU\QRUPDOUDQJHVDGDWHGFRS\IRUWHVWVWREHSHUIRUPHGGXULQJWKHVWXG\
x )LQDQFLDODJUHHPHQWLIDSSOLFDEOH
x 6LJQHGDQGGDWHG,QYHVWLJDWRU$JUHHPHQWSDJHRIWKHILQDOSURWRFRODQGDPHQGPHQWV
ZKHUHDSSOLFDEOH
13.3 Institutional Review Board (IRB)

7KLVWULDOZLOOEHXQGHUWDNHQRQO\DIWHUIXOODSSURYDORIWKHSURWRFRODQGDGGHQGDKDVEHHQREWDLQHG
IURPDORFDO,5%DQGDFRS\RIWKLVDSSURYDOKDVEHHQUHFHLYHGE\WKHVSRQVRU7KH,5%PXVWEH
LQIRUPHGRIDOOVXEVHTXHQWSURWRFRODPHQGPHQWVLVVXHGE\WKHVSRQVRU5HSRUWVRQDQGUHYLHZV
RIWKHWULDODQGLWVSURJUHVVZLOOEHVXEPLWWHGWRWKH,5%E\WKHLQYHVWLJDWRUDWLQWHUYDOVVHWIRUFH
LQLWVJXLGHOLQHV
13.4 Informed Consent

(DFKSDWLHQWPXVWJLYHZULWWHQFRQVHQWDQGVLJQRWKHUORFDOO\UHTXLUHGGRFXPHQWVDIWHUWKHQDWXUH
RI WKH VWXG\ KDV EHHQ IXOO\ H[SODLQHG  7KH LQIRUPHG FRQVHQW IRUP PXVW EH VLJQHG SULRU WR
SHUIRUPDQFH RI DQ\ VWXG\UHODWHG DFWLYLW\  7KH LQIRUPHG FRQVHQW IRUP WKDW LV XVHG PXVW EH
DSSURYHGERWKE\WKHVSRQVRUDQGE\WKHUHYLHZLQJ,5%7KH,QIRUPHG&RQVHQWVKRXOGEHLQ
DFFRUGDQFHZLWKWKH'HFODUDWLRQRI+HOVLQNLFXUUHQW,QWHUQDWLRQDO&RQIHUHQFHRQ+DUPRQL]DWLRQ
,&+DQG*RRG&OLQLFDO3UDFWLFHV*&3JXLGHOLQHV
13.5 Administrative Requirements

3URWRFROPRGLILFDWLRQV
7KHLQYHVWLJDWRUZLOOQRWPRGLI\WKLVSURWRFROZLWKRXWREWDLQLQJSHUPLVVLRQIURPWKHVSRQVRU$OO
SURWRFRODPHQGPHQWVPXVWEHLVVXHGE\WKHVSRQVRUVLJQHGDQGGDWHGE\WKHLQYHVWLJDWRUDQG
VKRXOG QRW EH LPSOHPHQWHG ZLWKRXW SULRU ,5% DSSURYDO H[FHSW ZKHUH QHFHVVDU\ WR HOLPLQDWH
LPPHGLDWHKD]DUGVWRWKHSDWLHQWVRUZKHQWKHFKDQJHVLQYROYHVRQO\ORJLVWLFDORUDGPLQLVWUDWLYH


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

DVSHFWV RI WKH WULDO HJ FKDQJH LQ PRQLWRUV FKDQJH RI WHOHSKRQH QXPEHUV ,Q VLWXDWLRQV
UHTXLULQJDPRGLILFDWLRQWKHLQYHVWLJDWRURURWKHUSK\VLFLDQLQDWWHQGDQFHZLOOFRQWDFWWKHPHGLFDO
PRQLWRUE\ID[RUWHOHSKRQHVHH&RQWDFW,QIRUPDWLRQSDJH7KLVFRQWDFWPXVWEHPDGHSULRUWR
LPSOHPHQWLQJDQ\GHSDUWXUHIURPSURWRFRO&RQWDFWZLWKWKHVSRQVRUPXVWEHPDGHDVVRRQDV
SRVVLEOHLQRUGHUWRRXWOLQHDQDSSURSULDWHFRXUVHRIDFWLRQ

5HFRUG5HWHQWLRQ
,QFRPSOLDQFHZLWKWKH,&+*&3JXLGHOLQHVWKHLQYHVWLJDWRULQVWLWXWLRQZLOOPDLQWDLQDOO&5)VDQG
DOOVRXUFHGRFXPHQWVWKDWVXSSRUWWKHGDWDFROOHFWHGIURPHDFKSDWLHQWDQGDOOWULDOGRFXPHQWVDV
VSHFLILHG LQ (VVHQWLDO 'RFXPHQWV IRU WKH &RQGXFW RI D &OLQLFDO7ULDO DQG DV VSHFLILHG E\ WKH
DSSOLFDEOHUHJXODWRU\UHTXLUHPHQWV7KHLQYHVWLJDWRULQVWLWXWLRQZLOOWDNHPHDVXUHVWRSUHYHQW
DFFLGHQWDORUSUHPDWXUHGHVWUXFWLRQRIWKHVHGRFXPHQWV(VVHQWLDOGRFXPHQWVPXVWEHUHWDLQHG
XQWLODWOHDVWWZR\HDUVDIWHUWKHODVWDSSURYDORIDPDUNHWLQJDSSOLFDWLRQLQDQ,&+UHJLRQRUDW
OHDVW WZR \HDUV KDYH HODSVHG VLQFH WKH IRUPDO GLVFRQWLQXDWLRQ RI FOLQLFDO GHYHORSPHQW RI WKH
LQYHVWLJDWLRQDOSURGXFW7KHVHGRFXPHQWVZLOOEHUHWDLQHGIRUDORQJHUSHULRGLIUHTXLUHGE\WKH
DSSOLFDEOHUHJXODWRU\UHTXLUHPHQWV

&DVH5HSRUW)RUP&5)&RPSOHWLRQ
&5)VDUHSURYLGHGIRUHDFKSDWLHQW'DWDPXVWEHHQWHUHGRQWR&5)VLQ(QJOLVK$OOIRUPVPXVW
EHILOOHGRXWLQEODFNEDOOSRLQWSHQ&5)VPXVWEHVLJQHGE\WKHLQYHVWLJDWRUZKHUHLQGLFDWHG

$OO&5)FRUUHFWLRQVDUHWREHPDGHE\WKHLQYHVWLJDWRURURWKHUDXWKRUL]HGVWXG\FHQWHUSHUVRQQHO
DVLQVWUXFWHGRQWKH&5)WLWOHSDJH7KHLQYHVWLJDWRUPXVWDXWKRUL]HFKDQJHVWRWKHUHFRUGHGVDIHW\
DQGHIILFDF\GDWD

0RQLWRULQJ
1HZ/LQN*HQHWLFVVSRQVRUZLOOSHUIRUPRQVLWHPRQLWRULQJYLVLWVDVRXWOLQHGLQWKH0RQLWRULQJ
3ODQIRUWKLVFOLQLFDOWULDO7KHGDWHVRIWKHYLVLWVZLOOEHUHFRUGHGE\WKHPRQLWRULQDWULDOFHQWHU
ZLWKWKHPRQLWRUYLVLWRU¶VORJWREHNHSWDWWKHVLWH7KHILUVWURXWLQHPRQLWRULQJYLVLWZLOOXVXDOO\
EHPDGHZLWKLQZHHNVDIWHUHQUROOPHQWKDVEHJXQDWWKDWVLWH$WWKHVHYLVLWVWKHPRQLWRUZLOO
YHULI\WKHGDWDHQWHUHGRQWRWKH&5)VZLWKWKHKRVSLWDORUFOLQLFUHFRUGVVRXUFHGRFXPHQWVDQG
IROORZ WKH SURFHGXUHV DV RXWOLQHG LQ 1HZ/LQN *HQHWLFV 623V  $W D PLQLPXP VRXUFH
GRFXPHQWDWLRQ PXVW EH DYDLODEOH WR VXEVWDQWLDWH SDWLHQW HOLJLELOLW\ DQG SDUWLFLSDWLRQ SURSHU
LQIRUPHG FRQVHQW SURFHGXUHVDGKHUHQFHWRSURWRFROSURFHGXUHVUHFRUG RI VDIHW\ DQG HIILFDF\
SDUDPHWHUVDGHTXDWHUHSRUWLQJDQGIROORZXSRIDGYHUVHHYHQWVDGPLQLVWUDWLRQRIFRQFRPLWDQW
PHGLFDWLRQGUXJUHFHLSWGLVSHQVLQJUHWXUQUHFRUGVVWXG\PHGLFDWLRQDGPLQLVWUDWLRQLQIRUPDWLRQ
DQGGDWHRIFRPSOHWLRQDQGUHDVRQ6SHFLILFLWHPVUHTXLUHGDVVRXUFHGRFXPHQWVZLOOEHUHYLHZHG
ZLWKWKHLQYHVWLJDWRUSULRUWRWKHVWXG\)LQGLQJVIURPWKLVUHYLHZRI&5)VDQGVRXUFHGRFXPHQWV
ZLOOEHRXWOLQHGLQD6LWH9LVLW5HSRUWDQGGLVFXVVHGZLWKWKHLQYHVWLJDWRU7KHVSRQVRUH[SHFWV
WKDWGXULQJPRQLWRULQJYLVLWVWKHLQYHVWLJDWRUDQGDVDSSURSULDWHWKHVWXG\FRRUGLQDWRUZLOOEH
DYDLODEOHWKHVRXUFHGRFXPHQWVZLOOEHDYDLODEOHDQGDVXLWDEOHHQYLURQPHQWZLOOEHSURYLGHGIRU
UHYLHZRIVWXG\UHODWHGGRFXPHQWV

'DWD4XDOLW\$VVXUDQFH
6WHSVWREHWDNHQWRDVVXUHWKHDFFXUDF\DQGUHOLDELOLW\RIGDWDLQFOXGHWKHVHOHFWLRQRITXDOLILHG
LQYHVWLJDWRUVUHYLHZRISURWRFROSURFHGXUHVZLWKWKHLQYHVWLJDWRUDQGDVVRFLDWHGSHUVRQQHOSULRU
WRWKHVWXG\DQGSHULRGLFPRQLWRULQJYLVLWVE\WKHVSRQVRU&5)VZLOOEHUHYLHZHGIRUDFFXUDF\
DQGFRPSOHWHQHVVE\WKHVSRQVRUGXULQJRQVLWHPRQLWRULQJYLVLWVDQGDIWHUUHWXUQRI&5)VWRWKH


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

VSRQVRU DQ\ GLVFUHSDQFLHV ZLOO EH UHVROYHG ZLWK WKH LQYHVWLJDWRU RU GHVLJQHHV SHU 1HZ/LQN
*HQHWLFV623V

2Q6LWH$XGLWV
5HSUHVHQWDWLYHVRIWKHVSRQVRU¶V&OLQLFDO4XDOLW\$VVXUDQFHGHSDUWPHQWPD\YLVLWWKHVLWHWRFDUU\
RXWDQDXGLWRIWKHVWXG\LQFRPSOLDQFHZLWKUHJXODWRU\JXLGHOLQHVDQGFRPSDQ\SROLF\6XFKDXGLWV
ZLOOUHTXLUHDFFHVVWRDOOVWXG\UHFRUGVLQFOXGLQJVRXUFHGRFXPHQWVIRULQVSHFWLRQDQGFRPSDULVRQ
ZLWKWKH&5)V$OOHIIRUWVZLOOEHPDGHWRSUHVHUYHSDWLHQWSULYDF\6XIILFLHQWSULRUQRWLFHZLOOEH
SURYLGHGWRDOORZWKHLQYHVWLJDWRUSURSHUSUHSDUDWLRQIRUWKHDXGLW$XGLWLQJSURFHGXUHVPD\DOVR
EHFRQGXFWHGE\DQ\UHJXODWRU\ERG\7KHLQYHVWLJDWRUVKRXOGLPPHGLDWHO\QRWLI\WKHVSRQVRU
DERXWDQ\DXGLW

8VHRI,QIRUPDWLRQDQG3XEOLFDWLRQ
$OOLQIRUPDWLRQRQ+\SHU$FXWHFDQFHULPPXQRWKHUDS\1HZ/LQNRSHUDWLRQVSDWHQWDSSOLFDWLRQ
PDQXIDFWXULQJSURFHVVEDVLFVFLHQWLILFGDWDVXSSOLHGE\WKHVSRQVRUWRWKHLQYHVWLJDWRUDQGQRW
SUHYLRXVO\ SXEOLVKHG LV FRQVLGHUHG FRQILGHQWLDO DQG UHPDLQV WKH VROH SURSHUW\ RI 1HZ/LQN
*HQHWLFV7KHLQYHVWLJDWRUDJUHHVWRXVHWKLVLQIRUPDWLRQRQO\WRDFFRPSOLVKWKLVVWXG\DQGZLOO
QRWXVHLWIRURWKHUSXUSRVHVZLWKRXWWKHVSRQVRU¶VZULWWHQFRQVHQW

7KHLQYHVWLJDWRUXQGHUVWDQGVWKDWWKHLQIRUPDWLRQGHYHORSHGLQWKHFOLQLFDOVWXG\ZLOOEHXVHGE\
1HZ/LQNLQFRQQHFWLRQZLWKWKHFRQWLQXHGGHYHORSPHQWRI+\SHU$FXWHLPPXQRWKHUDS\DQGWKXV
PD\EHGLVFORVHGDVUHTXLUHGWRRWKHUFOLQLFDOLQYHVWLJDWRUVRUJRYHUQPHQWUHJXODWRU\DJHQFLHV7R
SHUPLWWKHLQIRUPDWLRQGHULYHGIURPWKHFOLQLFDOVWXGLHVWREHXVHGWKHLQYHVWLJDWRULVREOLJDWHGWR
SURYLGHWKHVSRQVRUZLWKDOOGDWDREWDLQHGLQWKHVWXG\

$Q\SXEOLFDWLRQRURWKHUSXEOLFSUHVHQWDWLRQRIUHVXOWVIURPWKLVVWXG\UHTXLUHVSULRUUHYLHZRI
1HZ/LQN *HQHWLFV 'UDIW DEVWUDFWV PDQXVFULSWV DQG PDWHULDOV IRU SUHVHQWDWLRQ DW VFLHQWLILF
PHHWLQJVVKRXOGEHSURYLGHGWRWKHVSRQVRUDWOHDVWZRUNLQJGD\VSULRUWRDEVWUDFWRURWKHU
UHOHYDQWVXEPLVVLRQGHDGOLQHVRUDVRXWOLQHGLQWKHFOLQLFDOWULDODJUHHPHQW



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

 $33(1',&(6
14.1 APPENDIX A:  AJCC Staging of Melanoma
$-&&&DQFHU6WDJLQJ+DQGERRN6HYHQWK(GLWLRQ

7KH$-&&VWDJLQJV\VWHPLVEDVHGRQWKUHHVHWVRIFULWHULDKRZWKLFNWKHWXPRULV7WKHH[WHQW
WRZKLFKLWKDVVSUHDGWRWKHO\PSKQRGHV1DQGWKHH[WHQWWRZKLFKLWKDVPHWDVWDVL]HGWRRWKHU
SDUWVRIWKHERG\07KH$-&&VWDJLQJV\VWHPLVRXWOLQHGEHORZZLWKWKH710SDUDPHWHUV
&OLQLFDO6WDJLQJ
3DWKRORJLFDO6WDJLQJ
6WDJH
7LV
1
0
6WDJH
7LV
1
0
6WDJH,$
7D
1
0
6WDJH,$
7D
1
0
6WDJH,%
7E
7D
1
1
0
0
6WDJH,%
7E
7D
1
1
0
0
6WDJH,,$
7E
7D
1
1
0
0
6WDJH,,$
7E
7D
1
1
0
0
6WDJH,,%
7E
7D
1
1
0
0
6WDJH,,%
7E
7D
1
1
0
0
6WDJH,,&
7E
1
0
6WDJH,,&
7E
1
0
6WDJH,,,
$Q\7
!1
0
,,,$
7±D
7±D
1D
1D
0
0
,,,%
7±E
7±E
7±D
7±D
7±D
1D
1D
1E
1E
1F
0
0
0
0
0
,,,&
7±E
7±E
7±E
$Q\7
1E
1E
1F
1
0
0
0
0
6WDJH,9
$Q\7
$Q\1
0
,9
$Q\7
$Q\1
0
&OLQLFDO VWDJLQJ LQFOXGHV PLFURVWDJLQJ RI WKH SULPDU\ PHODQRPD DQG FOLQLFDOUDGLRORJLF
HYDOXDWLRQIRUPHWDVWDVHV%\FRQYHQWLRQLWVKRXOGEHXVHGDIWHUFRPSOHWHH[FLVLRQRIWKHSULPDU\
PHODQRPDZLWKFOLQLFDODVVHVVPHQWIRUUHJLRQDODQGGLVWDQWPHWDVWDVHV
3DWKRORJLFVWDJLQJLQFOXGHVPLFURVWDJLQJRIWKHSULPDU\PHODQRPDDQGSDWKRORJLFLQIRUPDWLRQ
DERXWWKHUHJLRQDOO\PSKQRGHVDIWHUSDUWLDORUFRPSOHWHO\PSKDGHQHFWRP\3DWKRORJLF6WDJH
RU6WDJH,$SDWLHQWVDUHWKHH[FHSWLRQWKH\GRQRWUHTXLUHSDWKRORJLFHYDOXDWLRQRIWKHLUO\PSK
QRGHV



1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

7FODVVLILFDWLRQV
7FODVVLILFDWLRQ
7KLFNQHVVPP
8OFHUDWLRQ6WDWXV0LWRVHV
7;
3ULPDU\WXPRUFDQQRWEHDVVHVVHG
7
1RHYLGHQFHRISULPDU\WXPRU
7

DZLWKRXWXOFHUDWLRQDQGPLWRVLVPP
EZLWKXOFHUDWLRQRUPLWRVHV!PP
7
±
DZLWKRXWXOFHUDWLRQ
EZLWKXOFHUDWLRQ
7
±
DZLWKRXWXOFHUDWLRQ
EZLWKXOFHUDWLRQ
7
!
DZLWKRXWXOFHUDWLRQ
EZLWKXOFHUDWLRQ

1&ODVVLILFDWLRQV
1FODVVLILFDWLRQ
1XPEHURI0HWDVWDWLF
1RGHV
1RGDO0HWDVWDWLF0DVV
1;
5HJLRQDOQRGHVFDQQRWEHDVVHVVHG
1
1RUHJLRQDOPHWDVWDVHVGHWHFWHG
1
QRGH
DPLFURPHWDVWDVLV
EPDFURPHWDVWDVLV
1
±QRGHV
DPLFURPHWDVWDVLV
EPDFURPHWDVWDVLV
FLQWUDQVLWPHWVVDWHOOLWHVwithoutPHWDVWDWLFQRGHV
1
RUPRUHPHWDVWDWLFQRGHVRUPDWWHGQRGHVRULQWUDQVLWPHWVVDWHOOLWHVZLWK
PHWDVWDWLFQRGHV
0LFURPHWDVWDVHV DUH GLDJQRVHG DIWHU VHQWLQHO O\PSK QRGH ELRSV\ DQG FRPSOHWLRQ
O\PSKDGHQHFWRP\LISHUIRUPHG

0DFURPHWDVWDVHVDUHGHILQHGDVFOLQLFDOO\GHWHFWDEOHQRGDOPHWDVWDVHVFRQILUPHGE\WKHUDSHXWLF
O\PSKDGHQHFWRP\RUZKHQQRGDOPHWDVWDVLVH[KLELWVJURVVH[WUDFDSVXODUH[WHQVLRQ

0&ODVVLILFDWLRQV
0FODVVLILFDWLRQ
6LWH
6HUXP/'+
0
1RGHWHFWDEOHHYLGHQFHRIGLVWDQWPHWDVWDVHV
0D
'LVWDQWVNLQVXEFXWDQHRXVRUQRGDOPHWV
1RUPDO
0E
/XQJPHWDVWDVHV
1RUPDO
0F
$OORWKHUYLVFHUDOPHWDVWDVHV
$Q\GLVWDQWPHWDVWDVLV
1RUPDO
(OHYDWHG


1/*

9HUVLRQ'DWHG
&RQILGHQWLDO

14.2 APPENDIX B:  ECOG Performance Status Criteria.†


(&2*3HUIRUPDQFH
'HVFULSWLRQ


)XOO\DFWLYHDQGDEOHWRFDUU\RQDOOSUHGLVHDVHDFWLYLWLHV
ZLWKRXWUHVWULFWLRQ


5HVWULFWHGLQSK\VLFDOO\VWUHQXRXVDFWLYLW\EXWDPEXODWRU\
DQGDEOHWRFDUU\RXWZRUNRIDOLJKWRUVHGHQWDU\QDWXUH
HJOLJKWKRXVHZRUNRIILFHZRUNHWF


$PEXODWRU\DQGFDSDEOHRIDOOVHOIFDUHEXWXQDEOHWRFDUU\
RXWDQ\ZRUNDFWLYLWLHV8SDQGDERXWPRUHWKDQRI
ZDNLQJKRXUV


&DSDEOHRIRQO\OLPLWHGVHOIFDUHFRQILQHGWREHGRUFKDLU
PRUHWKDQRIZDNLQJKRXUV


&RPSOHWHO\GLVDEOHG&DQQRWFDUU\RQDQ\VHOIFDUH
7RWDOO\FRQILQHGWREHGRUFKDLU


'HDG



2NHQ00&UHHFK5+7RUPH\'&+RUWRQ-'DYLV7(0F)DGGHQ(7&DUERQH
337R[LFLW\$QG5HVSRQVH&ULWHULD2I7KH(DVWHUQ&RRSHUDWLYH2QFRORJ\*URXSAm J 
Clin Oncol



